# Revvity offers comprehensive life science solutions, technologies, and services, covering workflows from discovery to cure.

## About Revvity

-[Our Story](https://www.revvity.com/company/our-story): We’re building on a legacy of innovation and commitment to revolutionizing health science.
-[Our Approach](https://www.revvity.com/company/approach): Together, we’re pushing the limits to bring next-generation solutions to every corner of our world.

## Who We Serve

-[Academia](https://www.revvity.com/who-we-serve/academia): Pioneer groundbreaking discoveries for clinical translation.
-[Pharma / Biotech](https://www.revvity.com/who-we-serve/pharma-biotech): Gain insights into predictive responses with data obtained from humanized model systems.

## Products and Services
 - [LabChip Instruments ](https://www.revvity.com/category/labchip-instruments): Optimize biomolecule analysis with Revvity LabChip™ GX Touch & GXII Touch™ systems. Fast microfluidics capillary electrophoresis technology for automated DNA, RNA, protein, and glycan analysis.
 - [AssayMate liquid handling applications](https://www.revvity.com/category/assaymate-liquid-handling-applications): Transition from manual plate preparation to automated protocols. Improve complex cell counting and screening workflow with the AssayMate liquid handling workstation.
 - [AI-based drug screening: biological validation](https://www.revvity.com/category/ai-based-drug-screening-biological-validation): Bridge AI predictions to biological reality in drug discovery. Explore Revvity’s biological validation solutions for AI-based drug screening.
 - [Viral Vector Center of Excellence](https://www.revvity.com/category/viral-vector-center-excellence): An integrated innovation and production hub advancing viral vector design, engineering, and manufacturing to support developers from early discovery through scalable process development.
 - [plate::handler Connect](https://www.revvity.com/category/platehandler-connect): Overcome manual workflow bottlenecks with the plate::handler™ Connect, a collaborative, four-axis SCARA robotic arm for a compact and cost-effective entry point into automated processing.
 - [Explorer G3 SmartBench automation solutions](https://www.revvity.com/category/explorer-g3-smartbench-automation-solutions): Affordable, scalable laboratory automation with the explorer™ G3 SmartBench workstations, that integrate 150+ instruments with collaborative robotics for seamless workflows.
 - [NGS Accessories](https://www.revvity.com/category/ngs-accessories): Explore NEXTFLEX NGS accessories for indexing, blocking, cleanup, normalization, mRNA enrichment, and targeted depletion in existing workflows.
 - [Drug Screening Transcriptomics](https://www.revvity.com/category/drug-screening-transcriptomics): Explore DRUG-seq and Total DRUG-seq workflows for drug and genetic screening, hit triage, MoA studies, target discovery, and target validation.
 - [Pin-point Base Editing Platform Licensing Options](https://www.revvity.com/category/pin-point-base-editing-platform-licensing-options): Explore the Pin-point™ base editing platform licensing options with discovery license for research or therapeutic license for clinical development.
 - [High-Throughput Cell Engineering](https://www.revvity.com/category/high-throughput-cell-engineering): By automating and miniaturizing electroporation, the DropGenie-Revvity solution enables high-efficiency CRISPR and mRNA delivery with 97% fewer cells than standard techniques.
 - [CRISPR-based RNA depletion](https://www.revvity.com/category/crispr-based-rna-depletion): Improve RNA-seq efficiency with CRISPR-based RNA depletion. Remove rRNA, globin, and mitochondrial transcripts to maximize usable reads and enhance detection of low-abundance genes.
 - [Customer Training](https://www.revvity.com/category/customer-training): Unlock everything your instrument has to offer through training and education! Through education, you will gain knowledge and insights into the latest techniques.
 - [Instrument Service & Maintenance](https://www.revvity.com/category/instrument-service-maintenance): Revvity puts you first. Because your success is entwined with ours, you can be confident your lab is guaranteed top-tier services at unmatched speeds. 
 - [Viral Vector Engineering and Manufacture](https://www.revvity.com/category/viral-vector-engineering-and-manufacture): Revvity provides viral vector engineering and manufacturing services, providing efficient scale-up with quality, cost-effective solutions.
 - [Customization Services](https://www.revvity.com/category/customization-services): We develop. You discover! Extend your lab’s capabilities with our experts in reagent and assay technologies and detection instrumentation
 - [Preclinical Services](https://www.revvity.com/category/preclinical-services): Accelerate drug discovery with Revvity’s comprehensive suite of preclinical CRO services, from target ID to therapeutic asset validation studies
 - [CHOSOURCE Certified Program for CDMOs](https://www.revvity.com/category/chosource-certified-program-cdmos): CHOSOURCE certified program for CDMO licensees provides Revvity attestation of your expertise in using the CHOSOURCE platform to help you stand out.
 - [Antibody Therapeutics Preclinical Services](https://www.revvity.com/category/antibody-therapeutics-preclinical-services): Revvity offers preclinical services for antibody therapeutics, including monoclonal, bispecific, and engineered formats to accelerate drug discovery.
 - [Cellular Internalization Kits and Reagents](https://www.revvity.com/category/cellular-internalization-kits-and-reagents): Cellular internalization kits for antibody trafficking studies. pHSense™ probes and PhenoVue™ reagents for ADC and GPCR research applications.
 - [Omni Homogenizers](https://www.revvity.com/category/sample-homogenization): Omni sample homogenization solutions support critical sample preparation steps, helping ensure consistent, high-quality results for downstream analysis.
 - [Omni Homogenizer Instruments](https://www.revvity.com/category/homogenizers): Omni homogenizers provide a comprehensive selection of solutions tailored to specific applications and laboratory requirements.
 - [Omni Homogenizer Consumables](https://www.revvity.com/category/homogenization-consumables): Omni homogenizer consumables offer a range of options to maximize bead-mill, rotor-stator, and automated sample homogenization workflows.
 - [Bead Mill Accessories](https://www.revvity.com/category/bead-mill-accessories): Omni bead mill tube and well-plate homogenizer accessories, lab sample adapters, cryo-milling jars
 - [Omni Bead Ruptor 96 Accessories](https://www.revvity.com/category/omni-bead-ruptor-96-accessories): Sample homogenization accessories for Omni Bead Ruptor 96 well plate homogenizer
 - [Omni Bead Ruptor Elite Accessories](https://www.revvity.com/category/omni-bead-ruptor-elite-accessories): Sample homogenization accessories for Omni Bead Ruptor Elite bead mill homogenizer.
 - [Generator probes](https://www.revvity.com/category/generator-probes): Explore our generator probes, including stainless steel, Omni Tip hybrid, and plastic options, optimized for performance with rotor stator-based homogenizers.
 - [Bead Mill Consumables](https://www.revvity.com/category/bead-mill-consumables): Revvity offers reliable and durable Omni bead mixes for your bead mill sample homogenization.
 - [Bulk caps, tubes, and well-plate consumables ](https://www.revvity.com/category/bulk-caps-tubes-and-well-plate-consumables): Bulk caps, tubes, and well-plate consumables to be used with automated homogenizers, bead mill homogenizers, rotor-stator homogenizers, or other applications
 - [Rotor Stator Consumables](https://www.revvity.com/category/rotor-stator-homogenizer-consumables): High-shear handheld rotor-stators and tabletop mixer homogenizer consumables for various lab applications, including plastic probes and tubes
 - [Rotor Stator Accessories](https://www.revvity.com/category/rotor-stator-accessories): High-shear handheld rotor-stators and tabletop mixer homogenizers for various lab applications requiring robust sample homogenization.
 - [Bead Mill Homogenizers](https://www.revvity.com/category/bead-mill-homogenizers): Omni bead mill homogenizers deliver reliable, consistent sample processing across a wide range of sample types.
 - [Rotor Stator Homogenizers](https://www.revvity.com/category/rotor-stator-homogenizers): Omni rotor stator homogenizers include high-shear handheld and large-volume solutions for diverse laboratory applications.
 - [Magnetic-bead based OEM solutions](https://www.revvity.com/category/magnetic-bead-based-oem-solutions): Accelerate your genetic workflow with Revvity's nucleic acid prep OEM solutions. Custom magnetic beads, reagents for nucleic acid extraction, and automation.
 - [Reference Standards](https://www.revvity.com/category/reference-standards): Explore Revvity’s range of reference standards and controls to support the verification and monitoring of your assays and workflows.
 - [IncRNA in Functional Studies](https://www.revvity.com/category/incrna-functional-studies): Learn about Revvity’s solutions designed to elucidate the roles of lncRNA and to profile lncRNA expression levels, ensuring robust and reliable results required for functional genomic studies.
 - [PhenoVue Antibody Internalization Kits and Reagents](https://www.revvity.com/category/phenovue-internalization-kits-and-reagents): PhenoVue cellular imaging reagents for visualization of antibody internalization, plus lysosomal stains, live-cell tubulin stains, antibody isotype controls.
 - [AssayMate Workstations](https://www.revvity.com/category/assaymate-workstations): The AssayMate workstation is a benchtop-size, automated liquid handler. It is an intelligent pipetting robot designed for a wide range of laboratory applications. Featuring technologies such as collision detection, error handling, and real-time protocol visualization, its software uses an intuitive drag-and-drop interface for easier protocol building.
 - [AAV Reference Standards](https://www.revvity.com/category/aav-reference-standards): Revvity’s AAV reference standards are fully characterized, quality materials for confidence in the reproducibility of your assays.
 - [Bioprocessing](https://www.revvity.com/category/bioprocessing): Helping you overcome upstream bioprocessing challenges with innovative solutions for antibody production and cell & gene therapy development.
 - [PhenoVue Ready-to-Use Kits](https://www.revvity.com/category/phenovue-ready-use-kits): Pre-configured kits for high-content imaging applications inc. cell painting, DNA damage, autophagy, neuronal, microglia & astrocyte differentiation kits.
 - [Small RNA Sequencing Library Prep Kits](https://www.revvity.com/category/small-rna-sequencing-library-prep-kits): Explore NEXTFLEX small RNA-seq kits, blockers, spike-in controls, and Ribo-seq tools for miRNA, piRNA, tRNA, and Y-RNA fragment analysis.
 - [ViaCord Cord Blood & Cord Tissue Banking](https://www.revvity.com/category/viacord-cord-blood-cord-tissue-banking): ViaCord provides private cord blood & tissue banking services in the US, as well as genetic testing for a proactive and informed approach to health.
 - [Revvity Omics Services](https://www.revvity.com/category/revvity-omics-services): A global leader in omics testing, Revvity Omics provides a comprehensive array of clinical and pharma services to support research and diagnosis in rare and common diseases.
 - [Reproductive Health Data Management](https://www.revvity.com/category/reproductive-health-data-management): Revvity's reproductive health software solutions optimize laboratory efficiency, streamline workflows, and enhance data management
 - [AAV Production Platform](https://www.revvity.com/category/aav-production-platform): Are you struggling to find a scalable suspension-adapted producer line? Wrestling with problematic payloads? Low production yields? Or a high proportion of empty vectors?
 - [Flow Cytometry Cocktail Prep Automation](https://www.revvity.com/category/flow-cytometry-cocktail-prep-automation): Flow Cytometry Cocktail Prep automated with Fontus liquid handler or FlexDrop Plus dispenser for precise antibody cocktail preparation enables reliable, reproducible data in this cellular analysis technique.
 - [pHSense Reagents](https://www.revvity.com/category/phsense-reagents): Discover a powerful new plate reader tool specifically designed for cell surface target internalization studies for ADC and GPCR research.
 - [WGS library prep kits](https://www.revvity.com/category/wgs-library-prep-kits): Explore NEXTFLEX WGS library prep kits for whole genome sequencing, including genomic DNA, cfDNA, shotgun metagenomics, and low-pass agrigenomics.
 - [RNA sequencing library prep kits](https://www.revvity.com/category/rna-sequencing-library-prep-kits): Explore Revvity’s comprehensive RNA sequencing library prep kits & methods for accurate transcriptome analysis, including non-coding RNAs and gene expression.
 - [Metagenomics](https://www.revvity.com/category/metagenomics): Explore Revvity metagenomics workflow solutions for 16S amplicon sequencing, shotgun metagenomics, metatranscriptomics, sample prep, library prep, automation, QC, and analysis.
 - [Revvity Genomics Software](https://www.revvity.com/category/revvity-genomics-software): Simplify genomic analysis with Revvity Genomics Software - a modular, cloud-based suite designed for newborn screening and genomic laboratories that transforms complex data into actionable insights.
 - [Bacterial & Viral Nucleic Acid Isolation](https://www.revvity.com/category/bacterial-viral-nucleic-acid-isolation): Discover our automated solutions for viral and microbial nucleic acid purification. Streamline your lab processes, increase efficiency, and achieve reliable results with our purification systems.
 - [Cancer Genome Research](https://www.revvity.com/category/cancer-genome-research): Tackle cfDNA, ctDNA, and liquid biopsy research challenges with Revvity's automated cancer genomics workflows - from extraction to library prep. Scalable and reliable.
 - [Single-Cell Sequencing](https://www.revvity.com/category/single-cell-sequencing): Single-cell analysis identifies information often overlooked by bulk approaches. Revvity offers solutions for key steps in the single cell sequencing workflow.
 - [Plate Reader Accessories](https://www.revvity.com/category/plate-reader-accessories): Discover Revvity's comprehensive range of multimode plate reader accessories, engineered for seamless integration and reliable performance. Your complete source for high-quality multimode detection solutions.
 - [MASLD, MASH, and Fibrosis Research Reagents](https://www.revvity.com/category/masld-mash-and-fibrosis-research-reagents): Explore Revvity’s ready-to-use assays and resources for studying MASLD, MASH, and liver fibrosis. Learn about key biomarkers, signaling pathways, and case studies supporting liver disease research and drug discovery.
 - [Proactive Testing](https://www.revvity.com/category/proactive-testing): Integrate proactive genomic testing into clinical care. Identify genetic predispositions early to deliver precision medicine and improve patient outcomes.
 - [Type 1 Diabetes Early Detection](https://www.revvity.com/category/type-1-diabetes-early-detection): The T1D Screening program is an autoantibody testing program designed to help clinicians identify individuals at risk of or in the early stages of Type 1 Diabetes (T1D).
 - [Proactive Whole Exome Sequencing](https://www.revvity.com/category/proactive-whole-exome-sequencing): Explore proactive prenatal whole exome sequencing for early detection of genetic conditions, aiding healthcare providers and families in making informed decisions regarding medical management during pregnancy.
 - [Proactive Whole Genome Sequencing ](https://www.revvity.com/category/proactive-whole-genome-sequencing): Discover how proactive WGS supports early diagnosis, personalized care, and better outcomes for families and clinicians.
 - [Pain and Cerebrovascular Panel](https://www.revvity.com/category/pain-and-cerebrovascular-panel): This panel tests for some genes associated with both common and complex neuropathies.
 - [Interstitial Lung Disease Panel](https://www.revvity.com/category/interstitial-lung-disease-panel): Multigene panel with glucocerebrosidase enzyme in parallel.
 - [Immunoassays Solutions](https://www.revvity.com/category/immunoassays-solutions): Revvity's all-in-one immunoassay solutions span traditional ELISAs to next-gen no-wash methods, with integrated instrumentation, consumables, software, and automation to accelerate your research workflow.
 - [NEXTFLEX Quality Assurance](https://www.revvity.com/category/nextflex-quality-assurance): Explore Revvity's ISO 9001-certified production of NEXTFLEX® NGS library preparation kits. Our dedicated QA team ensures transparency, traceability, and consistent product performance.
 - [NEXTFLEX Tech Support](https://www.revvity.com/category/nextflex-tech-support): Connect with Revvity's expert scientists for personalized support on NGS library prep reagents. Access guidance on experimental design, protocol optimization, and data interpretation.
 - [IVISense Fluorescent Cell Labeling Dyes](https://www.revvity.com/category/ivisense-fluorescent-cell-labeling-dyes): Label and track mammalian cells in vivo using IVISense™ fluorescent cell labeling dyes.
 - [Next-Generation Biologics](https://www.revvity.com/category/next-generation-biologics): Offering solutions to help develop and characterize next-generation biologics including multi-specific antibodies, RNA therapeutics and vaccines
 - [Biomarker Discovery](https://www.revvity.com/category/biomarker-discovery): Explore our multiplex and multi-omic biomarker discovery assays and identification solutions to uncover molecular signatures of diseases across diverse samples.
 - [miRNA Analysis](https://www.revvity.com/category/mirna-analysis): Discover efficient microRNA purification with chemagic miRNA kits. High-throughput extraction from 200µl or 1ml inputs, minimal hands-on time, and reliable performance for cancer and metabolic disease research.
 - [Host Cell Contamination Detection Solutions](https://www.revvity.com/category/host-cell-contamination-detection-solutions): Attain biopharmaceutical product purity with advanced host cell contamination detection solutions including residual DNA and protein assays.
 - [Cell Signaling Research Reagents](https://www.revvity.com/category/cell-signaling-research-reagents): Revvity's HTRF and AlphaLISA SureFire Ultra technologies support your cell signaling and intracellular phosphorylated proteins research, offering a streamlined and efficient approach to pathway analysis.
 - [Circulating cell-free DNA](https://www.revvity.com/category/circulating-cell-free-dna): High yields with chemagic automated or manual purification of circulating cell free DNA
 - [IVD Automated Liquid Handling](https://www.revvity.com/category/ivd-automated-liquid-handling): Enhance your clinical laboratory efficiency with our cutting-edge automated liquid handling solutions. Our customizable workstations, designed for a wide range of clinical applications, minimize human error, reduce hands-on time, and increase sample throughput.
 - [Library Prep OEM](https://www.revvity.com/category/library-prep-oem): Accelerate your time to market with OEM and custom NGS library prep solutions from Revvity. Collaborate with our experts for flexible, reliable, and innovative products that streamline workflows and deliver reproducible results.
 - [Automated HMW DNA Extraction](https://www.revvity.com/category/automated-hmw-dna-extraction): Discover the chemagic products for HMW DNA isolation from blood samples and the easy realization of your automated workflow.
 - [Genetic Testing](https://www.revvity.com/category/genetic-testing): Discover chemagic automated DNA and RNA isolation solutions for genetic testing. High-quality nucleic acids, flexible workflows for diverse human sample materials for clinical and research applications.
 - [Autoimmune Type 1 Diabetes Early Detection Program](https://www.revvity.com/category/autoimmune-type-1-diabetes-early-detection-program): The UncoverT1D Early Detection Program provides comprehensive testing to detect autoantibodies that may indicate early stages of autoimmune type 1 diabetes (T1D). The screening program is sponsored by Sanofi, with testing services provided by Revvity Omics. The testing can be ordered by health care professionals for eligible individuals living in Canada. The program addresses a critical need for comprehensive and reliable screening in the autoimmune T1D space in Canada.
 - [chemagic IVD Kits](https://www.revvity.com/category/chemagic-ivd-kits): Discover Revvity's chemagic IVD Kits: IVDR-compliant nucleic acid purification solutions for clinical diagnostics. High-yield, versatile extraction from multiple sample types. Designed for automation and superior DNA integrity.
 - [Low-pass WGS and Imputation Analysis](https://www.revvity.com/category/low-pass-wgs-and-imputation-analysis): Explore low-pass WGS and imputation analysis solutions for plant and animal breeding research, from sample prep and DNA extraction to library prep, automation, and analysis.
 - [Specialized and Customized Assays](https://www.revvity.com/category/specialized-and-customized-assays): At Revvity Omics, we pride ourselves on our ability to develop a wide range of specialized assays that cater to the unique needs of the scientific community. Our expertise spans from biomarker discovery to clinical diagnostic next-generation sequencing (NGS) assays, ensuring that we can support your research at every stage.
 - [chemagic IVD Instruments](https://www.revvity.com/category/chemagic-ivd-instruments): Discover IVDR compliant chemagic instruments for automated nucleic acid isolation. Flexible, high-performance solutions for clinical diagnostic labs.
 - [Quality Assurance and Control for Safe and Effective Therapy](https://www.revvity.com/category/quality-assurance-and-control-for-safe-and-effective-therapy): Ensure cell and gene therapy safety and efficacy with Revvity’s quality control and assurance solutions. Discover LabChip, AlphaLISA, and nucleic acid tools.
 - [Scale-up and Manufacturing](https://www.revvity.com/category/scale-up-and-manufacturing): Scale up cell and gene therapy manufacturing with Revvity’s automation tools, vector development platforms and GMP-compliant solutions for efficient production.
 - [Pre-clinical Development Solutions](https://www.revvity.com/category/pre-clinical-development-solutions): Advance your gene therapy research with Revvity’s pre-clinical development solutions - tools for imaging, cell counting, organoids, and assay development.
 - [Therapeutic Payload and Delivery Solutions](https://www.revvity.com/category/therapeutic-payload-and-delivery-solutions): Unlock therapeutic payload delivery solutions with Revvity. From CRISPR and base editing to viral vectors and CAR-T, optimize delivery for safe, precise gene therapy.
 - [Discovery and Lead Optimization](https://www.revvity.com/category/discovery-and-lead-optimization): Accelerate lead optimization and target discovery in gene therapy with Revvity’s cutting-edge tools - CRISPR libraries, Pin-point base editing, and validated assays.
 - [Development Stages in Cell and Gene Therapy](https://www.revvity.com/category/development-stages-in-cell-and-gene-therapy): Explore the full CGT development process with Revvity - tools and technologies supporting every stage, from discovery and delivery to manufacturing and QA/QC.
 - [Cell Therapy Solutions](https://www.revvity.com/category/cell-therapy-solutions): Explore Revvity’s cell therapy solutions with non-genetic tools, cell viability support, and scalable technologies for development and manufacturing.
 - [Ex Vivo Gene Therapy Solutions](https://www.revvity.com/category/ex-vivo-gene-therapy-solutions): Explore Revvity’s ex vivo gene therapy tools and solutions for gene-modified cell therapies—supporting vector development, cell processing, and analysis
 - [Oxford Diagnostic Laboratories Service Closures ](https://www.revvity.com/category/oxford-diagnostic-laboratories-service-closures): Learn about Oxford Diagnostic Laboratories' service closures due to bank holidays and plan your sample collection accordingly.
 - [Multiomics and TotalSeq Reagents by BioLegend](https://www.revvity.com/category/multiomics-and-totalseq-reagents-by-biolegend): Multiomics provides unparalleled protein and genetic analysis. Explore how our TotalSeq™ reagents can be integrated into your existing workflows and expand your capabilities.
 - [Automate the T-SPOT.TB workflow](https://www.revvity.com/category/automate-t-spottb-workflow): Streamline the T-SPOT.TB workflow with customizable, scalable automation solutions for enhanced efficiency and optimized hands-on time.
 - [Cytomegalovirus](https://www.revvity.com/category/cytomegalovirus): Explore the role of T cells in CMV immunity and disease management, highlighting the T-SPOT.CMV test and the benefits of ELISPOT assays.
 - [In Vivo Gene Therapy Solutions](https://www.revvity.com/category/in-vivo-gene-therapy-solutions): Explore Revvity’s in vivo gene therapy solutions - designed to enhance delivery precision, vector design, and therapeutic development for advanced gene therapies.
 - [Complex Cell Model Screening Services](https://www.revvity.com/category/complex-models-services): Explore Revvity's complex cell model screening services, offering services for advanced 3D tumor models and immune cell co-cultures for enhanced therapeutic research.
 - [Cytotoxicity and Cell Proliferation Assays](https://www.revvity.com/category/cytotoxicity-and-cell-proliferation-assays): Explore cytotoxicity and cell proliferation assays for measuring cell growth, viability, and drug response. Discover ATP-based assay solutions.
 - [Reporter Gene Luminescence Assays ](https://www.revvity.com/category/reporter-gene-assays): Reporter gene assays enable high sensitivity measurement of gene expression and cell signaling through the addition of bioluminescent genes into target cells.
 - [Gene Delivery Licensing](https://www.revvity.com/category/gene-delivery-licensing): Revvity's gene delivery team, where SIRION Biotech's expertise live on, partners with clients in gene and cell therapy to support their path to market success.
 - [Lentivirus Services](https://www.revvity.com/category/lentivirus-services): Revvity offers lentivirus services, including lentiviral vector manufacturing and production, with optimized processes and quality control for research and discovery.
 - [Ad19a Adenoviral Vector Manufacturing](https://www.revvity.com/category/ad19a-adenoviral-vector-manufacturing): Explore advanced adenoviral vector technology for gene therapy and vaccines, featuring enhanced cell transduction and robust immune response.
 - [LentiBOOST Transduction Enhancer](https://www.revvity.com/category/lentiboost-transduction-enhancer): Using the LentiBOOST™ lentivirus transduction enhancer, improve transduction without impacting cell health across various cell types, including T-cells and HSCs.
 - [Lentivirus](https://www.revvity.com/category/lentivirus): We specialize in the development and manufacturing of lentivirus vectors, providing quality lentiviral vectors to support advanced cell therapy solutions.
 - [Adenovirus](https://www.revvity.com/category/adenovirus): Explore Revvity Gene Delivery 's advanced adenoviral vectors for effective gene therapy, vaccinations, and cancer treatment with high efficacy.
 - [AAV](https://www.revvity.com/category/aav-capsid-development): Collaborate with Revvity’s gene delivery team to benefit from many years of experience and innovation in AAV capsid engineering and development.
 - [Viral Vector Products](https://www.revvity.com/category/viral-vector-products): Explore versatile viral vectors for gene therapy, including AAV, LV, and AV, ideal for a range of applications in research and clinical trials.
 - [Stem Cells](https://www.revvity.com/category/stem-cells): Research with confidence using our CD34+ stem cells from human umbilical cord blood, frozen and ready to use. <p>Your research deserves a reliable source of high-quality stem cells to support it.</p>
 - [AV Services](https://www.revvity.com/category/av-services): Supporting Adenoviral Vector Development for Gene Therapy and Vaccine Research Adenoviral vectors offer high levels of transgene expression in broad cell types, including both dividing and non-dividing cells.
 - [Cell and Gene Therapy Research Reagents](https://www.revvity.com/category/cell-and-gene-therapy-research-reagents): At Revvity, we provide a range of discovery and bioanalytical immunoassays for the development of cell and gene therapies
 - [AAV Services](https://www.revvity.com/category/aav-services): Revvity offers a comprehensive suite of services for AAV vector generation.
 - [GMP Workflows](https://www.revvity.com/category/gmp-workflows): GMP workflow applications and solutions for large molecule biotherapeutics and cell and gene therapy
 - [AlphaLISA SureFire Ultra](https://www.revvity.com/category/alphalisa-surefire-ultra): AlphaLISA® SureFire® Ultra™ is a homogeneous, no-wash assay platform designed for the sensitive detection of endogenous and tagged phosphorylated or non-phosphorylated proteins in cell lysates.
 - [High Content Screening Instruments](https://www.revvity.com/category/high-content-screening-instruments): High content screening instruments or high content imaging systems measures multi-parametric data at the single-cell level using high-throughput imaging and analysis.
 - [Newborn Screening](https://www.revvity.com/category/newborn-screening): As the global leader in newborn screening, over 700 million babies have been screened with Revvity products over the last 25 years.
 - [Maternal and Prenatal Testing](https://www.revvity.com/category/maternal-and-prenatal-testing): As the global leader in prenatal screening, Revvity offers laboratories and clinics complete solutions for Maternal & Fetal health screening.
 - [PhenoVue Cell Health Reagents](https://www.revvity.com/category/phenovue-cell-function-reagents-and-kits): PhenoVue Cell Function Reagents and Kits for visualizing key cellular events
 - [Radiometric Consumables & Accessories ](https://www.revvity.com/category/radiometric-consumables-accessories): Revvity offers consumables and accessories for radiometric detection designed to work together with our instruments and radiochemicals for high-quality results.
 - [Assay Development Workflows ](https://www.revvity.com/category/assay-development-workflows): Optimize your assay development with Revvity's workflows, enhancing efficiency and accuracy in scientific research and analysis.
 - [Functional Genomic Screening Solutions](https://www.revvity.com/category/functional-genomic-screening-solutions): Optimize CRISPR workflows with Revvity's automation & analysis tools, streamlining gene editing and modulation for innovative drug discovery.
 - [Precision Medicine Research](https://www.revvity.com/category/precision-medicine): Discover advanced precision medicine research solutions at Revvity, empowering groundbreaking research and innovations in precision medicine.
 - [Drug Development ](https://www.revvity.com/category/drug-development): Streamline your drug development process with Revvity’s end-to-end solutions, for faster market entry.
 - [Target Class ](https://www.revvity.com/category/target-class): Revvity offers high-throughput screening assays for target specific needs to detect biomarkers, cytokines, protein interactions, GPCRs, kinases, and more.
 - [Disease Research ](https://www.revvity.com/category/disease-research): Our solutions provide deeper insights and enable interactions between cell types and organ systems that may lead to the development of future breakthroughs in prevention, early detection, and treatment of diseases.
 - [Small Molecule Drug Discovery](https://www.revvity.com/category/small-molecule-drug-discovery): Accelerate drug discovery with Revvity: from target selection to lead optimization. Explore advanced screening and analysis tools.
 - [Biologics ](https://www.revvity.com/category/biologics): Empowering scientists with tools to develop and streamline their biologics workflow to help accelerate progress towards breakthrough discoveries
 - [Cell and Gene Therapy](https://www.revvity.com/category/cell-and-gene-therapy): Discover advanced cell and gene therapy solutions at Revvity—tools for gene editing, vector design, and scalable manufacturing.
 - [NGS/PCR cfDNA Solutions](https://www.revvity.com/category/ngspcr-cfdna-solutions): Learn more about Revvity´s PCR and NGS workflows for cfDNA analysis.
 - [Vanadis cfDNA Platform](https://www.revvity.com/category/vanadis-cfdna-platform): Our Vanadis cfDNA analysis system with no PCR enables cost-efficient cell-free DNA analysis using rolling-circle replication technology
 - [Cell-free DNA Analysis](https://www.revvity.com/category/cell-free-dna-analysis): Offering end-to-end cell-free DNA solutions or individual components to enhance your current workflow, Revvity is making cfDNA analysis accessible to all labs.
 - [Transfer Membranes](https://www.revvity.com/category/transfer-membranes): Transfer membranes for northern, southern, and western blotting.
 - [Radioactive Spill Cleaners](https://www.revvity.com/category/radioactive-spill-cleaners): Laboratory decontaminants and cleaners.
 - [In Vivo Imaging Accessories](https://www.revvity.com/category/in-vivo-imaging-accessories): Expand functionality of your IVIS® optical. Quantum micriCT and Vega ultrasound imaging systems with wide range of accessories
 - [Cassettes](https://www.revvity.com/category/cassettes): We offer a full line of high-quality microplate assay cassette products for our radiometric detectors, including cassettes for 24-, 96- and 384-well plates.
 - [Sample Sonication](https://www.revvity.com/category/sample-sonication): For many labs, sample preparation workflows tend to include some type of tissue or cell lysis technology to permit access to nucleic acids or protein, among other biological and chemical analytes, within a cell or tissue.
 - [Sample Centrifugation](https://www.revvity.com/category/sample-centrifugation): Within a molecular biology lab, one could argue that a centrifuge is one of the most critical components to a laboratory workflow and numerous protocols in basic cell biology.
 - [Omni Homogenizer Accessories](https://www.revvity.com/category/homogenizer-accessories): Omni homogenizer accessories support optimal sample preparation, a critical component for successful downstream multi-omic and molecular analysis.
 - [In Vivo Imaging](https://www.revvity.com/category/in-vivo-imaging): Preclinical imaging systems for small animal imaging to accelerate your drug discovery & development projects.
 - [Microfluidic Protein Characterization ](https://www.revvity.com/category/microfluidic-protein-characterization): Microfluidic Protein Characterization
 - [Integrated Automated Workflows](https://www.revvity.com/category/integrated-automated-workflows): By adopting automated workflows, laboratories can effectively improve their scientific output by reducing manual labor and associated risks and allow for samples to be treated with consistency.
 - [Scheduling & Control Software](https://www.revvity.com/category/scheduling-control-software): Increase workflow efficiency and throughput with Plate::Works™, a flexible no-code scheduling & control platform for workflow orchestration, simulation, and reliable 24/7 automation.
 - [Automated Plate Loading](https://www.revvity.com/category/automated-plate-loading): Increase the throughout, flexibility, and walkaway time of your imaging and cell counting workflows with robotic plate loading automation.
 - [Liquid Handling Consumables & Accessories](https://www.revvity.com/category/liquid-handling-consumables-accessories): For research or discovery workflows, Revvity offers high-quality consumables to support liquid handling needs, pipette tips microplates reagent troughs library prep kits.
 - [Automated Liquid Handling Applications](https://www.revvity.com/category/automated-liquid-handling-applications): Revvity has a wide library of automated liquid handling applications, such as NGS library prep including workflows for: DNA, RNA, target capture and metagenomics, extraction, PCR, protein, drug discovery, blood fractionation and more.
 - [Liquid Handling Workstations](https://www.revvity.com/category/liquid-handling-workstations): Customizable liquid handlers to automate common to complex lab workflows enabling you to minimize errors, increase walkaway time, throughput, reproducibility.
 - [Liquid Scintillation Cocktails](https://www.revvity.com/category/liquid-scintillation-cocktails): Liquid scintillation cocktails for liquid scintillation counting and radiometic detection.
 - [Radiochemicals](https://www.revvity.com/category/radiochemicals): We are the leading supplier of radiochemicals in a wide range of fields, from drug discovery to plant sciences.
 - [Cell Harvesters](https://www.revvity.com/category/cell-harvesters): Cell harvesters for harvesting cells and membranes from microplates using an automated vacuum manifold/washer.
 - [Radiometric Detectors](https://www.revvity.com/category/radiometric-detectors): Revvity has been a leading supplier of radiation detection instruments, liquid scintillation cocktails, vials and radiometric assays.
 - [Cell Health & Viability](https://www.revvity.com/category/cell-health-viability): Explore advanced cell viability assays and cell health solutions to monitor cell health and viability accurately and support essential research needs.
 - [Western Blotting](https://www.revvity.com/category/western-blotting): Explore the wide range of western blot detection reagents from Revvity. Find the right western blotting reagents for the detection and quantitation of proteins and nucleic acids.
 - [Microplates for Radiometric assays](https://www.revvity.com/category/microplates-for-radiometric-assays): Microplates for radiometric assays.
 - [Microplates for Genomic Analysis](https://www.revvity.com/category/microplates-for-genomic-analysis): High quality microplates and consumables engineered specifically for NGS applications.
 - [Microplates for Cell Culture](https://www.revvity.com/category/microplates-for-cell-culture): Cell culture microplates designed for cell growth, imaging, & assays. Supports 3D cell culture plates, PDL coated plates, ULA-coated plates, TC-treated & more.
 - [Microplates for Assays](https://www.revvity.com/category/microplates-for-assays): Microplates designed to give optimal performance of your fluorescence, luminescence, and absorbance-based assays.
 - [Microplates for Storage](https://www.revvity.com/category/microplates-for-storage): Microplates designed to keep your samples and compound safe.
 - [Microplates](https://www.revvity.com/category/microplates): Explore Revvity microplates in various well formats, materials, and coatings-engineered for assay performance and compatibility with leading instruments.
 - [Microplate Readers](https://www.revvity.com/category/microplate-readers): Multimode microplate reader equipped with latest detections like fluorescence, absorbance etc. to meet all your research needs.
 - [LANCE](https://www.revvity.com/category/lance-tr-fret-assays): Explore LANCE Ultra TR-FRET assays for biomarker, cAMP/GPCR, kinase, and epigenetic studies with reliable, time-saving TR-FRET technology.
 - [HTRF](https://www.revvity.com/category/htrf): HTRF technology performs as cellular or biochemical assays in competitive and non-competitive formats.
 - [DELFIA](https://www.revvity.com/category/delfia-trf-assays): By combining the benefits of TRF with the use of lanthanide chelates, DELFIA offers multiple advantages over standard fluorometric detection.
 - [Alpha Assays](https://www.revvity.com/category/alpha-assays): Measure quickly and easily with Alpha homogeneous assay bead-based technology, an alternative to ELISA reagents.
 - [Immunoassays](https://www.revvity.com/category/immunoassays): Discover our range of immunoassay technologies, including high-quality reagents and kits that enable the selection of optimal platforms for your requirements.
 - [Microfluidic Nucleic Acid Analysis](https://www.revvity.com/category/microfluidic-nucleic-acid-analysis): Analyze your DNA, RNA, and NGS libraries in seconds with scalable microfluidic capillary electrophoresis (micro-CE) technology.
 - [Library Prep Kits](https://www.revvity.com/category/library-prep-kits): Explore NEXTFLEX NGS library prep kits for Illumina and Element AVITI workflows, including DNA-seq, RNA-seq, small RNA-seq, and accessories.
 - [NGS Workflows](https://www.revvity.com/category/ngs-workflows): Learn how you can improve your lab’s productivity with Revvity’s complete library prep workflows.
 - [Tuberculosis Management](https://www.revvity.com/category/tuberculosis-management): Learn about TB, its impact, and the importance of accurately detecting latent infections using advanced IGRA tests for effective TB management.
 - [Consumables & Accessories](https://www.revvity.com/category/consumables-accessories): Revvity offers a range of consumables and accessories for Life Sciences designed to work together with our instruments and reagents.
 - [Capillary Electrophoresis Analysis](https://www.revvity.com/category/capillary-electrophoresis-analysis): Now you can separate, identify, and characterize AAV proteins, mAb, DNA, RNA, cfDNA and NGS libraries in seconds and visualize your data in multiple reporting formats.
 - [Nucleic Acid Purification](https://www.revvity.com/category/nucleic-acid-purification): Learn more about Revvity´s solutions for (automated) nucleic acid isolation from diverse sample materials based on the unique chemagic™ technology.
 - [Automated Supplementary Applications & Protocols](https://www.revvity.com/category/automated-supplementary-applications-protocols): Supplementary Applications & Protocols. Automated on Revvity liquid handlers, these methods streamline processes, making them efficient and reproducible. NGS sequencing.
 - [Automated Small RNA Library Prep Kits](https://www.revvity.com/category/automated-methods-small-rna-library-prep-kits): Small RNA sequencing (smRNA-Seq) is a powerful technique used to identify and quantify these small RNA molecules (microRNAs, piRNAs and snoRNAs). Automated on Revvity liquid handlers, these kits streamline the process, making it efficient and reproducible. NGS sequencing.
 - [Automated Metagenomics Library Prep Kits](https://www.revvity.com/category/automated-methods-metagenomics-library-prep-kits): Metagenomics library prep kits are essential tools in modern microbiology research. Automated on Revvity liquid handlers, these kits streamline the process, making it efficient and reproducible. NGS sequencing.
 - [Microplates for Cell imaging ](https://www.revvity.com/category/microplates-for-cell-imaging): Top quality Imaging microplates for high-content imaging to complete your research and accelerate your drug discovery.
 - [Cellular Imaging Software](https://www.revvity.com/category/cellular-imaging-software): Revvity offers sophisticated cellular imaging and analysis software to help you acquire, visualize, analyze and share your image data more effectively and efficiently, so you can spend more time discovering.
 - [Automated Exome & Targeted Sequencing Kits](https://www.revvity.com/category/automated-methods-exome-targeted-sequencing-kits): Automated Exome and Targeted Sequencing Kits, sample prep, liquid handling workstation, bioprocessing, liquid handler, sequencing, NGS, vendor-qualified methods, applications, cancer research
 - [chemagic Instruments](https://www.revvity.com/category/chemagic-instruments): Discover chemagic instruments for automated DNA and RNA extraction, offering flexible, high-throughput nucleic acid purification for research labs.
 - [chemagic Kits](https://www.revvity.com/category/chemagic-kits): Realize your reliable nucleic acid extraction workflow with chemagic kits on chemagic instruments and learn how easy automation can be!
 - [chemagic Applications](https://www.revvity.com/category/chemagic-applications): Discover which automated DNA7RNA extraction workflows you can realize with chemagic Technology.
 - [Pin-point base editing platform cell line engineering services](https://www.revvity.com/category/pin-point-base-editing-platform-cell-line-engineering-services): Pin-point Base Editing Platform Cell Line Engineering Services for rapid, precise gene targeting with base editing for customizable cell models.
 - [Pin-point base editing platform pooled tiled screening services](https://www.revvity.com/category/pin-point-base-editing-platform-pooled-tiled-screening-services): Leverage Pin-point™ Base Editing services for pooled tiled screening, allowing precise single-base edits, functional genomic analysis, & mutation identification.
 - [NGS Barcode Adapters](https://www.revvity.com/category/ngs-barcode-adapters): Compare NEXTFLEX™ UDI and UDI-UMI barcode adapters for Illumina® and Element® workflows, including options for multiplexing and molecule-level tracking.
 - [Antibody Drug Conjugate Services](https://www.revvity.com/category/antibody-drug-conjugate-services): Antibody Drug Conjugate Services for ADC development, including preclinical screening, optimization, and resistance research for oncology therapeutics.
 - [Reagents for Receptor Binding](https://www.revvity.com/category/reagents-receptor-binding): Tag-lite demonstrates its effectiveness in the lab, taking the lead over traditional SPA and radioligand binding assays.
 - [Reagents for Deciphering the Interactome](https://www.revvity.com/category/reagents-deciphering-interactome): Understanding and modulating protein-protein interactions a challenge in the discovery of innovative drugs. Discover immunoassays to help.
 - [Obesity, Diabetes and Metabolic Disease Reagents](https://www.revvity.com/category/obesity-diabetes-metabolic-disease-reagents): At Revvity, we are committed to providing homogeneous time- and sample-saving solutions to advance research on diabetes and metabolic disorders.
 - [Reagents for Fibrosis Research](https://www.revvity.com/category/reagents-fibrosis-research): Discover a wide range of documents with educational content and reagents dedicated to help with your fibrosis research.
 - [Biologics Screening and Characterization Assays ](https://www.revvity.com/category/biologics-screening-and-characterization-assays): Discover comprehensive reagents for biologics screening, mechanism-of-action studies, and biomanufacturing, using no-wash technologies.
 - [Autoimmune Disease Research Reagents](https://www.revvity.com/category/autoimmune-disease-research-reagents): Explore pathways, content, and immunoassays designed to further your autoimmune disease drug discovery research.
 - [Neonatal Research](https://www.revvity.com/category/neonatal-research): Revvity has a variety of solutions to power your neonatal research from molecular instrumentation, sample collection and kits.
 - [3D Cell Model Imaging and Analysis](https://www.revvity.com/category/3d-cell-model-imaging-and-analysis): Advanced 3D cell culture imaging systems optimized for 3D cellular models. High-performance cell culture imaging solutions for accurate 3D cell imaging applications.
 - [Cellular Imaging Reagents](https://www.revvity.com/category/cellular-imaging-reagents): Cell imaging reagents to complement your HCS instruments and image analysis software across the cellular imaging workflow.
 - [Cellular Imaging Applications](https://www.revvity.com/category/cellular-imaging-applications): Explore our cell imaging application solutions like live-cell imaging and high-throughput screening solutions that can benefit your research.
 - [Cellular Imaging & Analysis](https://www.revvity.com/category/cellular-imaging-analysis): Cell Imaging Systems designed to accurately capture vital information in cell-based assays during life science research.
 - [16S rRNA Library Prep Solutions](https://www.revvity.com/category/16s-rrna-library-prep-solutions): Compare NEXTFLEX™ 16S rRNA Amplicon-Seq kits for V1-V3, V3-V4, and V4 microbial community profiling, with low-input, multiplexed workflows.
 - [Transfection and Ancillary Reagents](https://www.revvity.com/category/transfection-and-ancillary-reagents): Revvity’s Dharmacon™ DharmaFECT™ reagents, controls, buffers, and kits for reliable transfection of small RNA and/or plasmids into any cell type.
 - [High-throughput Cell Counting Plates](https://www.revvity.com/category/high-throughput-cell-counting-plates): High-throughput cell counting plates designed for use with Revvity’s Cellaca high-throughput cell counters and Celigo image cytometers
 - [Cell Counting Slides](https://www.revvity.com/category/cell-counting-slides): Cell counting slides with counting chambers designed for Cellometer and Cellaca cell counters
 - [Cell Counting Beads](https://www.revvity.com/category/cell-counting-beads): Cellometer and Cellaca cell counting bead products enable users to verify instrument functionality and establish routine quality control SOPs
 - [Cell Counting & Image Cytometry Slides, Plates, and Beads](https://www.revvity.com/category/cell-counting-image-cytometry-slides-plates-and-beads): Designed for Revvity’s Cellometer, Cellaca and Celigo platforms, our slides, plates and beads help streamline your cell counting and generate excellent results
 - [Cell Counting & Image Cytometry Reagents](https://www.revvity.com/category/cell-counting-image-cytometry-reagents): Revvity’s fluorescent reagents and kits for cell counting, cell viability, and cell-based assays – optimized for Cellometer™, Cellaca™ and Celigo™ systems
 - [Yeast Viability and Vitality Assay Kits and Reagents](https://www.revvity.com/category/yeast-viability-and-vitality-assay-kits-and-reagents): Reagents and kits for determining yeast viability, concentration and vitality in biofuel production and brewing
 - [Proliferation and Tracer Reagents](https://www.revvity.com/category/proliferation-and-tracer-reagents): Fluorescent proliferation and cell-labeling dyes for cell identification, cell tracking and co-culture experiments
 - [Cell Health and Fitness Assay Kits and Reagents](https://www.revvity.com/category/cell-health-and-fitness-assay-kits-and-reagents): Assay kits to assess cell fitness - viability, vitality, mid and late-stage apoptosis, and reactive oxidative stress
 - [Cell Cycle Assay Kits](https://www.revvity.com/category/cell-cycle-assay-kits): Assay kits for assessing cell cycle optimized for Cellometer cell counters and Celigo Image cytometer
 - [Cell Counting and Viability Assay Kits and Reagents](https://www.revvity.com/category/cell-counting-and-viability-assay-kits-and-reagents): Revvity’s reagents and kits for cell counting and cell viability assays – optimized for Cellometer™, Cellaca™ and Celigo™ systems
 - [Apoptosis Assay Kits and Reagents](https://www.revvity.com/category/apoptosis-assay-kits-and-reagents): Apoptosis Assay kits and reagents – optimized for Cellometer™, Cellaca™ and Celigo™ systems.
 - [Antibodies for Immunophenotyping](https://www.revvity.com/category/antibodies-immunophenotyping): Fluorescent labeled antibodies and stains for immunophenotyping using the Cellaca PLX image cytometry system
 - [Ribodepletion Solutions](https://www.revvity.com/category/ribodepletion-solutions): Reduce rRNA, globin, and mitochondrial-derived reads with probe-based and Cas9-gRNA depletion solutions for RNA-seq and related NGS workflows.
 - [Licensing](https://www.revvity.com/category/licensing): Transform drug discovery with our licensing opportunities. We support in-licensing, processing, scale-up, and regulatory de-risking for innovative therapeutics.
 - [Automation Accessories](https://www.revvity.com/category/automation-accessories): Automation accessories for Omni Prep, Prep 96, and LH96 automated homogenizers and workstation, including racks, probes, and tube holders
 - [Automated Homogenizer Consumables](https://www.revvity.com/category/automated-homogenizer-consumables): Omni automated homogenizer consumables support high-throughput labs, helping maintain performance as sample volumes scale.
 - [Centrifuge Accessories](https://www.revvity.com/category/centrifuge-accessories): Centrifuge accessories - centrifuge rotors, buckets, inserts, tube adapters, and tube adapter reducer plates for diverse sample formats and lab workflows.
 - [OEM Solutions](https://www.revvity.com/category/oem-solutions): Bring your life science product to market faster by leveraging our high-quality raw materials, secure supply chains, and extensive experience.
 - [Clinical & Testing Services](https://www.revvity.com/category/clinical-services): We offer a comprehensive suite of services that empowers biopharma and clinicians to improve patient care and therapeutic development.
 - [Centrifuges](https://www.revvity.com/category/centrifuges): Explore lab centrifuge solutions, including ergonomic, quiet benchtop centrifuges for efficient sample separation, cell collection, DNA prep, and more.
 - [Sonicator Accessories](https://www.revvity.com/category/sonicator-accessories): Sonicator accessories – range of sonicator probe, horn, sonicator tip, stand, and sound enclosure for ultrasonic homogenizers for lab workflows.
 - [Sonicators](https://www.revvity.com/category/sonicators): Explore lab sonicators - ultrasonic homogenizers - for cell lysis, DNA fragmentation, and emulsification. Compact probe sonicators for lab application.
 - [ADME/Tox Studies ](https://www.revvity.com/category/admetox-studies): Enhance your research with Revvity's ADME/Tox studies solutions, optimizing pharmacokinetics and toxicity analysis for drug development.
 - [Drug Repurposing](https://www.revvity.com/category/drug-repurposing): Explore Revvity’s solutions for drug repurposing, leveraging existing compounds for new therapeutic uses, speeding up development
 - [Pregnancy Complications](https://www.revvity.com/category/pregnancy-complications): We deliver complete screening solutions for a wide range of pregnancy complications – and more than 9 million prenatal risk assessments are done every year using those tests.
 - [Oncology Drug Discovery Reagents](https://www.revvity.com/category/oncology-drug-discovery-reagents): Explore Revvity’s no-wash oncology reagents and homogenous cancer kits. Find advanced homogenous oncology assay and reagent solutions for streamlined discovery.
 - [CHOSOURCE CLE Services](https://www.revvity.com/category/chosource-cle-services): Providing custom editing of bioproduction cell lines that support your specific manufacturing needs for protein and viral vector therapeutics
 - [Safety & Efficacy](https://www.revvity.com/category/safety-efficacy): In vitro, ex vivo and in vivo platforms for understanding safety and mechanism of effect for large molecule drugs.
 - [Manufacturing and QA/QC of Biologics](https://www.revvity.com/category/manufacturing-of-biologics): Providing tools to facilitate quality compliance for method development and validation within drug development manufacturing.
 - [Immune function](https://www.revvity.com/category/immune-function): Access assay platforms to support multi-dimensional measurements of the innate and adaptive immune response for your drug development workflows
 - [Biologics Characterization](https://www.revvity.com/category/biologics-characterization): Enhance biologics molecule evaluation via characterization and stability studies leveraging bioanalytical solutions and services
 - [Biomolecular Discovery](https://www.revvity.com/category/biomolecular-discovery): Understand the target biology through automated workflow solutions and help accelerate your journey to biomolecular discovery
 - [输血安全血液筛查](https://www.revvity.com/category/blood-transfusion-safety-screening): 珀金埃尔默旗下的浩源生物，是中国采供血系统血液核酸筛查领先供应商，为超过40%的中国血站提供服务，有力地保障了输血和手术的安全性。我们始终致力于为您提供更好的血液筛查解决方案。
 - [In Vivo Imaging Solutions Cancer Research ](https://www.revvity.com/category/vivo-imaging-solutions-cancer-research): We have tools to help monitor tumor growth and progression, perform drug efficacy and toxicology studies, or enhance your understanding of cancer biology pathways in vivo.
 - [Biologics Purity & Impurity Profile](https://www.revvity.com/category/biologics-purity-impurity-profile): Access contamination and impurities testing of biologicals that utilize bioanalytical and analytical technologies
 - [Biologics Immunogenicity and PK & PD](https://www.revvity.com/category/biologics-immunogenicity-and-pk-pd): Providing solutions to evaluate the immune response and pharmacological effects of biologics
 - [Biomolecular Target ID & Validation](https://www.revvity.com/category/biomolecular-target-id-validation): Leverage the right application and solution to aid your biologics target identification and validation
 - [Clone Selection & Development](https://www.revvity.com/category/clone-selection-development): Providing new approaches and technologies for clone selection and expression during your biomolecular discovery
 - [Ultragenyx MPS Testing Program](https://www.revvity.com/category/ultragenyx-mps-testing-program): Discover the Ultragenyx and Revvity Omics sponsored testing program for MPS. Learn how this program can provide valuable insights and support for individuals with MPS. Find out more about eligibility and how to participate today.
 - [Biologics Identity](https://www.revvity.com/category/biologics-identity): Providing the tools to assist you to confidently identify your biologic or biotherapeutic molecule of interest during late drug discovery stages.
 - [Decode Duchenne](https://www.revvity.com/category/decode-duchenne): Supporting research for Duchenne Muscular Dystrophy is critical. Our sponsored testing program helps advance research to find potential treatments for DMD.
 - [Screening & Monitoring](https://www.revvity.com/category/screening-monitoring): Revvity Omics prides itself on offering a complete continuum of care for our patients in order to meet all of their diagnostic needs.
 - [Newborn Genetic Panels](https://www.revvity.com/category/newborn-genetic-panels): Offering a range of genetic panels to confirm the results from the primary newborn screen.
 - [Global Laboratory Network](https://www.revvity.com/category/global-laboratory-network): State-of-the-art, clinical grade global laboratory network.
 - [Second Tier Testing](https://www.revvity.com/category/second-tier-testing): Second-tier testing aids in the confirmation of a diagnosis in babies who have positive newborn screening results.
 - [Microphysiological Systems](https://www.revvity.com/category/physiological-model-solutions): Explore our microphysiological system solutions to culture, treat, and analyze complex 3D cell models, enhancing physiological relevance in research.
 - [StepOne Test](https://www.revvity.com/category/stepone-test): The StepOne® comprehensive biochemical profile screens newborns for over 70 disorders using just a few drops of blood, offering early detection for a healthier start.
 - [Global Laboratory Network - China](https://www.revvity.com/category/global-laboratory-network-china): Revvity Omics Laboratory- China
 - [Global Laboratory Network - The United States of America](https://www.revvity.com/category/global-laboratory-network-usa): Revvity Omics Laboratory- USA
 - [Basic Newborn Screening Panel](https://www.revvity.com/category/basic-newborn-screening-panel): Screening panel covering up to seven common metabolic disorders for newborns.
 - [Global Laboratory Network - The United Kingdom](https://www.revvity.com/category/global-laboratory-network-uk): Revvity Omics Laboratory- UK
 - [Non-invasive Prenatal Testing](https://www.revvity.com/category/non-invasive-prenatal-testing): Empower healthcare providers with cutting-edge noninvasive prenatal screening solutions for accurate and early detection. Elevate patient care and outcomes.
 - [Second Trimester Screening](https://www.revvity.com/category/second-trimester-screening): Discover valuable insights into your baby’s health with our second-tier prenatal screening test.
 - [Global Laboratory Network - India](https://www.revvity.com/category/global-laboratory-network-india): Revvity Omics India lab is situated in Chennai, Tamil Nadu.
 - [First Trimester Screening](https://www.revvity.com/category/first-trimester-screening): Enhance prenatal care with First Trimester Screening – a comprehensive solution for healthcare providers ensuring early detection and optimal management.
 - [Newborn Screening Services](https://www.revvity.com/category/newborn-screening-services): Discover the importance of newborn screening tests offered by our laboratory. Our comprehensive screening helps identify potential health conditions early on, providing peace of mind for parents and helping to ensure the well-being of your precious newborn.
 - [Prenatal Screening Services](https://www.revvity.com/category/prenatal-screening-services): Prenatal screening enables early identification of any possible risk of having a baby with Down syndrome and other chromosomal conditions.
 - [Fluorescence in Situ Hybridization (FISH)](https://www.revvity.com/category/fluorescence-in-situ-hybridization-fish): Discover the power of Fluorescence in situ hybridization (FISH) for genetic analysis. Learn more about our cutting-edge FISH solutions and how they can revolutionize your research or diagnostic applications.
 - [Karyotype](https://www.revvity.com/category/karyotyping): Learn about structural and numerical chromosomal aberrations with karyotyping test.
 - [CNGnome NGS Array](https://www.revvity.com/category/cngnome-ngs-array): The CNGnome® NGS Array is setting new benchmarks for CNV analysis using genomic sequencing technology and advanced bioinformatics techniques.
 - [Cytogenomics](https://www.revvity.com/category/cytogenomics): Understand chromosomal genetic disorders with advanced cytogenomic techniques to gain insights into human health and disease.
 - [Mucopolysaccharidosis I (MPS I)](https://www.revvity.com/category/r2r-mucopolysaccharidosis-i): Supporting research for mucopolysaccharidosis I (MPS I) is critical. Our sponsored testing program helps advance research to find potential treatments for MPS I and other MPS Disorders.
 - [Gaucher Disease & Niemann - Pick Type A & B (ASMD)](https://www.revvity.com/category/r2r-gaucher-disease): Supporting research for Gaucher disease and Acid Sphingomyelinase Deficiency is critical. Our sponsored testing program helps advance research to find potential treatments for Gaucher disease and Niemann- Pick Type A and B (ASMD).
 - [Fabry Disease](https://www.revvity.com/category/r2r-fabry-disease): Supporting research for Fabry Disease is critical. Our sponsored testing program helps advance research to find potential treatments for Fabry Disease.
 - [Pompe Disease](https://www.revvity.com/category/r2r-pompe-disease): Supporting research for Pompe Disease is critical. Our sponsored testing program helps advance research to find potential treatments for Pompe Disease.
 - [Roadmap2Rare](https://www.revvity.com/category/roadmap-2-rare): Sanofi Canada is partnering with Revvity Omics to offer a complimentary genetic testing program called Roadmap2Rare Diagnostic program. Find out more about eligibility and how to participate today.
 - [Focused Neuromuscular Disease Panel](https://www.revvity.com/category/focused-neuromuscular-disease-panel): Supporting research for limb girdle muscle weakness is critical. Our sponsored testing program helps advance research to find potential treatments for limb girdle muscular dystrophy and related disorders.
 - [Mucopolysaccharidosis I (MPS I) & Other MPS Disorders](https://www.revvity.com/category/mucopolysaccharidosis-i-other-mps-disorders): Supporting research for mucopolysaccharidosis I (MPS I) is critical. Our sponsored testing program helps advance research to find potential treatments for MPS I and other MPS disorders.
 - [Gaucher Disease & Niemann - Pick Type A & B (ASMD)](https://www.revvity.com/category/gaucher-disease): Supporting research for Gaucher disease and Acid Sphingomyelinase Deficiency is critical. Our sponsored testing program helps advance research to find potential treatments for Gaucher disease and Niemann- Pick Type A and B (ASMD).
 - [Pompe Disease](https://www.revvity.com/category/pompe-disease): Supporting research for Pompe disease is critical. Our sponsored testing program helps advance research to find potential treatments for Pompe disease.
 - [In Vitro Assays](https://www.revvity.com/category/vitro-assays): Helping you comprehend the interactions between innate and adaptive immunity for screening biologics
 - [Fabry Disease](https://www.revvity.com/category/fabry-disease): Supporting research for Fabry Disease is critical. Our sponsored testing program helps advance research to find potential treatments for Fabry disease.
 - [The Lantern Project](https://www.revvity.com/category/the-lantern-project): Sanofi is partnering with Revvity Omics to offer a complimentary genetic testing program called The Lantern Project. Find out more about eligibility and how to participate today.
 - [Sponsored Testing Programs](https://www.revvity.com/category/sponsored-testing-programs): Revvity Omics partners with pharmaceutical companies to offer sponsored testing and free genetic testing programs for rare disorders.
 - [Single Site Analysis](https://www.revvity.com/category/single-site-analysis): Single site analysis by sanger sequencing can help confirm the presence of a known familial gene variant.
 - [WholePanel Testing](https://www.revvity.com/category/wholepanel-testing): WholePanel™ testing provides expertly curated gene panels that use whole genome sequencing to offer extensive coverage.
 - [AnyPanel & AnyGene Testing](https://www.revvity.com/category/anypanel-anygene-testing): AnyPanel™ and AnyGene™ testing option provides you with flexibility to order customized gene panels or select from our wide range of pre-curated panels to meet your testing needs.
 - [Whole Exome Sequencing](https://www.revvity.com/category/whole-exome-sequencing): Explore our Whole exome sequencing (WES) test and delve into the intricacies of protein-coding regions, paving the way for personalized medicine.
 - [Preeclampsia Testing](https://www.revvity.com/category/preeclampsia-testing): Pre-eclampsia screening in the 1st trimester for identifying the high risk pregnancies, and aid in diagnosis in the 2nd and 3rd trimesters with PlGF based solutions.
 - [Whole Genome Sequencing](https://www.revvity.com/category/whole-genome-sequencing): Maximize genomic insights and reduce diagnostic odyssey through whole genome sequencing and testing using flexible sample types, including dried blood spots.
 - [Rare Disease Testing](https://www.revvity.com/category/rare-disease-testing): Advanced rare disease testing is revolutionizing healthcare by providing personalized genomic information for precise diagnosis and treatment, paving the way for breakthroughs in precision medicine.
 - [Cardiovascular Disease Research](https://www.revvity.com/category/cardiovascular-disease-research): We deliver a broad range of advanced solutions to help you research cardiovascular disease.
 - [Automate & Analyze](https://www.revvity.com/category/automate-analyze): Explore Revvity’s automation & data analysis solutions, enhancing efficiency and insights in research workflows
 - [Interrogate Biology ](https://www.revvity.com/category/interrogate-biology): Dive deep into biological complexities with Revvity's solutions, uncovering insights for advanced drug research and development.
 - [NASH](https://www.revvity.com/category/nash): Revvity offers a comprehensive portfolio of tools to enable further understanding of NASH pathophysiology, aid in the development of NASH solutions for the assessment of NASH, help identify new therapeutic targets, and characterize novel drug therapies.
 - [Cell-Based Solutions Cancer Research](https://www.revvity.com/category/cell-based-solutions-cancer-research): Whether you are a researcher trying to better understand biological processes in cancer cells or investigating how drugs affect those processes, we have the tools you need.
 - [Automated Homogenizers](https://www.revvity.com/category/automated-homogenizers): Omni automated homogenizers enable labs to scale workflows, improving efficiency and throughput in sample preparation.
 - [Inflammation Research ](https://www.revvity.com/category/inflammation-research): Detect and quantitate inflammatory biomarkers with our wide range of in vivo, cellular, in situ and biochemical inflammation research products.
 - [Metabolic Disease ](https://www.revvity.com/category/metabolic-disease): Revvity offers a wide range of reagents, kits and instrumentation to help identify new metabolic disease biomarkers.
 - [Neurological biomarker discovery](https://www.revvity.com/category/neurological-biomarker-discovery): We provide solutions to help you overcome the hurdles of biomarker and drug discovery to accelerate research in neuroscience.
 - [Neurological Rare Diseases ](https://www.revvity.com/category/neurological-rare-diseases): Revvity supports the efforts of leading scientists by offering reliable reagents and instrumentation for neurological rare disease research.
 - [Altered Cellular Processes](https://www.revvity.com/category/altered-cellular-processes): We offer solutions to better assess cellular, molecular and or phenotypic changes in the central nervous system.
 - [Neuroinflammation ](https://www.revvity.com/category/neuroinflammation): We offer a wide variety of solutions to explore the role of neuroinflammation and its impact on neurotoxicity.
 - [Protein Aggregation](https://www.revvity.com/category/protein-aggregation): Revvity offers a range of reagents, consumables, instruments, and corresponding software to accelerate your neuroscience research.
 - [Neuroscience Research](https://www.revvity.com/category/neuroscience-research): Revvity offers neuroscience solutions to help elucidate mechanisms that may better explain disease development and accelerate molecular biomarker and therapeutic discoveries.
 - [Agrigenomics Workflows](https://www.revvity.com/category/agrigenomics-workflows): Discover agrigenomics workflows for agricultural genomics research, including low pass whole genome sequencing to advance crop and livestock improvement.
 - [Agricultural Metagenomics](https://www.revvity.com/category/agricultural-metagenomics): Explore agricultural metagenomics solutions for accurate microbial genomics and metagenomics analysis to optimize crop production and soil health.
 - [Diabetes](https://www.revvity.com/category/diabetes): We’re committed to helping you understand the complex cellular and molecular pathways involved in diabetes and translating these findings into new prevention and treatment strategies.
 - [Biobanking Workflows ](https://www.revvity.com/category/biobanking-workflows): Explore the automation solutions enabling biobanks to serve their customers’ needs with complete, single-source workflow solutions.
 - [Biologics Potency](https://www.revvity.com/category/biologics-potency): Providing accurate determination of mode of action and potency of a biotherapeutic using a variety of bioassay platforms.
 - [Metabolic Testing ](https://www.revvity.com/category/metabolic-testing): Providing biochemical analysis for inborn errors of metabolism (IEM), newborn screening (NBS) positive cases and functional analysis for variants of uncertain significance (VOUS).
 - [Cancer Research Solutions ](https://www.revvity.com/category/cancer-research-solutions): We offer a diverse range of solutions to accelerate your cancer research, helping scientists to study all aspects of cancer, from genomics to precision medicine research and beyond.
 - [Viral Research Solutions ](https://www.revvity.com/category/viral-research-solutions): We offer solutions to help you understand viral diseases and translate develop research findings into more effective vaccines and treatments.
 - [Target Selection](https://www.revvity.com/category/target-selection): Enhance target selection with Revvity’s solutions for precise identification and validation, ensuring efficient drug discovery and development.
 - [Detect & Measure](https://www.revvity.com/category/detect-measure): Explore Revvity’s laboratory instrument solutions for your drug discovery workflow, enhancing research accuracy and efficiency.
 - [Lead Discovery](https://www.revvity.com/category/lead-discovery): Streamline lead discovery with Revvity's robust identification solutions, driving forward your drug discovery with precision and speed.
 - [Lead Optimization](https://www.revvity.com/category/lead-optimization): Refine lead optimization for drug discovery with Revvity's precise tools and techniques, enhancing efficacy and safety for successful development.
 - [Pooled Screening](https://www.revvity.com/category/pooled-screening): Accelerate drug discovery with Revvity's pooled screening technologies, enabling efficient high-throughput analysis and insights.
 - [Finding the Next Novel Drug: Understanding Biology](https://www.revvity.com/category/understanding-biology): Unlock the secrets of biology to fuel drug discovery with Revvity's innovative tools and insights. Drive novel therapeutic breakthroughs.
 - [Arrayed Screening](https://www.revvity.com/category/arrayed-screening): Enhance drug discovery with Revvity's arrayed screening technologies, enabling precise targeting and analysis for fast, accurate results.
 - [Infectious Disease Research](https://www.revvity.com/category/infectious-disease-research): We offer solutions that help scientists make critical discoveries in infectious disease research through genomic analysis, in vitro, cell-based, and in vivo studies.
 - [Automated RNA Library Preparation Kits](https://www.revvity.com/category/automated-methods-rna-library-prep-kits): RNA Library Preparation Kits, sample prep, liquid handling workstation, bioprocessing, liquid handler, sequencing, NGS, vendor-qualified methods, applications, transcriptome studies
 - [Automated DNA Library Preparation Kits](https://www.revvity.com/category/automated-methods-dna-library-prep-kits): DNA Library Preparation Kits, sample prep, liquid handling workstation, bioprocessing, liquid handler, sequencing, NGS, vendor-qualified methods, applications
 - [Molecular Cytogenetics](https://www.revvity.com/category/molecular-cytogenetics): Revvity brings reliable molecular cytogenetic techniques to cytogenetic laboratories performing molecular karyotyping.
 - [SARS-COV-2 Testing Solutions](https://www.revvity.com/category/sars-cov-2-testing-solutions): Overcome your SARS-CoV-2 testing challenges with solutions optimizing each step in the workflow. Revvity’s solutions allow labs to increase throughput, improve accuracy, and increase the efficiency of their COVID testing.
 - [CHOSOURCE Platform](https://www.revvity.com/category/chosource-platform): The CHOSOURCE™ expression platform accelerates stable cell line development by providing a robust CHO expression system for biotherapeutics.
 - [Microplate Services](https://www.revvity.com/category/microplate-services): We offer a range of custom microplate services including barcoding, surface treatments and coatings, and customized packaging.
 - [Cell Counting and Image Cytometry](https://www.revvity.com/category/cell-counting-image-cytometry): Revvity’s cell counting solutions provide fast, reliable and efficient ways to assess cell health and viability, immunophenotyping, and a range of other cell-based assays.
 - [cDNAs and ORF Clones](https://www.revvity.com/category/cdnas-and-orf-clones): Fully sequenced, pre-cloned cDNA & ORFs for rapid gene overexpression studies. Available as individual reagents or in a variety of overexpression library formats covering human, mouse, rat, and bovine genes.
 - [Oligonucleotide Custom Synthesis](https://www.revvity.com/category/oligonucleotide-custom-synthesis): Leveraging almost 30 years of experience as a leading provider in oligo design and synthesis, Revvity's oligo synthesis team offers a range of services. Explore our Dharmacon™ oligo synthesis services to discover solutions that align with your specific requirements. We are dedicated to delivering RNA and DNA solutions with flexibility in scale and purity, taking into consideration your requirements, all within a budget-friendly framework
 - [RNA Interference](https://www.revvity.com/category/rna-interference): Dharmacon™ siRNA, shRNA, and microRNA-based reagents, leading the field for for nearly 30 years providing highly specific and efficient gene silencing.
 - [CRISPR Technologies](https://www.revvity.com/category/crispr-technologies): CRISPR-Cas9 genome engineering technologies hold great promise for understanding diseases and for the development of life saving treatments.
 - [Functional Genomic Screening Services](https://www.revvity.com/category/functional-genomic-screening-services): Identify drug discovery targets with functional genomic screening services, including CRISPR knockout, activation, inhibition, dual screening, and RNAi technologies.
 - [Virus Screening](https://www.revvity.com/category/virus-screening): Discover advanced adenoviral vectors for effective vaccination, superior transduction, immune responses, and unique receptor affinities.
 - [TnT Transposon Vector System](https://www.revvity.com/category/tnt-transposon-vector-system): Accelerate biologics development with CHOSOURCE™ TnT Transposon Technology, a CHO transposon system for efficient gene integration and stable cell line development.
 - [CHOSOURCE GS KO](https://www.revvity.com/category/chosource-gs-ko): The CHOSOURCE™ GS KO is an established cGMP manufacturing cell line with proven performance and flexibility for the development and manufacturing of biotherapeutics.
 - [ADCC+](https://www.revvity.com/category/adcc-plus): CHOSOURCE™ ADCC+ is a glycoengineered CHO-K1 GS KO cell line for the production of afucosylated proteins for enhanced therapeutic activity. Available for commercial and research applications.
 - [Cell Isolation](https://www.revvity.com/category/cell-isolation): MojoSort™ is BioLegend’s magnetic cell separation system. It allows cells of interest to be isolated and purified by positive or negative selection.
 - [Preimplantation Genetic Testing](https://www.revvity.com/category/preimplantation-genetic-testing): Explore Revvity preimplantation genetic testing research solutions, including PG-Seq and DOPLify, for PGT-A/CNV analysis, WGA, indexing, and sample traceability.
 - [Custom Labeling](https://www.revvity.com/category/alpha-htrf-lance-delfia): We offer custom biomolecule labeling with a large variety of linkers and dyes. Discovery Revvity’s custom labeling services.
 - [Newborn Sequencing Research](https://www.revvity.com/category/newborn-sequencing-research): Our end-to-end NGS workflow has been designed to identify a wide panel of genes, providing you with the means to produce reliable, high quality sequencing data
 - [Radioimaging & Radiotherapeutics](https://www.revvity.com/category/radioimaging-radiotherapeutics): We provide radio imaging nuclides for safe, quantitative evaluation in Radiotherapeutics.
 - [Plate Storage Solutions](https://www.revvity.com/category/plate-storage-solutions): Revvity's plate storage solutions for liquid handling designed and built to fit under any liquid handler deck or workstation.
 - [IVD Radiometric Detectors](https://www.revvity.com/category/ivd-radiometric-detectors): With our Gamma counters you can have outstanding sensitivity together with highest-level security and ease of use, giving you greater command over gamma counting process.
 - [Radionuclides](https://www.revvity.com/category/radionuclides): Revvity Radionuclides provide a highly specific and sensitive labeling option for proteins, cells, and tissues.
 - [Ligands](https://www.revvity.com/category/ligands): Radioligands for ligand binding assays.
 - [Cell Counting & Image Cytometry Instruments](https://www.revvity.com/category/cell-counters-image-cytometers): Revvity’s portfolio includes automated, high-throughput, fluorescent and brightfield cell counters and image cytometers, many with 21 CFR part 11 modules.
 - [Engineered Cell Lines](https://www.revvity.com/category/engineered-cell-lines): Providing an extensive catalog of ready-to-go gene edited cell lines including knockout and knockin models in HAP1 and cancer related cells
 - [Frozen cells](https://www.revvity.com/category/frozen-cells): Revvity's frozen, irradiated cells express a variety of GPCRs for binding and functional assays.
 - [Membrane Preparations](https://www.revvity.com/category/membrane-preparations): Revvity's Membrane Target Systems include a variety of GPCR membrane preparations for binding assays.
 - [GPCR Cell Lines](https://www.revvity.com/category/gpcr-cell-lines): Revvity offers more than 300 stable GPCR lines for binding and functional testing.
 - [Cell Lines & Stem Cells](https://www.revvity.com/category/cell-lines): Elevate your research with versatile cell lines for biologics discovery and preclinical development. Choose from GPCR, luciferase-labeled, and engineered options for biotherapeutic application.
 - [Cell Painting](https://www.revvity.com/category/cell-painting): Cell painting is a type of phenotypic assay and a powerful application of high-content screening.
 - [IVISbrite Bioluminescent Substrates and Lentiviral Particles](https://www.revvity.com/category/bioluminescent-substrates-lentiviral-particles): Enhance your research with our bioluminescent & chemiluminescent substrates and lentiviral particles validated in a number of optical imaging applications.
 - [IVISense Fluorescent Nanoparticles](https://www.revvity.com/category/ivisense-fluorescent-nanoparticles): High quality fluorescent nanoparticles offering superior brightness and longer photostability to fulfil your bioimaging research needs.
 - [IVISense Fluorescent Panels](https://www.revvity.com/category/ivisense-fluorescent-panels): Our IVISense fluorescent panel pre-packaged with fluorescent imaging probes enable researchers to monitor, evaluate and characterize disease pathways.
 - [Revvity Omics Clinical Services](https://www.revvity.com/category/clinical-genomic-services): Revvity Omics offers comprehensive genetic testing solutions, including sequencing for targeted genes, multiple genes, the whole exome or genome, and CNV analysis.
 - [Drug Discovery & Protein Purification](https://www.revvity.com/category/drug-discovery-protein-purification): Obtain consistent small scale protein purification and sample prep for analytical protein characterization with the JANUS® G3 BioTx Pro workstations.
 - [IVISense Fluorescent Dyes](https://www.revvity.com/category/ivisense-labels-dyes): Label proteins, antibodies, small molecules, or peptides with IVISense NIR fluorescent dyes.
 - [Functional Testing ](https://www.revvity.com/category/functional-testing): Comprehensive solutions to screen drug sensitivity and resistance using patient derived tumor cells.
 - [Primary Sample Reformatting](https://www.revvity.com/category/primary-sample-reformatting): Revvity automated liquid handling workstations for traceable sample reformatting into various labware to support downstream processing.
 - [Mimix Reference Standards](https://www.revvity.com/category/mimix-reference-standards): Optimize assay workflows with Mimix cell-line derived reference standards, including molecular reference standards for diagnostics and assay verification.
 - [Recombinant Proteins](https://www.revvity.com/category/recombinant-proteins): Our recombinant proteins are developed in-house, with quality-testing and bioassay validation to ensure activity and performance in your experiments.
 - [IVISense Fluorescent Probes](https://www.revvity.com/category/ivisense-fluorescent-probes): High purity fluorescent imaging probes to achieve accurate and reliable results in detecting, identifying, and quantifying biomolecules.
 - [In Vivo Imaging Reagents](https://www.revvity.com/category/in-vivo-imaging-reagents): Our comprehensive range of bioluminescent and fluorescent imaging reagents provides researchers with the necessary tools to evaluate efficacy and safety of drug candidates.
 - [In Vivo Imaging Instruments](https://www.revvity.com/category/in-vivo-imaging-instruments): At Revvity, we offer in vivo imaging systems with integrated x-ray or microCT facilitating the quickest workflow for data acquisition and analysis.
 - [Multimodality Imaging](https://www.revvity.com/category/multimodality-imaging): By combining imaging modalities you get more insight into functional, molecular and anatomical information which ultimately enables you to broaden your understanding of disease biology.
 - [Targeted Sequencing](https://www.revvity.com/category/targeted-sequencing): Support hybrid capture-based targeted sequencing workflows with solutions for sample preparation, library QC, blockers, reference standards, and automation.
 - [Ultrasound Imaging](https://www.revvity.com/category/ultrasound-imaging): Vega™ preclinical in vivo ultrasound imaging system that delivers rapid 2D & 3D ultrasound images for your in vivo ultrasound studies.
 - [Exosome/cfRNA Analysis](https://www.revvity.com/category/exosome-cfRNA-analysis): Explore exosome & cfRNA analysis with NGS and miRNA sequencing to uncover biomarkers and disease insights with Revvity's advanced research solutions.
 - [MicroCT Imaging](https://www.revvity.com/category/microct-imaging): Whether you are studying tumor biology, cardiovascular or pulmonary disease research, our Micro-computed tomography (micro-CT) imaging solutions can help you.
 - [miRNA-seq Analysis ](https://www.revvity.com/category/mirna-seq-analysis): Explore Revvity's optimized miRNA seq solutions for accurate miRNA sequencing, miRNA discovery, gene expression analysis, and efficient small RNA sequencing.
 - [Nimbus AI Accelerated Analysis Pilot Program](https://www.revvity.com/category/nimbus-ai-accelerated-analysis-pilot-program): Nimbus AI Pilot program for accelerated analysis of in vivo imaging data from optical, ultrasound, microCT, PET, MRI, x-ray, or other imaging modalities
 - [Optical Imaging](https://www.revvity.com/category/optical-imaging): Revvity helps you achieve your research goals with our fluorescence and bioluminescence molecular imaging platforms and diverse range of optical imaging reagents
 - [In Vivo Imaging Software](https://www.revvity.com/category/in-vivo-imaging-software): In vivo imaging software solutions to analyze complex data with ease. Choose Living Image or TrueQuant software for 2D and 3D optical imaging analysis with co-registration.
 - [VesselVue Microbubble Contrast Agent](https://www.revvity.com/category/vesselvue-microbubble-contrast-agent): VesselVue® microbubble agents for contrast enhanced ultrasound (CEUS) imaging of vasculature
 - [IVISbrite Bioluminescent Bacterial Strains](https://www.revvity.com/category/ivisbrite-bioluminescent-bacterial-strains): Wide range of gram-positive and gram-negative bioluminescent bacterial strains labeled with lux operon for any in vitro and in vivo applications.
 - [IVISbrite Bioluminescent Tumor Cell Lines](https://www.revvity.com/category/ivisbrite-bioluminescent-tumor-cell-lines): Get highest quality bioluminescent tumor cell lines bright enough to measure tumor growth in optical imaging systems right after injection. We offer luciferase labeled tumor cell lines covering a range of cancer models.
 - [Equipment Service Plans](https://www.revvity.com/category/equipment-service-plans): Minimise downtime and maximise uptime with Revvity Equipment Service Plans.
 - [Dispensers](https://www.revvity.com/category/dispensers): Dispenser pumps for dispensing liquid scintillation cocktail and other harsh or viscous chemicals.
 - [On-demand Equipment Service](https://www.revvity.com/category/on-demand-equipment-service): Minimise downtime and maximise uptime with trusted, professional, on-demand Revvity services performed at your site by qualified personnel.
 - [Vials, Caps, & Accessories](https://www.revvity.com/category/vials-caps-accessories): Vials, caps, and accessories for liquid scintillation counting
 - [Charcoal Traps](https://www.revvity.com/category/charcoal-traps): Charcoal trap for venting volatile radiochemical breakdown products in bottles
 - [Small Molecule ](https://www.revvity.com/category/small-molecule): We can label your small molecules: discover our offer and process.
 - [Pipette Tips](https://www.revvity.com/category/pipette-tips): A variety of dispense channel sizes as well as disposable tips to support liquid transfers from test tubes, vials, troughs, deep-well plates and microplates.
 - [Nucleic Acid Extraction](https://www.revvity.com/category/nucleic-acid-extraction): Achieve rapid quantitation and normalization of nucleic acid using Revvity's easy-to-use automated nucleic acid quantitation system.
 - [NGS Library Prep Solutions](https://www.revvity.com/category/ngs-library-prep-solutions): With over 150 standardized and tested automated NGS protocols available, Revvity's liquid handlers offer a large breadth of NGS applications to meet your automation needs.
 - [Nucleic Acid Isolation for Pathogen Detection](https://www.revvity.com/category/nucleic-acid-isolation-for-pathogen-detection): Learn more about Revvity´s solutions for (automated) chemagic™ nucleic acid isolation from pathogen containing sample material for infectious disease testing.
 - [Application Specific Workstations](https://www.revvity.com/category/application-specific-workstations): Leverage our application-specific automated workstations to increase efficiency and throughput capability, while reducing tedious manual pipetting steps from particular application workflows.
 - [T-SPOT Technology](https://www.revvity.com/category/t-spot-technology): Discover Revvity's T-SPOT Technology, utilizing ELISPOT to measure T cell responses for accurate infection detection and immune monitoring.
 - [Fontus Workstations](https://www.revvity.com/category/fontus-workstations): With easy-to-use software, optimized deck access, verified protocols, and reformatting capabilities to simplify your workflows and improve turnaround times, the new Fontus automation is a powerhouse, helping you to achieve even more.
 - [Gene Expression Systems](https://www.revvity.com/category/gene-expression-systems): Streamlining biotherapeutic development programs with cell line and gene expression systems, providing speed, reliability, and adaptability at every stage of your cell line development
 - [Custom Conjugation & Labeling](https://www.revvity.com/category/custom-conjugation-labeling): We offer custom biomolecule labeling with a large variety of linkers and dyes. Discover our numerous labeling options.
 - [Base Editing Platform](https://www.revvity.com/category/pin-point-base-editing-platform-services): Pin-point Base Editing Services offer precise genomic edits, improving cell viability for gene editing, disease modeling, and ideal for iPSCs and immune cells.
 - [Whole Blood Fractionation](https://www.revvity.com/category/whole-blood-fractionation): Discover our Blood fractionation workstations for the automated processing of whole blood into separate components of plasma, buffy layer or red blood cells.
 - [Steroids](https://www.revvity.com/category/steroids): Radiolabeled steroids for radiometric applications.
 - [qPCR](https://www.revvity.com/category/qpcr): Our qPCR testing workflows incorporate innovative assays, robust nucleic acid extraction, automation with flexible throughput, and full traceability.
 - [Lipids](https://www.revvity.com/category/lipids): Radiolabeled lipids for metabolic and mechanistic studies.
 - [Carbohydrates](https://www.revvity.com/category/carbohydrates): Radiolabeled carbohydrates for metabolic and mechanistic studies.
 - [Nucleic Acid Interactions](https://www.revvity.com/category/nucleic-acid-interactions): Products for measuring nucleic acid binding interactions
 - [FlexDrop Non-contact Dispenser](https://www.revvity.com/category/flexdrop-non-contact-dispenser): Get non-contact dispenser from Revvity that provides rapid, precise, and flexible contact-free dispensing for use in biomedical application.
 - [Amino Acids & Derivatives](https://www.revvity.com/category/amino-acids-derivatives): We offer a broad portfolio of radiolabeled amino acids labeled with 3H, 14C, or 35S.
 - [Sciclone Workstations](https://www.revvity.com/category/sciclone-workstations): Find the best automated liquid handling workstations at Revvity, flexible to meet your specific needs. Our Sciclone G3 liquid handling workstation is easy-to-use and offer maximum flexibility.
 - [JANUS Workstations](https://www.revvity.com/category/janus-workstations): Explore our JANUS® G3 automated liquid handling workstations designed to optimize dependability and improve efficiency in high-throughput labs.
 - [Scintillation Proximity Assay (SPA)](https://www.revvity.com/category/scintillation-proximity-assay-spa): SPA beads for no-wash radiometric applications.
 - [Setting up NGS for Service Labs](https://www.revvity.com/category/setting-up-ngs-for-service-labs): Setting up a NGS service facility lab or augmenting an existing one can be a daunting task. Our NGS workflows improve efficiency & flexibility.
 - [Reservoirs, Troughs and Accessories](https://www.revvity.com/category/reservoirs-troughs-and-accessories): Choose the ideal option for on-deck storage of liquids and reagents based on your specific volume range and pipetting requirements.
 - [PlGF Testing Research](https://www.revvity.com/category/pigf-testing-research): The portable Ronia ™ platform delivers a complete workflow and seamlessly transforms a whole blood sample into quantitative PlGF concentration value without the need for laboratory facilities in just 30 minutes. No centrifuging or sample shipping is needed, and the calibration is done simply from RFID.
 - [PCR Solutions](https://www.revvity.com/category/pcr-solutions): Meet all your PCR automation needs! We offer automated PCR setup from simple to advanced with integrated thermocycler, to fully automated PCR solutions.
 - [Iodinated Compounds](https://www.revvity.com/category/iodinated-compounds): Wide range of 125I labeled compounds available for your basic research and drug discovery needs.
 - [Custom Integration Solutions](https://www.revvity.com/category/custom-integration-solutions): Customized automation integrations – from cellular screening and imaging applications to high-throughput screening, NGS, and genomics-based applications.
 - [Newborn Screening Software](https://www.revvity.com/category/newborn-screening-software): Newborn screening software is the result of years of continuous development, and the product is widely used in all parts of the world. Specimen Gate® software modules provide control and monitoring tools for the entire screening process.
 - [High Content Screening Research Areas](https://www.revvity.com/category/high-content-screening-research-areas): Discover how high content screening & analysis can advance your research in a selection of areas including Oncology, Neuroscience, Infectious disease and Toxicology.
 - [Vanadis NIPT System](https://www.revvity.com/category/vanadis-nipt-system): The Vanadis® NIPT system is a fully automated cfDNA testing platform enabling targeted analysis without PCR, nor sequencing, making noninvasive prenatal testing more cost-effective
 - [High Content Screening Assays](https://www.revvity.com/category/high-content-screening-assays): Explore high-content screening (HCS) assays to develop, perform, and analyze cellular and phenotypic assays using advanced high content analysis systems.
 - [Zephyr Workstations](https://www.revvity.com/category/zephyr-workstations): Automate your lab with Zephyr G3 liquid handler workstations from Revvity that offer high-accuracy and flexibility to adapt to your needs.
 - [Live-Cell Imaging](https://www.revvity.com/category/live-cell-imaging): Live-cell imaging is becoming a requisite technique for cell biology, developmental biology, cancer biology, and many other related biomedical research laboratories.
 - [Newborn Screening Kits](https://www.revvity.com/category/newborn-screening-kits): Our Newborn Screening (NBS) reagents are the industry standard for analytical performance and reliability in detecting congenital diseases
 - [Newborn Screening Instruments](https://www.revvity.com/category/newborn-screening-instruments): We provide complete newborn screening systems including newborn screening instrument, kits, consumables and software
 - [Risk Calculation Software](https://www.revvity.com/category/risk-calculation-software): LifeCycle™ software is the complete data management solution for prenatal screening laboratories
 - [GrowDex Hydrogels](https://www.revvity.com/category/growdex-hydrogels): Our GrowDex animal-free matrix for 3D cell culture is an easy-to-use hydrogel that supports cell growth and differentiation.
 - [Biochemical Prenatal & Preeclampsia Testing Kits](https://www.revvity.com/category/biochemical-prenatal-preeclampsia-testing-kits): Revvity offers a comprehensive range of prenatal and pre-eclampsia assays with a high analytical sensitivity of the DELFIA® chemistry
 - [Biochemical Prenatal & Preeclampsia Testing Instruments](https://www.revvity.com/category/biochemical-prenatal-preeclampsia-testing-instruments): Market leader in prenatal care, Revvity provides complete solutions for Prenatal and pre-eclampsia testing
 - [ImagAmp Signal Amplification Reagents](https://www.revvity.com/category/imagamp-signal-amplification-reagents): Flexible and efficient, HCA ImagAmp technology can be added to virtually any assay protocol for detection of weakly-expressed targets.
 - [PhenoVue Complementary Reagents](https://www.revvity.com/category/phenovue-complementary-reagents): PhenoVue complementary reagents, suitable for use with cell painting kits, organelle and cell compartment stains, and fluorescent labelled secondary antibodies.
 - [Biochemical Prenatal Testing](https://www.revvity.com/category/biochemical-prenatal-testing): Cost-efficient, customizable, and reliable biochemical screening solutions for aneuploidies and other pregnancy-related complications to support population-based prenatal screening.
 - [M-PVA Magnetic Beads ](https://www.revvity.com/category/m-pva-magnetic-beads): Check out chemagic™ M-PVA Magnetic Beads, e.g. SAV, OligodT, NHS, COOH, with various functionalities and size ranges to find the best option for your workflow.
 - [PhenoVue Fluorescent Secondary Antibodies](https://www.revvity.com/category/phenovue-fluorescent-secondary-antibodies): Fluorescent secondary antibodies (PhenoVue™) are everyday research tools to perform cell imaging, high content analysis, western blotting and flow cytometry.
 - [Luminescence Assays](https://www.revvity.com/category/luciferase-assay-systems): Luciferase assay systems from Revvity, designed for high sensitivity and reliable results, including reporter gene assays and Cytotoxicity and cell proliferation assays.
 - [PhenoVue Fluorescent Probes for Organelles & Subcellular Compartments](https://www.revvity.com/category/phenovue-fluorescent-probes-for-organelles-subcellular-compartments): Our PhenoVue™ organelle-specific fluorescent stains detect various organelles and cellular compartments and are optimized for high-content analysis and screening.
 - [PhenoVue Cell Painting Kits](https://www.revvity.com/category/phenovue-cell-painting-kits): Streamline your workflow and save time and costs with a validated, pre-optimized PhenoVue cell painting kit.
 - [Assays and Reagents](https://www.revvity.com/category/assays-and-reagents): Solutions to support your drug discovery needs. Revvity has 30+ years of experience in custom lab services, including assay development and compound profiling.
 - [Tuberculosis Testing Services](https://www.revvity.com/category/tuberculosis-testing): UK’s premier lab for TB testing with the T-SPOT.TB test.
 - [High-Content Screening System Filters, Lenses and Instrument Upgrades](https://www.revvity.com/category/high-content-screening-system-filters-lenses-instrument-upgrades): Filters and objective lenses for Revvity Opera Phenix, Opera Phenix Plus, Operetta CLS, Operetta high-content screening systems.
 - [Machine Learning](https://www.revvity.com/category/machine-learning): Revvity offers a range of easy-to-use machine learning tools for its Harmony® High content Imaging and Analysis Software and Signals Image Artist™ software.
 - [Intelligent Image Acquisition](https://www.revvity.com/category/intelligent-image-acquisition): High-content screening can be used to capture fine sub-cellular detail with very high resolution images,
 - [Illumination](https://www.revvity.com/category/illumination): Lasers and LEDs are both modern light sources for HCS instruments. Learn more about the difference between lasers vs LEDs.
 - [Cell Line Engineering](https://www.revvity.com/category/cell-line-engineering): Achieve your custom cell line development goals with our specialized cell line engineering services, backed by extensive gene-editing licenses and expertise.
 - [Cell Panel Screening](https://www.revvity.com/category/cell-panel-screening): Identify hits with Revvity’s cell panel screening CRO services and screen over 300 cancer cell lines with our 2D/3D OncoSignature platform.
 - [Water Immersion Objectives](https://www.revvity.com/category/water-immersion-objectives): Proprietary automated water-immersion objectives with very high numerical aperture deliver and capture more photons and provide a higher resolution in XYZ than conventional objectives
 - [Confocal Imaging](https://www.revvity.com/category/confocal-imaging): Confocal imaging using spinning disk confocal microscopy technique allows fast and efficient acquisition of high-resolution images of live samples.
 - [Secondary Antibodies & Proteins](https://www.revvity.com/category/secondary-antibodies-proteins): Secondary antibodies and proteins for ELISA, western blotting, TSA, and other applications.
 - [Chromogenic Substrates](https://www.revvity.com/category/chromogenic-substrates): Revvity’s chromogenic substrates for direct colorimetric visualization of your western blot for simple, economical, and quick results without the need for special equipment.
 - [Chemiluminescent Blotting Substrates](https://www.revvity.com/category/chemiluminescent-blotting-substrates): Chemiluminescent substrates are important tools in the detection of proteins and nucleic acids.
 - [Immune Cell Screening](https://www.revvity.com/category/immune-cell-screening): Preclinical immune cell screening services using primary human immune cells to address biologically relevant questions for target identification & optimization
 - [Pin-point™ Base Editing Platform](https://www.revvity.com/category/pin-point-base-editing-platform): Pin-point Base Editing Platform – (a CRISPR alternative) for precise, safer, and multiplex gene editing in cell and gene therapy using base editing technology.
 - [Radiosynthesis and Labeling](https://www.revvity.com/category/radiosynthesis-and-labeling): Custom radiolabeling and radiosynthesis services from NEN/Revvity.
 - [Compound profiling](https://www.revvity.com/category/compound-profiling): Compound profiling done by experts. Our Profiling and Screening Services allow us to run your material using biochemical and cellular assays.
 - [Assay Development](https://www.revvity.com/category/assay-development): We aim to simplify custom assay development for drug discovery and development scientists. Focus on the technology.
 - [Revvity Omics Pharma Services](https://www.revvity.com/category/pharma-omics-services): Forming partnerships with biopharma to accelerate therapeutic development and support patients with rare disorders.
 - [Phenotypic Screening](https://www.revvity.com/category/phenotypic-screening): Phenotypic screening tests large numbers of compounds in a target-agnostic assay which assesses phenotypic changes, such as the size and shape of cells.
 - [Virology Reagents](https://www.revvity.com/category/virology-reagents): Revvity's assay technologies provide simple, sensitive, streamlined workflows to help accelerate your viral studies.
 - [Neuroscience Research Reagents](https://www.revvity.com/category/neuroscience-research-reagents): Explore our wide range of reagents and assays for neuroscience research that will support your research into different neurodegenerative disorders.
 - [Immuno-oncology Reagents](https://www.revvity.com/category/immuno-oncology-reagents): Choose from a broad range of immuno-oncology assays and reagents to advance cancer immunotherapy research, including immune checkpoint and cytokine tools.
 - [Targeted Protein Degradation](https://www.revvity.com/category/targeted-protein-degradation): Explore cutting-edge targeted protein degradation technologies at Revvity, offering innovative solutions for protein degradation research and applications.
 - [Target engagement reagents](https://www.revvity.com/category/target-engagement-reagents): Measuring Target Engagement in drug discovery using the Cellular Thermal Shift Assay (CETSA®).
 - [Protein-protein interaction research reagents](https://www.revvity.com/category/protein-protein-interaction-research-reagents): Our protein-protein interaction analysis assays allow fast detection of protein-protein interaction for drug discovery.
 - [Protein kinase research reagents](https://www.revvity.com/category/protein-kinase-research-reagents): Revvity offers a range of end-point and real-time kinetic protein kinase assays, technologies, and instruments that allow rapid kinase detection and screening.
 - [Epigenetic research reagents](https://www.revvity.com/category/epigenetic-research-reagents): Whether you need an epigenetics kit or validated assay, our epigenetic research reagents offer a faster, more efficient path in the race to identify epigenetic drug candidates.
 - [Cytokine Research Reagents](https://www.revvity.com/category/cytokine-research-reagents-and-kits): High-quality cytokine assay reagent kit, a no-wash alternative to cytokine detection ELISA kits for research, pre-clinical and clinical assays.
 - [Biomarker detection reagents](https://www.revvity.com/category/biomarker-detection-reagents): Complete portfolio of biomarker detection reagents.
 - [GPCR research reagents](https://www.revvity.com/category/gpcr-research-reagents): We offer assays & reagents for any GPCR target, including Gs-, Gq- and Gi-coupled receptors. Explore our GPCR assay kits!
 - [Newest assay kits](https://www.revvity.com/category/newest-assay-kits): To keep up with the speed of your innovation, we strive to provide tools designed to benefit your research.
 - [Binding Assays](https://www.revvity.com/category/binding-assays): We offer a range of tools for receptor-ligand binding assays including radioligands, receptor-transfected cell membranes, and cell lines.
 - [Nucleotides](https://www.revvity.com/category/nucleotides): Radiolabeled nucleotides for probe labeling, sequencing, GTP binding, and other applications.
 - [Labeled Nucleotides](https://www.revvity.com/category/labeled-nucleotides): Labeled nucleotides (Hapten and Fluorescent labeled) are commonly used for detection of specific DNA & RNA sequences.
 - [Rapid Patient Testing](https://www.revvity.com/category/rapid-patient-testing): Learn how rapid patient Cardiology and Inflammation assays can improve your patient management by delivering sensitive results in 15 minutes or less.
 - [Research Solutions](https://www.revvity.com/category/research-solutions): Our solutions seamlessly guide researchers through each critical stage, addressing current obstacles and anticipating emerging challenges on the path to impactful discoveries.
 - [In Vitro Diagnostics (IVD) Platforms & Automation](https://www.revvity.com/category/ivd-platforms-automation): Our broad portfolio of automated platforms brings testing efficiency and uncompromised quality to diagnostic laboratories of all types and volumes.
 - [Automated Liquid Handling](https://www.revvity.com/category/automated-liquid-handling): We offer a comprehensive portfolio of liquid handling workstations to automate common to complex workflows designed to automate your laboratory’s needs.
 - [Genomic Analysis](https://www.revvity.com/category/genomic-analysis): Improve the efficiency of your genomic workflows with solutions designed to address your challenges.
 - [Imaging](https://www.revvity.com/category/imaging): Discover how our imaging solutions can help you accelerate the drug discovery and development process from target to cure.
 - [Detection Solutions](https://www.revvity.com/category/detection): Discover our portfolio of sensitive, accurate and reliable multimode plate readers and radiometric detection solutions
 - [Cell Analysis](https://www.revvity.com/category/cell-analysis): Discover our solutions for cellular analysis and let us help you for health cells analysis, cell counting, single cell analysis and more.
 - [Protein Analysis](https://www.revvity.com/category/protein-analysis): Discover how we can support your research with our powerful portfolio of protein analysis solutions.
 - [Allergy](https://www.revvity.com/category/allergy): Find out more about our fully automated quantitative single-parameter testing and indication-oriented multiparameter assays designed for allergy diagnostics.
 - [Signals Software](https://www.revvity.com/category/signals-software): Revvity Signals software offers scientific SaaS solutions for early-stage research and later-stage development, accelerating breakthroughs across life sciences industries.
 - [Instruments & Automation](https://www.revvity.com/category/instruments-automation): Discover our Instruments and Automation to improve efficiency, quality, and throughput, while eliminating repetitive tasks in sample preparation and analysis.
 - [Clinical & Diagnostics](https://www.revvity.com/category/clinical-diagnostics): Comprehensive portfolio of end-to-end laboratory solutions customized for reproductive health, infectious diseases, autoimmunity, allergy, endocrinology, cancer, clinical genomic services.
 - [Research & Development](https://www.revvity.com/category/research-development): Discover the breadth and depth of our products and solutions for Life Science Research and Development – and see how you can go faster from target to cure.
 - [Integrated Lab Automation](https://www.revvity.com/category/integrated-lab-automation): Automate your workflow with our integrated laboratory automation solution to improve your efficiency, productivity, reduce hands-on time, and increase standardization.
 - [Cancer](https://www.revvity.com/category/cancer): Enable your cancer research and cancer diagnostics with complete workflow solutions optimized to improve your lab’s efficiency.
 - [Reproductive Health](https://www.revvity.com/category/reproductive-health): We are committed to advancing reproductive health through innovative research workflows and implementing effective solutions for maternal and newborn screening.
 - [Infectious Diseases](https://www.revvity.com/category/infectious-diseases): Explore solutions for infectious disease diagnostics and research, empowering healthcare providers, laboratorians, and scientists to make critical decisions.
 - [Endocrinology](https://www.revvity.com/category/endocrinology): Our wide range of endocrinology diagnostic solutions comprises tools to assist the clinicians for the assessment and management of patients with endocrine conditions.
 - [Autoimmunity](https://www.revvity.com/category/autoimmunity): Complete portfolio of IVD solutions dedicated to autoimmune diagnostics encompassing a broad array of assays and innovative automation platforms.
 - [Neurodegeneration](https://www.revvity.com/category/neurodegeneration): Complete solutions for laboratories including a broad assay portfolio and innovative automation platforms for neurodegenerative disease diagnostics.
 - [Services](https://www.revvity.com/category/services): Services to support you extending your lab’s assay capabilities, venturing into enhanced data analysis solutions, training for specialized instrument and more.

## Blogs
 - [Building tomorrow - the professional journey of an SMA scientist.](https://www.revvity.com/blog/building-tomorrow-the-professional-journey-of-an-sma-scientist): Vanessa Romanelli's journey from SMA diagnosis to leading scientist in newborn screening highlights significant advancements in SMA research and early detection.
 - [The future of glycan profiling is faster, simpler, and more complete.](https://www.revvity.com/blog/future-glycan-profiling-faster-simpler-and-more-complete): Read how microfluidic glycan analysis enables faster, more complete glycan profiling to support biotherapeutic development and quality control.
 - [Beyond serendipity: the rise of rational AAV retargeting.](https://www.revvity.com/blog/beyond-serendipity-rise-rational-aav-retargeting): Learn about the shift in AAV development from screening large capsid libraries to rational engineering and how nanobody platforms can be applied in this blog.
 - [Modern genomics needs updated tools: The power of updated library designs for CRISPR and RNAi screening.](https://www.revvity.com/blog/modern-genomics-needs-updated-tools-power-updated-library-designs-crispr-and-rnai-screening): Discover how updated genome annotations and redesigned Dharmacon RNAi and CRISPR libraries improve on-target performance in functional genomics screens.
 - [Diverse applications of long-read sequencing: stories from chemagic users.](https://www.revvity.com/blog/diverse-applications-long-read-sequencing-stories-chemagic-users): Long-read sequencing (LRS) has evolved from a niche research tool to a transformative force in genomics. The latest FDA clearance of long-read whole genome sequencing (WGS) tests has been driving adoption in clinical labs, invigorated by the prospect of replacing multiple, disjointed tests with one comprehensive scan.
 - [Recognizing world sickle cell day 2026: strengthening newborn screening capacity across sub-Saharan Africa.](https://www.revvity.com/blog/recognizing-world-sickle-cell-day-2026-strengthening-newborn-screening-capacity): Revvity marks World Sickle Cell Day 2026 by supporting newborn screening expansion across sub-Saharan Africa through training, collaboration, and lab investment.
 - [From exploration to navigation: key insights from ASGCT 2026.](https://www.revvity.com/blog/exploration-navigation-key-insights-asgct-2026): What ASGCT 2026 revealed about where cell and gene therapy research is heading, across vector engineering, base editing, and gene delivery.
 - [Accelerating cell line development workflows with automated imaging. ](https://www.revvity.com/blog/accelerating-cell-line-development-workflows-automated-imaging): Explore how automated whole-well imaging and the Celigo™ image cytometer can streamline cell line development workflows for biologics and cell therapy
 - [Why accurate cell counting is critical to successful single-cell and single-nucleus RNA sequencing.](https://www.revvity.com/blog/why-accurate-cell-counting-critical-successful-single-cell-and-single-nucleus-rna-sequencing): Discover how accurate cell counting with AOPI fluorescence can support successful single-cell RNA sequencing and help reduce potential run failures.
 - [Active ribosome profiling versus classical Ribo-seq: choosing the right assay for the right biological question.](https://www.revvity.com/blog/active-ribosome-profiling-versus-classical-ribo-seq-choosing-right-assay-right-biological): Learn how active ribosome profiling and classical Ribo-seq differ, what each assay measures, and how to choose the right approach for your translation study.
 - [How rRNA contamination affects small RNA sequencing results. ](https://www.revvity.com/blog/how-rrna-contamination-affects-small-rna-sequencing-results): Learn how sequence-specific 2S rRNA blocking reduces dominant reads in Drosophila small RNA-seq and preserves usable depth for biologically relevant small RNAs.
 - [Decades of innovation: Revvity's legacy in prenatal healthcare.](https://www.revvity.com/blog/decades-innovation-revvitys-legacy-prenatal-healthcare): Explore Revvity's 40-year legacy in prenatal healthcare innovation, from pioneering Down syndrome screening to developing NIPT system that transformed care.
 - [How to design a DRUG-seq screen for interpretable biology.](https://www.revvity.com/blog/how-design-drug-seq-screen-interpretable-biology): Learn how to design a DRUG-seq screen with the right cell model, controls, dose, and timing for clearer transcriptomic signatures and better MoA insight.
 - [Demonstrating preclinical efficacy of a targeted CDK4 inhibitor by image cytometry.](https://www.revvity.com/blog/demonstrating-preclinical-efficacy-targeted-cdk4-inhibitor-image-cytometry): Discover how image cytometry helps demonstrate the inhibitory effect of atirmociclib on cancer cell growth in preclinical breast cancer models.
 - [How to optimize your DNA/RNA extraction to improve long-read sequencing results in WGS and beyond.](https://www.revvity.com/blog/how-optimize-your-dnarna-extraction-improve-long-read-sequencing-results-wgs-and-beyond): Optimize DNA/RNA extraction for long-read sequencing in WGS. Learn best practices for HMW DNA isolation to improve structural variant detection.
 - [RNA-seq as a screening readout: DRUG-seq vs. classic RNA-seq.](https://www.revvity.com/blog/rna-seq-screening-readout-drug-seq-vs-classic-rna-seq): Compare DRUG-seq and conventional RNA-seq for drug discovery screening, including cost, throughput, gene detection, and when each method is the better fit.
 - [When DRUG-seq is enough, and when Total DRUG-seq adds value after imaging.](https://www.revvity.com/blog/when-drug-seq-enough-and-when-total-drug-seq-adds-value-after-imaging): Learn when 3′ DRUG-seq is sufficient after imaging screens, and when Total DRUG-seq adds value for splicing, promoter usage, fusion transcripts, and ncRNA.
 - [From signatures to mechanism: a practical MoA workflow from DRUG-seq data.](https://www.revvity.com/blog/signatures-mechanism-practical-moa-workflow-drug-seq-data): Learn how DRUG-seq supports mechanism-of-action inference through pathway enrichment, connectivity mapping, clustering, and orthogonal validation in early drug discovery.
 - [Why early insight is becoming critical for antibody characterization: Q&A with Stéphane Martinez, MD.](https://www.revvity.com/blog/why-early-insight-becoming-critical-antibody-characterization-qa-stephane-martinez-md): Early antibody characterization is becoming critical for de-risking development. Discover how high-throughput assays support better decisions earlier.
 - [The collaborative advantage: accelerating next-generation cell and gene therapy development through scientific partnership.](https://www.revvity.com/blog/collaborative-advantage-accelerating-next-generation-cell-and-gene-therapy-development-through): Why collaboration beats competition in cell and gene therapy development. Learn how strategic partnerships accelerate therapeutic genome editing programs.
 - [Accelerating academic drug discovery: The Opera Phenix Plus at UC Santa Cruz.](https://www.revvity.com/blog/accelerating-academic-drug-discovery-opera-phenix-plus-uc-santa-cruz): Learn how the Opera Phenix transforms research with fast, high-resolution confocal imaging
 - [The power of streptavidin-coated magnetic beads in research: two compelling examples.](https://www.revvity.com/blog/power-streptavidin-coated-magnetic-beads-research-two-compelling-examples): Discover how streptavidin-coated magnetic beads revolutionize research through rRNA depletion in RNA-Seq and chemiluminescent immunoassays.
 - [Adapting plate reader workflows to ever-evolving assay requirements.](https://www.revvity.com/blog/adapting-plate-reader-workflows-ever-evolving-assay-requirements): Discover how VICTOR Kira™ multimode plate reader adapts to your evolving research, from protein quantification to kinase screening, all on one platform.
 - [Got the cell counting blues? Why Trypan Blue may no longer be the gold standard for cell counting and viability measurements.](https://www.revvity.com/blog/got-cell-counting-blues-why-trypan-blue-may-no-longer-be-gold-standard-cell-counting): Why Trypan Blue may no longer be the gold standard for cell counting and viability measurements.
 - [Ribosome profiling: how to interpret QC metrics for robust translational analysis.](https://www.revvity.com/blog/ribosome-profiling-how-interpret-qc-metrics-robust-translational-analysis): Learn the core Ribo-seq quality metrics, including footprint length, periodicity, CDS enrichment, rRNA contamination, and replicate reproducibility.
 - [Solving the real bottlenecks in multiplex immune cell engineering.](https://www.revvity.com/blog/solving-real-bottlenecks-multiplex-immune-cell-engineering): Explore the importance of multiplex immune cell engineering in cell therapies and how base editing can mitigate the associated risks.
 - [Ribosome profiling in drug discovery and perturbation screens.](https://www.revvity.com/blog/ribosome-profiling-drug-discovery-and-perturbation-screens): Ribo-seq and active ribosome enrichment uncover translational regulation in drug discovery
 - [MicroRNAs in fish biology: development, reproduction, and stress response introduction.](https://www.revvity.com/blog/micrornas-fish-biology-development-reproduction-and-stress-response-introduction): Small RNA-Seq in Fish Biology: miRNAs & Biomarkers Explore how small RNA sequencing reveals miRNA regulation in fish development, reproduction, and stress, plus biomarker potential for aquaculture research..
 - [Solving the five key challenges in ADC development with advanced assays.](https://www.revvity.com/blog/solving-five-key-challenges-adc-development-advanced-assays): Explore five key challenges in ADC development and the advanced assay technologies available to improve prediction, insights, and candidate selection.
 - [Beyond the hype: base editing enters its clinical era.](https://www.revvity.com/blog/beyond-hype-base-editing-enters-its-clinical-era): Base editing is moving from promise to clinical reality. Explore how precision, safety, and collaboration are shaping the next era of genome engineering.
 - [Ribosome profiling with the NEXTFLEX Small RNA-seq kit: A streamlined workflow for translational research in Oncology.](https://www.revvity.com/blog/ribosome-profiling-nextflex-small-rna-seq-kit-streamlined-workflow-translational-research): Learn how NEXTFLEX Small RNA-seq Kit enables qualified ribosome profiling to uncover translational control in cancer research, with protocols and QC benchmarks.
 - [WHO Global Tuberculosis Report 2025: Where are we now and what needs to change?](https://www.revvity.com/blog/who-global-tuberculosis-report-2025-where-are-we-now-and-what-needs-change): In this blog, explore WHO’s Global TB Report 2025. Dive into progress, challenges, and why diagnostic tools are key for improving TB incidence and deaths.
 - [Reduce mitochondrial reads in scRNA-seq without losing a critical QC signal.](https://www.revvity.com/blog/reduce-mitochondrial-reads-scrna-seq-without-losing-critical-qc-signal): Partial Mitochondrial Depletion for scRNA-seq with Cas9 Learn how post-library Cas9 gRNA depletion lowers mitochondrial reads in single-cell RNA-seq to boost sensitivity while preserving mitochondrial QC metrics.
 - [Streamlining bioprocessing: from cell line development to CMC readiness: Q&A with Dr. Neha Mishra, Senior Scientists.](https://www.revvity.com/blog/streamlining-bioprocessing-cell-line-development-cmc-readiness-qa-dr-neha-mishra-senior): Streamlining bioprocessing development from cell line generation to CMC readiness through stable pools, robust expression systems, and smarter analytics.
 - [MicroRNA evolution in animals: origins of miRNA biogenesis machinery.](https://www.revvity.com/blog/microrna-evolution-animals-origins-mirna-biogenesis-machinery): Explore how microRNAs and key biogenesis factors like Drosha, DGCR8, Dicer, and Argonaute emerged in animals, and what genomes reveal about metazoan evolution.
 - [Why your GPCR assays are perfect on paper and a mess in real life.](https://www.revvity.com/blog/why-your-gpcr-assays-are-perfect-paper-and-mess-real-life): When GPCR assays drift, the problem is often upstream. Discover how inconsistent cell handling and membrane prep create noise—and how to fix it.
 - [Top lab strategies for tackling chronic wasting disease.](https://www.revvity.com/blog/top-lab-strategies-tackling-chronic-wasting-disease): Struggling with Chronic Wasting Disease detection? Discover lab breakthroughs and prevention techniques now.
 - [What is a lab homogenizer?](https://www.revvity.com/blog/what-is-a-lab-homogenizer): Our 2025 guide to lab homogenizers reveals effective solutions for your lab needs now.
 - [How to streamline sample prep with automated homogenization.](https://www.revvity.com/blog/how-to-streamline-sample-prep-automated-homogenization): Tired of spending hours manually homogenizing samples, only to face inconsistent results and endless repetition?
 - [How to choose a rotor stator homogenizer?](https://www.revvity.com/blog/how-choose-rotor-stator-homogenizer): Rotor Stator Homogenizer: Contamination from sample prep can throw off your entire downstream.
 - [Next-generation sequencing (ngs): cutting edge applications.](https://www.revvity.com/blog/next-generation-sequencing-ngs-cutting-edge-applications): Learn about next-generation sequencing, exploring the latest techniques, bioinformatics workflows, and cutting-edge applications that are driving.
 - [Intro to proteomics data analysis.](https://www.revvity.com/blog/intro-proteomics-data-analysis): Proteomics data analysis is key for understanding protein structure, function, and interactions in biological systems. In this article we provide a comprehensive introduction, exploring key techniques, tools, and best practices.
 - [High-end platforms, high-quality prep: matching your homogenizer to your sequencer.](https://www.revvity.com/blog/high-end-platforms-high-quality-prep-matching-your-homogenizer-your-sequencer): In a world where throughput, accuracy and reproducibility are king, your homogenizer has to match your sequencer. If you’re performing sequencing downstream, but your upstream.
 - [Help for your new lab techs: avoiding sample prep mistakes.](https://www.revvity.com/blog/help-your-new-lab-techs-avoiding-sample-prep-mistakes): Learn how to help new lab techs avoid common sample preparation mistakes that can ruin experiments. From precision techniques to contamination prevention, these tips build stronger lab skills and more reliable results.
 - [How to reduce sample contamination.](https://www.revvity.com/blog/how-reduce-sample-contamination): Really, in any research environment samples are precious.
 - [Examining tick-borne pathogens: obstacles & strategies to tackle them (2024 update).](https://www.revvity.com/blog/examining-tick-borne-pathogens-obstacles-strategies-tackle-them-2024-update): Explore the hurdles to examining tick-born pathogens, limitations to common methods, and novel strategies for overcoming them.
 - [Diagnostic microbiology and infectious diseases in 2026: why front-end automation decides who survives the crush.](https://www.revvity.com/blog/diagnostic-microbiology-and-infectious-diseases-2026-why-front-end-automation-decides-who): Rising test volumes and staffing shortages are reshaping infectious disease labs. Discover why front-end automation is now critical to throughput, quality, and survival.
 - [Capacity planning for high-demand sequencing platforms: best practices for scheduling.](https://www.revvity.com/blog/capacity-planning-high-demand-sequencing-platforms-best-practices-scheduling): In this post, we walk through how to think about capacity planning for high-demand sequencing platforms—from mapping your real workflow to building a schedule that doesn’t depend on heroics.
 - [Garbage in, garbage out: dealing with data errors bioinformatics.](https://www.revvity.com/blog/garbage-in-garbage-out-dealing-data-errors-bioinformatics): Ensure cleaner pipelines and stronger insights—learn proven strategies for spotting and fixing data errors in bioinformatics, from sample prep to QC in your lab.
 - [Addressing bias in metagenomic studies.](https://www.revvity.com/blog/addressing-bias-metagenomic-studies): Learn how to address bias in metagenomic studies: your data can skew fast—see how DNA extraction and library preparation introduce bias, and apply standardized protocols and controls for reliable results.
 - [About GPCRs fragile biology, expensive decisions.](https://www.revvity.com/blog/about-gpcrs-fragile-biology-expensive-decisions): GPCR assays fail quietly when sample prep is inconsistent. Discover how standardized, automated homogenization reduces variability, reruns, and costly decisions.
 - [Common lab issues that impact biomarker data.](https://www.revvity.com/blog/common-lab-issues-impact-biomarker-data): Ensure biomarker data accuracy by addressing lab issues like temperature regulation, sample preparation consistency, and contamination control, and boost efficiency with automation.
 - [Cell lysis: the secret to protein access.](https://www.revvity.com/blog/cell-lysis-secret-protein-access): Cell Lysis, an often overlooked yet fundamental technique in the life sciences, is pivotal for understanding cellular functions, disease mechanisms, and for developing new therapies.
 - [Accelerating nucleic acid extraction in agriculture.](https://www.revvity.com/blog/accelerating-nucleic-acid-extraction-agriculture): Extracting and purifying nucleic acids (DNA and RNA) from plant samples is a crucial step in agricultural research and crop analysis.
 - [Choosing the right bead mill homogenization technology for your laboratory.](https://www.revvity.com/blog/choosing-right-bead-mill-homogenization-technology-your-laboratory): Choosing the right bead mill process and equipment for your needs depends on the type, size, volume, and dissociative resistance of the samples you are preparing.
 - [Helminth-derived miRNAs in host cell-free fluids.](https://www.revvity.com/blog/helminth-derived-mirnas-host-cell-free-fluids): Review of helminth-derived miRNAs packaged in extracellular vesicles, evidence for host modulation, and potential as circulating biomarkers for parasites.
 - [Advancing siRNA design for today’s transcriptome.](https://www.revvity.com/blog/advancing-sirna-design-todays-transcriptome): ON-TARGETplus 2.0: proven siRNA chemistry updated with latest RefSeq data for more precise gene targeting across today's expanded transcriptome.
 - [The central role of 5′-triphosphate small RNAs in <em>Caenorhabditis elegans.</em>](https://www.revvity.com/blog/central-role-5-triphosphate-small-rnas-caenorhabditis-elegans): Learn why 5' triphosphate 22G-RNAs in C. elegans are missed by standard small RNA-seq, and how RppH/TAP enables accurate secondary siRNA profiling.
 - [Obelisks: viroid-like circular RNAs in microbiomes.](https://www.revvity.com/blog/obelisks-viroid-circular-rnas-microbiomes): Obelisks are newly described viroid-like circular RNAs found in microbiomes. Discover their traits, host links, and detection methods.
 - [Advancing awareness: Revvity’s dedication to rare disease & newborn screening.](https://www.revvity.com/blog/advancing-awareness-revvitys-dedication-rare-disease-newborn-screening): Revvity advances rare disease awareness through newborn screening, early detection, and innovative technologies supporting better outcomes worldwide.
 - [10 trends in plant and animal genomics inspired by PAG33. ](https://www.revvity.com/blog/plant-and-animal-genomics-research-automated-sample-prep-workflows): Plant and animal genomics (PAG conference) trends on NGS, trait discovery, genomic-assisted breeding programs, seed and livestock programs, and deployment.
 - [Getting the most from ATAC-seq: key QC metrics and the mitochondrial DNA problem.](https://www.revvity.com/blog/getting-most-atac-seq-key-qc-metrics-and-mitochondrial-dna-problem): Learn how to interpret ATAC-seq QC metrics, deal with high mitochondrial DNA reads, and assess Cas9-based depletion strategies.
 - [Revvity and mo:re collaborate to improve reproducibility in 3D model research.](https://www.revvity.com/blog/revvity-and-more-collaborate-improve-reproducibility-3d-model-research): Revvity partners with mo:re to standardize organoid workflows through automation, improving reproducibility in 3D cell model-based applications
 - [Ribosomal RNA fragments in small RNA-seq: biological signals or artifacts?](https://www.revvity.com/blog/ribosomal-rna-fragments-small-rna-seq-biological-signals-or-artifacts): rRNA-derived fragments are common in biofluid small RNA-seq. Learn why they appear, when they matter biologically, and how to interpret them correctly.
 - [How to achieve tight temporal control over CRISPRa, CRISPRi, and CRISPRko applications.](https://www.revvity.com/blog/how-achieve-tight-temporal-control-over-crispra-crispri-and-crisprko-applications): Discover how Dharmacon™ Strict-R™ systems offer tight, reversible temporal control for CRISPRa, CRISPRi, and CRISPRko applications.
 - [Decoding tirzepatide’s dual agonism with advanced pharmacology assays.](https://www.revvity.com/blog/decoding-tirzepatides-dual-agonism-advanced-pharmacology-assays): Tirzepatide (Mounjaro) is a dual incretin agonist targeting GLP-1R and GIPR, improving glycemic control via biased signaling and Revvity-powered assays.
 - [Automated normalization of small RNA libraries with AutoNorm™ technology.](https://www.revvity.com/blog/automated-normalization-small-rna-libraries-autonormtm-technology): See how AutoNorm™ technology on the iconPCR™ system standardizes small RNA library yields using NEXTFLEX™ chemistry, boosting reproducibility and throughput.
 - [Uniting for early detection: the role of Revvity in DMD screening.](https://www.revvity.com/blog/uniting-for-early-detection-the-role-of-revvity-in-dmd-screening): Early detection of Duchenne Muscular Dystrophy with Revvity's automated newborn screening solutions for improved outcomes. Advanced CK-MM testing simplifies DMD diagnosis.
 - [Enhancing whole blood RNA-seq with globin depletion strategies.](https://www.revvity.com/blog/enhancing-whole-blood-rna-seq-globin-depletion-strategies): Learn how hybrid capture, RNase H, and Cas9-gRNA globin depletion improve whole blood RNA-seq sensitivity, reduce sequencing costs, and enable applications.
 - [Study reveals multifaceted roles of β-arrestins in GPCR internalization, including GLP-1R.](https://www.revvity.com/blog/study-reveals-multifaceted-roles-b-arrestins-gpcr-internalization-including-glp-1r): Study reveals multiple mechanisms regulating GPCR internalization, challenging the traditional view that β-arrestins are universally required for GPCR endocytosis.
 - [Addressing technical barriers in primary T cell research.](https://www.revvity.com/blog/addressing-technical-barriers-primary-t-cell-research): Discover how advanced lentiviral delivery and functional genomics tools overcome barriers in primary T cell research to accelerate autoimmune studies
 - [From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.](https://www.revvity.com/blog/policy-practice-what-fdas-2025-direction-means-your-precision-medicine-pipeline): This blog discusses the implications of the FDA’s “plausible mechanism pathway” guidance for gene therapy developers and precision therapy.
 - [Enhancing CAR NK-cell research with chemically defined serum-free culture solutions.](https://www.revvity.com/blog/enhancing-car-nk-cell-research-chemically-defined-serum-free-culture-solutions): Discover how chemically defined serum-free solutions optimize CAR NK-cell culture, enabling expansion, phenotyping, and cytotoxicity analysis
 - [Programmable depletion with CRISPR–Cas9: what DASH is, why it works, and where to use it.](https://www.revvity.com/blog/programmable-depletion-crispr-cas9-what-dash-why-it-works-and-where-use-it): Learn how DASH uses CRISPR-Cas9 RNPs to remove rRNA, globin, adapter dimers, and mtDNA from NGS libraries. Protocol tips, guide design, and use cases.
 - [What to consider when scaling tissue lysis workflows for multi-analyte DNA/RNA workstreams.](https://www.revvity.com/blog/tissue-homogenization-with-well-plate-bead-mill-homogenizers-into-dual-DNA-and-RNA-extraction): Dual DNA and RNA extraction using bead mill homogenizers for high-throughput, well-plate tissue lysis workflows. Scalable, reproducible, and cryogen-free lysis.
 - [The 2025 bioinformatics toolkit: from sample prep to ai-driven analysis.](https://www.revvity.com/blog/2025-bioinformatics-toolkit-sample-prep-ai-driven-analysis): Great sequencing starts before the run. Discover how smart prep and scalable bioinformatics tools are driving better genomics results in 2025.
 - [How to work with challenging or limited genomic samples (updated for 2025).](https://www.revvity.com/blog/how-work-challenging-or-limited-genomic-samples-updated-2025): Research-based methods for working with challenging or limited genomic samples. Expert protocols from DNA extraction to data analysis.
 - [What is a tissue homogenizer? We take a closer look for 2025.](https://www.revvity.com/blog/what-tissue-homogenizer-we-take-closer-look-2025): Learn what a tissue homogenizer is, and why it's such a valuable tool in your lab's arsenal.
 - [Variant calling through bulk RNA-seq is growing up: implications for oncology introduction.](https://www.revvity.com/blog/variant-calling-through-bulk-rna-seq-growing-implications-oncology-introduction): Learn how VarRNA classifies artifact, germline, and somatic variants from bulk RNA-Seq and what it means for oncology research and assay setup.
 - [What are biomarkers? Definition, applications and updates for 2025.](https://www.revvity.com/blog/what-are-biomarkers-definition-applications-and-updates-2025): What are Biomarkers? Learn how new tech is enhancing medicine in 2025.
 - [Next GeneSiS: cfDNA sequencing outperforms blood culture in sepsis.](https://www.revvity.com/blog/next-genesis-cfdna-sequencing-outperforms-blood-culture-sepsis): Prospective multicenter data show plasma microbial cfDNA sequencing detects pathogens more often than blood culture and can inform stewardship decisions.
 - [Understanding hybrid capture and the role of universal blockers.](https://www.revvity.com/blog/understanding-hybrid-capture-and-role-universal-blockers): Learn how hybrid capture targeted sequencing works and how universal blockers increase on target reads, reduce off target noise, and lower sequencing costs
 - [Challenges in synthetic oligonucleotide production: implications for NGS adapters introduction to NGS adapter synthesis.](https://www.revvity.com/blog/challenges-synthetic-oligonucleotide-production-implications-ngs-adapters-introduction-ngs): Long adapters push phosphoramidite chemistry. See how coupling efficiency, purification, and carryover control affect NGS library yield and index balance.
 - [High-content conversations: Professor Luca Magnani, Institute of Cancer Research, London.](https://www.revvity.com/blog/high-content-conversations-professor-luca-magnani-institute-cancer-research-london): Dr Luca Magnani (Breast Epigenetic & Evolution lab, ICR London) describes his use of the Operetta CLS high-content system to research adaptations to treatments.
 - [Managing abundant molecules in small RNA sequencing.](https://www.revvity.com/blog/managing-abundant-molecules-small-rna-sequencing): Blocking oligonucleotides curb dominant tRNA, Y RNA, and highly expressed miRNAs, boosting small RNA-seq library diversity and detection of rare targets.
 - [What to consider when choosing sonicators for tissue and cell lysis.](https://www.revvity.com/blog/choosing-a-sonicator): Top considerations when choosing a sonicator for your lab. Ultrasonic baths, probe sonicators, homogenizers for cell lysis.
 - [Optimal selection of read depth and length for bulk RNA-Seq: an updated perspective.](https://www.revvity.com/blog/optimal-selection-read-depth-and-length-bulk-rna-seq-updated-perspective): Plan bulk RNA-seq with confidence. See clear guidance on read depth, read length, poly(A) vs rRNA depletion, QC for FFPE, and when ≥100M reads are worth it.
 - [4 high-content imaging myths every researcher should know.](https://www.revvity.com/blog/4-high-content-imaging-myths-every-researcher-should-know): Debunking common high-content imaging myths about lasers, multiplexing, data collection, and AI so you can get the most out of your workflows.
 - [Small RNA-seq best practices for challenging samples.](https://www.revvity.com/blog/small-rna-seq-best-practices-challenging-samples): Read this blog post to learn about best practices for working with low input or degraded sample as input for your small RNA sequencing.
 - [ From Nobel recognition to therapeutics screening: the Treg revolution.](https://www.revvity.com/blog/nobel-recognition-therapeutics-screening-treg-revolution): Learn about impact of the 2025 Nobel Prize in Physiology or Medicine research into regulatory T cells and how it’s transforming therapeutic innovation.
 - [Oligonucleotide drug discovery: its journey through time.](https://www.revvity.com/blog/oligonucleotide-drug-discovery-its-journey-through-time): From antisense discovery to FDA approvals, explore oligonucleotide drug evolution and emerging trends shaping precision medicine
 - [Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.](https://www.revvity.com/blog/optimizing-functional-genomics-research-tools-aligning-their-design-ongoing-evolution-genome): Revvity's Dharmacon reagents provide world-class RNAi and CRISPR tools with advanced oligonucleotide chemistry for precise gene modulation and editing research.
 - [Tending to urolithiasis: tackling kidney stone disease research for stone formers.](https://www.revvity.com/blog/kidney-stone-disease-urolithiasis-research-bead-beating-homogenizer-improves-microbial-detection-compared-to-mortar-pestle): Bead beating on bead mill homogenizer shows enhanced bacterial detection on kidney stone cultures vs mortar-pestle processing – a publication spotlight.
 - [Real-time hypoxia monitoring using live cell imaging.](https://www.revvity.com/blog/real-time-hypoxia-monitoring-using-live-cell-imaging): Real-time live cell imaging allows dynamic monitoring of tumor hypoxia and reoxygenation to optimize KORTUC radiosensitization therapy timing.
 - [Strand-specific RNA-Seq: accurate transcriptomics.](https://www.revvity.com/blog/strand-specific-rna-seq-accurate-transcriptomics): Preserve strand information to avoid mis-quantification, antisense errors, and ensure reproducibility. Learn when stranded RNA-Seq justifies extra cost.
 - [How emerging epitranscriptomic modifications are reshaping our understanding of miRNA biology.](https://www.revvity.com/blog/how-emerging-epitranscriptomic-modifications-are-reshaping-our-understanding-mirna-biology): Learn how emerging epitranscriptomic modifications are reshaping our understanding of miRNA biology.
 - [Precision profiling of extracellular vesicle small RNAs.](https://www.revvity.com/blog/precision-profiling-extracellular-vesicle-small-rnas): How NEXPLOR enriches hepatocyte EVs in plasma, improves small RNA-seq signal, and reveals HCC-relevant miRNAs while reducing hematopoietic noise.
 - [Small RNAs with big roles: the emerging significance of Y RNAs.](https://www.revvity.com/blog/small-rnas-big-roles-emerging-significance-y-rnas): This review examines current knowledge on Y RNA biogenesis, isoform-specific biology, fragment classification, biomarker potential, and methods of detection.
 - [Unlocking the power of small RNA-seq in melanoma.](https://www.revvity.com/blog/unlocking-power-small-rna-seq-melanoma): Explore MEL38 and MEL12 microRNA signatures validated on FFPE and plasma with small RNA-seq, showing strong classification and risk stratification for research.
 - [Small nucleolar RNAs: emerging insights.](https://www.revvity.com/blog/small-nucleolar-rnas-emerging-insights): What snoRNAs do, how C/D and H/ACA classes form snoRNPs, non-canonical roles, and practical RNA-seq strategies for mature snoRNAs and sdRNAs.
 - [From birth to decay: a multi layer view of the mRNA lifecycle.](https://www.revvity.com/blog/birth-decay-multi-layer-view-mrna-lifecycle): Explore how nascent transcriptomics, ribosome profiling, and RNA-seq capture unique snapshots of mRNA dynamics to reveal layered gene regulation.
 - [Exploring the importance of sequencing guide RNAs in Functional Genomics.](https://www.revvity.com/blog/exploring-importance-sequencing-guide-rnas-functional-genomics): See how sgRNA sequencing boosts CRISPR QC, screen de-convolution, with small-RNA-seq to capture synthesis errors.
 - [Small nuclear RNAs: biogenesis, function, and NGS-based study techniques.](https://www.revvity.com/blog/small-nuclear-rnas-biogenesis-function-and-ngs-based-study-techniques): Clear guide to snRNA classes, the major and minor spliceosomes, Sm and Lsm biology, and how to profile snRNAs with total RNA-seq and small RNA-seq.
 - [Discordant mapping of R1 and R2 in WGS studies: understanding Illumina paired-end sequencing.](https://www.revvity.com/blog/discordant-mapping-r1-and-r2-wgs-studies-understanding-illumina-paired-end-sequencing): Learn why paired-end reads map in unexpected orientations, how to diagnose technical vs biological causes, and which QC and alignment steps reduce artifacts.
 - [Extracellular vesicle isolation for small RNA analysis: a methodological review.](https://www.revvity.com/blog/extracellular-vesicle-isolation-small-rna-analysis-methodological-review): Compare ultracentrifugation, SEC, TFF and microfluidic EV isolation workflows to capture intact vesicles and microRNAs for reliable small RNA sequencing.
 - [Small RNA biomarkers in cancer: how NGS is revolutionizing miRNA-based research.](https://www.revvity.com/blog/small-rna-biomarkers-cancer-how-ngs-revolutionizing-mirna-based-research): Explore how small RNA sequencing and NGS are transforming cancer biomarker discovery. Learn why miRNAs are key to precision oncology and liquid biopsy research.
 - [Characterization of small RNA in human extracellular vesicles.](https://www.revvity.com/blog/characterization-small-rna-human-extracellular-vesicles): Explore EVmiRNA, EVAtlas & EVPsort data on biofluid-specific miRNA, rRNA & tRNA signatures in human extracellular vesicles—vital for next-gen biomarkers.
 - [Profiling host and microbial small RNAs in saliva.](https://www.revvity.com/blog/profiling-host-and-microbial-small-rnas-saliva): Salivary EV small RNAs capture host immunity and bacterial signals. See best-practice library prep, blockers, and spike-ins for robust small RNA-seq.
 - [Advancing therapeutic strategies for CSF1R-ALSP. ](https://www.revvity.com/blog/advancing-therapeutic-strategies-csf1r-alsp): CSF1R-ALSP is a rare, fatal neurodegenerative disease marked by white matter loss, cognitive decline, and misdiagnosis—no approved treatments exist.
 - [Elucidating critical anti-tumor immunity pathways via imaging-based cytotoxicity assays.](https://www.revvity.com/blog/elucidating-critical-anti-tumor-immunity-pathways-imaging-based-cytotoxicity-assays): Imaging Cytometry is a Highly Useful Tool for In vitro T cell Immunology Studies
 - [Blurring the line: lncRNAs as hidden encoders of micropeptides.](https://www.revvity.com/blog/blurring-line-lncrnas-hidden-encoders-micropeptides): How lncRNAs encode functional micropeptides, how to detect them with Ribo-seq and proteomics, and what it means for translational research.
 - [Revvity and AIM Biotech collaborate to accelerate 3D biology and drug discovery.](https://www.revvity.com/blog/revvity-and-aim-biotech-collaborate-accelerate-3d-biology-and-drug-discovery): Revvity partners with AIM Biotech to develop integrated workflows for organoid and MPS technologies
 - [Circular RNAs as stable age and experience markers: new insights from Drosophila.](https://www.revvity.com/blog/circular-rnas-stable-age-and-experience-markers-new-insights-drosophila): CircRNAs accumulate with age and record stress in Drosophila brain. Methods and kit tips for rRNA-depleted, directional RNA-seq.
 - [Landmark Huntington’s gene therapy success brings promise for neuroscience research.](https://www.revvity.com/blog/landmark-huntingtons-gene-therapy-success-brings-promise-neuroscience-research): Landmark gene therapy shows 75% slowing of Huntington’s disease progression, representing a pivotal moment in neuroscience research.
 - [Biomarker discovery in the era of multi-omics.](https://www.revvity.com/blog/biomarker-discovery-era-multi-omics): Discover how multi-omics is transforming biomarker discovery, supporting clinically relevant insights to advance precision medicine and research
 - [How microphysiological systems are transforming cancer drug discovery.](https://www.revvity.com/blog/how-microphysiological-systems-are-transforming-cancer-drug-discovery): Discover how microphysiological systems are transforming cancer drug discovery, especially the use of organoids, organ-on-chips, and spheroids.
 - [Introduction to 16S amplicon profiling.](https://www.revvity.com/blog/introduction-16s-amplicon-profiling): Compare V1-V3, V3-V4, and V4 regions to choose the right NEXTFLEX 16S kit for your microbial profiling study.
 - [Transforming research with organoids and the tools that make it possible.](https://www.revvity.com/blog/transforming-research-organoids-and-tools-make-it-possible): Discover how organoids are transforming research in disease modeling, drug discovery & more—plus tools to analyze these 3D models effectively.
 - [The critical importance of high molecular weight DNA for long-read sequencing.](https://www.revvity.com/blog/critical-importance-high-molecular-weight-dna-long-read-sequencing): Discover why high molecular weight DNA extraction is critical for long-read sequencing success. Learn how top-performing technology enables future-ready genomic research.
 - [Quantifying CAR T-cell mediated tumor killing using image-based cytometry.](https://www.revvity.com/blog/quantifying-car-t-cell-mediated-tumor-killing-using-image-based-cytometry): The Celigo image cytometer provided unbiased, quantitative data to evaluate CAR T-cell efficacy in a humanized model of ccRCC
 - [PIWI-interacting RNAs, a unique class of small RNAs. ](https://www.revvity.com/blog/piwi-interacting-rnas-unique-class-small-rnas): What piRNAs are, how they form, and how they protect animal germline genomes, plus key sequencing and analysis considerations for piRNA studies.
 - [Introducing GlycoRNAs, a new frontier in small RNA biology. ](https://www.revvity.com/blog/introducing-glycornas-new-frontier-small-rna-biology): Overview of glycoRNAs: discovery, acp³U-linked glycosylation, detection tools (rPAL, drFRET), immune interactions, and emerging diagnostic potential.
 - [Improving Read 2 quality on Illumina NovaSeq X/X Plus PCR-free runs.](https://www.revvity.com/blog/improving-read-2-quality-illumina-novaseq-xx-plus-pcr-free-runs): Improve Read 2 quality on Illumina® NovaSeq® X/X Plus PCR-free runs with post-ligation double-SPRI cleanup and Y-shaped full-length adapters.
 - [Assessing error suppression strategies: a technical review of simplex and duplex UMIs.](https://www.revvity.com/blog/assessing-error-suppression-strategies-technical-review-simplex-and-duplex-umis): Review of simplex and duplex unique molecular identifiers, their error-suppression limits, depth costs, and use-case boundaries for RNA-seq, cfDNA, MRD and more.
 - [Closing the gap: how Revvity and Women’s Health Hub Finland are advancing women’s healthcare.](https://www.revvity.com/blog/closing-gap-how-revvity-and-womens-health-hub-finland-are-advancing-womens-healthcare): Revvity joins Women’s Health Hub Finland to advance maternal care, innovation, and equity in women’s health through science and collaboration.
 - [Poly(A) selection vs rRNA depletion: guide for picking the right upstream method.](https://www.revvity.com/blog/polya-selection-vs-rrna-depletion-guide-picking-right-upstream-method): How to choose poly(A) selection or rRNA depletion for RNA-seq based on organism, RNA quality, and study goals, with mechanisms, data traits, QC, and pitfalls.
 - [Validating brain-penetrating nanobodies with HTRF GPCR second messenger and receptor binding assays.](https://www.revvity.com/blog/validating-brain-penetrating-nanobodies-htrf-gpcr-second-messenger-and-receptor-binding-assays): Discover how Revvity's HTRF and Tag-lite assays validated brain-penetrating nanobodies targeting mGlu2 receptors, offering new hope for CNS therapeutic development
 - [How conditional bispecific antibodies are advancing precision immunotherapy.](https://www.revvity.com/blog/how-conditional-bispecific-antibodies-are-advancing-precision-immunotherapy): Conditional bispecific antibodies improve cancer immunotherapy by targeting tumors precisely, enhancing efficacy and safety through localized immune activation.
 - [Color balance in Illumina sequencing: why it still matters.](https://www.revvity.com/blog/color-balance-illumina-sequencing-why-it-still-matters): Learn why color balance still matters on Illumina systems, how modern UDI plates are engineered for it, and get step-by-step tips to build balanced pools that demultiplex cleanly.
 - [Scaling up oligonucleotide discovery: accelerating therapeutic lead identification from months to weeks.](https://www.revvity.com/blog/scaling-oligonucleotide-discovery-accelerating-therapeutic-lead-identification-months-weeks): Read how to scale up oligonucleotide discovery and accelerate therapeutic lead identification from months to weeks in this informative blog post from Revvity.
 - [Building on Ambros and Ruvkun's Nobel-Winning studies with Revvity’s microRNA toolkit.](https://www.revvity.com/blog/building-ambros-and-ruvkuns-nobel-winning-studies-revvitys-microrna-toolkit): Explore how Nobel-winning microRNA discoveries by Ambros and Ruvkun are advancing disease research with Revvity’s miRNA tools for modulation and sequencing.
 - [What to consider when choosing a homogenizer for your lab.](https://www.revvity.com/blog/what-consider-when-choosing-homogenizer-your-lab): Choosing a lab bead mill, rotor stator homogenizer, sonicator from sample characteristics, application needs, equipment features, usage, and maintenance
 - [Cell-free DNA: dynamic regulation and NGS strategies for ultra-low-frequency variant detection.](https://www.revvity.com/blog/cell-free-dna-dynamic-regulation-and-ngs-strategies-ultra-low-frequency-variant-detection): Read this blog post to learn how cfDNA is regulated and NGS strategies for ultra-low-frequency variant detection.
 - [Transfer RNA beyond translation.](https://www.revvity.com/blog/transfer-rna-beyond-translation): Discover how tRNA derived fragments (tRFs, tiRNAs) shape gene regulation and disease, plus key pointers for sequencing these challenging small RNAs.
 - [Methods for nascent transcriptome analysis](https://www.revvity.com/blog/methods-nascent-transcriptome-analysis): Explore GRO-seq, PRO-seq, NET-seq, and chromatin-bound RNA methods for nascent RNA profiling and learn how to prepare samples for Small RNA-seq.
 - [Fragmentation bias in NGS, and why this matters.](https://www.revvity.com/blog/fragmentation-bias-ngs-and-why-matters): Compare mechanical, enzymatic, and tagmentation fragmentation for NGS. Learn how each method impacts coverage bias, variant calling, and data quality.
 - [Why using orthogonal loss-of function approaches can strengthen your genetic research.](https://www.revvity.com/blog/why-using-orthogonal-loss-function-approaches-can-strengthen-your-genetic-research): Validate gene disruption studies using multiple loss-of-function technologies to reduce ambiguity and strengthen research findings
 - [Optimizing small RNA-Seq with spike-in controls.](https://www.revvity.com/blog/optimizing-small-rna-seq-spike-controls): Learn how synthetic spike-ins monitor recovery, correct ligation bias, and enable absolute quantification for reproducible small RNA-seq data.
 - [Microfluidic electrophoresis for nucleic acid and protein analysis.](https://www.revvity.com/blog/microfluidic-electrophoresis-nucleic-acid-and-protein-analysis): Metadata for SEM: 160 characters max Microfluidic electrophoresis has many advantages over traditional capillary electrophoresis including shorter run times, higher resolution, and fewer steps.
 - [Automation in routine PGT-A workflow.](https://www.revvity.com/blog/automation-routine-pgt-workflow): The field of genetics continues to grow at an unforeseen pace. Sequencing instrument manufacturers are rising to the challenge by offering larger and larger sequencing platforms capable of sequencing the entire human genome in just a few days with the promise of achieving the $1,000 genome.
 - [Challenges in analyzing data with UMI-UDIs in next-generation sequencing.](https://www.revvity.com/blog/challenges-analyzing-data-umi-udis-next-generation-sequencing): Explore the challenges in UMI-UDI data analysis, error correction, and data management to enhance accuracy in next-generation sequencing workflows.
 - [Cutting NGS costs without cutting science.](https://www.revvity.com/blog/cutting-ngs-costs-without-cutting-science): Reduce your NGS expenses without compromising data quality. Discover affordable NEXTFLEX™ barcoded adapters, universal blockers, and cleanup beads today.
 - [Barcode series: multiplexing with indexes of varying lengths.](https://www.revvity.com/blog/barcode-series-multiplexing-indexes-varying-lengths): Explore barcode series for sample multiplexing in NGS, using multiplex sequencing with indexes of varying lengths to improve accuracy and efficiency.
 - [Navigating the complexities of miRNA sequencing data analysis.](https://www.revvity.com/blog/navigating-complexities-mirna-sequencing-data-analysis): Explore the complexities of miRNA sequencing data analysis, alignment challenges, and small RNA-seq pipelines for accurate next-generation sequencing insights.
 - [Leveraging small RNA-Seq library preparation for ribosome profiling (ribo-seq).](https://www.revvity.com/blog/leveraging-small-rna-seq-library-preparation-ribosome-profiling-ribo-seq): Explore how Small RNA-Seq library preparation optimizes Ribosome Profiling (Ribo-Seq) for deeper insights into gene expression and translational research
 - [Guide to sample preparation for metagenomic analysis.](https://www.revvity.com/blog/guide-sample-preparation-metagenomic-analysis): Ultimate guide to sample preparation for metagenomic analysis. Discover best practices for microbial lysis, DNA/RNA extraction, and sequencing.
 - [Exploring long noncoding RNAs: structure, function, biomarker potential and sequencing considerations.](https://www.revvity.com/blog/exploring-long-noncoding-rnas-structure-function-biomarker-potential-and-sequencing): Delve into the latest in long noncoding RNA research using Next-Generation Sequencing
 - [Impact of ribodepletion on gene expression studies.](https://www.revvity.com/blog/impact-ribodepletion-gene-expression-studies): Discover how ribodepletion methods improve RNA-seq by removing rRNA, enhancing transcript detection, and enabling accurate gene expression analysis.
 - [Existing depletion technologies for Next-Generation Sequencing (NGS).](https://www.revvity.com/blog/existing-depletion-technologies-next-generation-sequencing-ngs): Explore existing NGS depletion technologies like hybridization, RNase H, CRISPR, and kinetic folding to enhance sequencing accuracy and data quality.
 - [Tips on establishing a reliable cell free DNA (cfDNA) workflow from plasma samples.](https://www.revvity.com/blog/tips-establishing-reliable-cell-free-dna-cfdna-workflow-plasma-samples): Explore the essential tips for establishing a reliable cell-free DNA (cfDNA) workflow from plasma samples. Learn how to optimize sample collection, streamline cfDNA extraction, and ensure accurate quantification for consistent results in non-invasive biomarker analysis.
 - [What to consider when selecting a centrifuge for your lab.](https://www.revvity.com/blog/selecting-a-tabletop-centrifuge-best-for-lab): Centrifuges are one of the most ubiquitous and important equipment in most labs. They play a key role in virtually all molecular workflows and assay protocols spanning numerous applications.
 - [Minimizing false positives in newborn screening is a critical priority.](https://www.revvity.com/blog/minimizing-false-positives-newborn-screening-critical-priority): Exploring impacts of false positives in newborn screening and how new technologies reduce their occurrence while maintaining sensitivity
 - [Three productivity advantages of switching to transposon-based integration.](https://www.revvity.com/blog/three-productivity-advantages-switching-transposon-based-integration): Switch from random integration to transposon-based integration and improve your efficiency, stability, and consistency for faster biotherapeutic production
 - [Understanding the impact of GC and PCR biases on Whole Genome Sequencing.](https://www.revvity.com/blog/understanding-impact-gc-and-pcr-biases-whole-genome-sequencing): Discover how GC content and PCR amplification biases distort whole-genome sequencing results—and learn lab, UMI, PCR-free, and QC strategies for uniform coverage.
 - [Cell panel screens play nicely with CRISPR screens: an integrated approach to drug target discovery.](https://www.revvity.com/blog/cell-panel-screens-play-nicely-crispr-screens-integrated-approach-drug-target-discovery): This blog explores how cell panel screens can be effectively combined with CRISPR screens for an integrated approach to drug target discovery.
 - [Optimizing assay duration in cell panel screens for slow-acting therapeutics.](https://www.revvity.com/blog/optimizing-assay-duration-cell-panel-screens-slow-acting-therapeutics): Explore the importance of long-term assays for cell panel screening to help advance cancer drug discovery in this educational blog post.
 - [Top tips for getting started with antibody validation using cell lines.](https://www.revvity.com/blog/top-tips-getting-started-antibody-validation-using-cell-lines): Get useful tips and expert guidance for getting started with antibody validation using cell lines in this informative blog post.
 - [The critical role of hamming distance in NGS barcodes.](https://www.revvity.com/blog/critical-role-hamming-distance-ngs-barcodes): Learn how optimal Hamming distance reduces index hopping and barcode misassignment in multiplex NGS, and how Unique Dual Indices safeguard data integrity.
 - [Mechanism Supports function: The Dharmacon™ siRNA algorithm 20 years strong.](https://www.revvity.com/blog/mechanism-supports-function-dharmacontm-sirna-algorithm-20-years-strong): Dharmacon™ siRNA design principles, mechanistic understanding of Ago2 function spanning 20 years of siRNA research (2004-2024) Key Findings: New mechanistic explanation confirming previously empirical siRNA design rules
 - [Beyond the pool: how CRISPR single cell screening can reveal hidden detailed phenotypic insights.](https://www.revvity.com/blog/beyond-pool-how-crispr-single-cell-screening-can-reveal-hidden-detailed-phenotypic-insights): Learn about the advantages and limitations of a CRISPR single cell screening and why a hybrid approach is beneficial in this informative blog post.
 - [How to combine functional genomic and cell panel screening to identify novel targets.](https://www.revvity.com/blog/how-combine-functional-genomic-and-cell-panel-screening-identify-novel-targets): This blog post provides practical guidance on how to combine cell panel screening and functional genomic screening to identify novel targets for drug discovery.
 - [Choosing the right WGS Library-Prep approach](https://www.revvity.com/blog/choosing-right-wgs-library-prep-approach): Match your sample and variant goals to the right NEXTFLEX kit—compare enzymatic, mechanical, and cfDNA workflows for accurate short-read WGS.
 - [High-content conversations: Dr. Francesco Neri, NeuroAge Therapeutics.](https://www.revvity.com/blog/high-content-conversations-dr-francesco-neri-neuroage-therapeutics): Dr. Francesco Neri of NeuroAge Therapeutics describes how he’s using Revvity’s Operetta CLS™ high-content analysis system to study neurodegenerative disorders.
 - [Good gut feelings about the health of microbial research.](https://www.revvity.com/blog/metagenomics-for-microbiome-research-in-cancer-and-antimicrobial-resistance): Microbial research and metagenomics in laboratories – perspectives from a researcher on microbiome in cancer and antimicrobial resistance.
 - [A practical guide to modern Ribo-seq protocols.](https://www.revvity.com/blog/practical-guide-modern-ribo-seq-protocols): This Ribo-seq blog post reviews the five most widely used protocols to prepare ribosome-protected mRNA fragments, outlining the key steps, major advantages, and trade-offs of each.
 - [Decoding long non-coding RNAs: Emerging tools and technologies in functional genomics](https://www.revvity.com/blog/decoding-long-non-coding-rnas-emerging-tools-and-technologies-functional-genomics): This blog focuses on functional genomics approaches that extend beyond transcript identification to elucidate the roles of lncRNAs at a genome-wide scale
 - [CHOSOURCE in action: Powering global tetanus prevention.](https://www.revvity.com/blog/chosource-action-powering-global-tetanus-prevention): Trinomab Therapeutics has partnered with Revvity’s CHOSOURCE expression platform to gain market approval of a first-in-class recombinant anti-tetanus toxin drug.
 - [The need for NGS automation for single-cell and spatial omics.](https://www.revvity.com/blog/need-ngs-automation): Advances in NGS techniques have increased the need for high-throughput and reliability. Read our blog to discover why NGS automation is key.
 - [How extracellular vesicles are reshaping biomarker discovery.](https://www.revvity.com/blog/how-extracellular-vesicles-are-reshaping-biomarker-discovery): Explore how extracellular vesicles are transforming biomarker discovery through advanced profiling techniques
 - [How to improve plasmid DNA quality control to accelerate RNA innovation.](https://www.revvity.com/blog/how-improve-plasmid-dna-quality-control-accelerate-rna-innovation): Explore how plasmid DNA quality impacts RNA therapeutics and how tools like the LabChip™ enable faster analysis and streamlined workflows
 - [Index hopping in Illumina NGS: what it is, why it matters, and how unique dual indexing solves the problem.](https://www.revvity.com/blog/index-hopping-illumina-ngs-what-it-why-it-matters-and-how-unique-dual-indexing-solves-problem): Learn how index hopping affects Illumina NGS accuracy and how UDIs can prevent costly misassignments in multiplexed runs.
 - [AlphaLISA technology: implementing a rapid, high-throughput screening method for immunomodulatory compounds.](https://www.revvity.com/blog/alphalisa-technology-implementing-rapid-high-throughput-screening-method-immunomodulatory): AlphaLISA technology, complemented by flow cytometry, enables high-throughput screening of immunomodulatory compounds by measuring cytokine release in PBMCs.
 - [CRISPR screening strategies: resistance vs. sensitivity - what’s right for your study?](https://www.revvity.com/blog/crispr-screening-strategies-resistance-vs-sensitivity-whats-right-your-study): Metadata for SEM: 160 characters max Guidance on which selection mechanism to choose for a pooled CRISPR drug-gene interaction screen to probe for gene perturbations.
 - [Precision base editing unlocks new potential for <em>in vivo</em> gene therapies.](https://www.revvity.com/blog/precision-base-editing-unlocks-new-potential-vivo-gene-therapies): Explore how the Pin-point base editing platform can help advance gene therapy in this blog and get the supporting scientific poster.
 - [Unlocking drug secrets: how functional genomic screening reveals valuable mechanism of action insights.](https://www.revvity.com/blog/unlocking-drug-secrets-how-functional-genomic-screening-reveals-valuable-mechanism-action): Explore how Functional Genomic Screening (FGS) can reveal valuable mechanism of action insights and find out our top 5 considerations for effective screening design.
 - [Arrayed or pooled library? Make the right first move in your CRISPR screen.](https://www.revvity.com/blog/arrayed-or-pooled-library-make-right-first-move-your-crispr-screen): An informative blog post providing practical guidance on how to make the right choice between an arrayed and pooled library as a first step to a successful CRISPR screen.
 - [Selecting the right reference panel for agrigenomics: optimizing low-pass WGS and skim-seq workflows with imputation.](https://www.revvity.com/blog/selecting-right-reference-panel-agrigenomics-optimizing-low-pass-wgs-and-skim-seq-workflows): Learn how to choose or build a reference panel that maximizes imputation accuracy for low pass whole genome sequencing (LP WGS) and Skim Seq in agrigenomics.
 - [Rethinking Alzheimer’s disease with brain-on-chip technology.](https://www.revvity.com/blog/rethinking-alzheimers-disease-brain-chip-technology): Explore how brain-on-chip models are advancing Alzheimer’s research by targeting toxic amyloid-beta oligomers in ETAP-Lab’s latest preclinical work.
 - [CircRNAs and their potential as biomarkers.](https://www.revvity.com/blog/circrnas-and-their-potential-biomarkers): Discover how circular RNAs (circRNAs) function as stable cancer biomarkers, their biogenesis through backsplicing, and how NGS with RNase R enhances detection for research and diagnostics.
 - [From bottleneck to breakthrough: mastering automation in nucleic acid purification for the modern lab.](https://www.revvity.com/blog/bottleneck-breakthrough-mastering-automation-nucleic-acid-purification-modern-lab): Discover how automation in nucleic acid purification can transform your lab from bottleneck to breakthrough. Learn practical strategies to overcome implementation challenges, reduce costs, and scale operations while maintaining quality and compliance. Ideal for lab managers seeking to modernize their genetic testing workflows.
 - [Revolutionizing cell therapies with base editing and AI-engineered CRISPR-Cas enzymes.](https://www.revvity.com/blog/revolutionizing-cell-therapies-base-editing-and-ai-engineered-crispr-cas-enzymes): Discover how base editing and AI-engineered CRISPR-Cas enzymes are revolutionizing cell therapies in this blog.
 - [Skim-seq vs. Low-Pass Whole Genome Sequencing (lp-WGS) in agrigenomics: choosing the right strategy.](https://www.revvity.com/blog/skim-seq-vs-low-pass-whole-genome-sequencing-lp-wgs-agrigenomics-choosing-right-strategy): Compare Skim-seq and low-pass whole genome sequencing (lp-WGS) for agrigenomics applications. Discover key differences in cost, coverage, imputation, and practical use cases.
 - [Early intervention matters: the value of first-trimester preeclampsia screening.](https://www.revvity.com/blog/early-intervention-matters-value-first-trimester-preeclampsia-screening): Exploring the importance of early intervention for preeclampsia, highlighting screening benefits and Revvity's commitment to maternal health solutions.
 - [Celebrating people in the lab on World Laboratory Day.](https://www.revvity.com/blog/preanalytical-analytical-sample-prep-labs-worldlabday): Celebrating world lab day from our scientists speaking to their experiences supporting labs and researchers with sample prep.
 - [Synthetic CRISPR sgRNA libraries enable scalable genome-wide activation screening.](https://www.revvity.com/blog/synthetic-crispr-sgrna-libraries-enable-scalable-genome-wide-activation-screening): Synthetic CRISPR solutions represent the next evolution in arrayed screening technology, offering researchers a powerful tool to accelerate their genomic studies
 - [CRISPRa and CRISPRi: tracing the origins and exploring the future.](https://www.revvity.com/blog/crispra-and-crispri-tracing-origins-and-exploring-future): Learn about the origins of CRISPRa and CRISPRi and what the future holds for these technologies in this blog post.
 - [Clonal cell lines or pool cell populations? Choosing the right solution to help avoid inconsistent results.](https://www.revvity.com/blog/clonal-cell-lines-or-pool-cell-populations-choosing-right-solution-help-avoid-inconsistent): Choosing between clonal cell lines and pool cell populations to help limit inconsistent results.
 - [Essential characterization techniques for organoid cell models.](https://www.revvity.com/blog/essential-characterization-techniques-organoid-cell-models): Advanced characterization tools play a pivotal role in standardizing organoid production, enabling more accurate disease modeling and drug screening
 - [Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.](https://www.revvity.com/blog/happy-birthday-cellometer-ascend-and-qa-charles-hernandez): Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.
 - [The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.](https://www.revvity.com/blog/mixed-lymphocyte-reaction-mlr-classic-assay-modern-drug-immune-assessment): This blog post describes the use of mixed lymphocyte reaction assays (MLR) as a technique to assess immunogenicity in drug discovery and development.
 - [The economic factors shaping expression system decisions and manufacturing strategies.](https://www.revvity.com/blog/economic-factors-shaping-expression-system-decisions-and-manufacturing-strategies): Explore the financial implications of expression system selection in recombinant protein production. Learn how to optimize costs, timelines, and sustainability for better returns on investment.
 - [World tuberculosis day 2025: Raising awareness to support global TB control efforts.](https://www.revvity.com/blog/world-tuberculosis-day-2025-raising-awareness-support-global-tb-control-efforts): Explore the latest global TB trends, challenges, and breakthroughs on World Tuberculosis Day. Learn how innovative diagnostics are shaping the fight against TB.
 - [Revolutionizing newborn screening: next-generation sequencing in genetic disease research.](https://www.revvity.com/blog/revolutionizing-newborn-screening-next-generation-sequencing-genetic-disease-research): Explore NGS technologies in genetic disease research, focusing on newborn screening advancements. Discover Revvity's role in Early Check and Screen4Care programs.
 - [Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.](https://www.revvity.com/blog/utilizing-alphalisa-technology-elucidate-cdk2-signaling-pathways-ccne-1-amplified-ovarian): High-grade serous ovarian cancer (HGSOC) is a highly lethal form of ovarian cancer characterized by genetic instability, with CCNE1 amplification occurring in about 15-20% of cases. Utilizing AlphaLISA technology, researchers aim to elucidate CDK2 signaling pathways in CCNE1-amplified HGSOC to identify potential therapeutic targets and improve treatment outcomes.
 - [How Mimix™ Reference Standards are generated, and how they can support your oncology research.](https://www.revvity.com/blog/how-mimix-reference-standards-are-generated-and-how-they-can-support-your-oncology-research): Find out how Mimix™ reference standards are generated, and how they can support your oncology research
 - [Unlocking biological questions with functional genomics.](https://www.revvity.com/blog/unlocking-biological-questions-functional-genomics): Learn about the biological questions that functional genomics approaches can help answer and key considerations when applying FGS.
 - [Genetic testing: a critical tool for diagnosing rare disorders and enhancing patient care.](https://www.revvity.com/blog/genetic-testing-critical-tool-diagnosing-rare-disorders-and-enhancing-patient-care): Genetic Testing: Essential for Diagnosing Rare Disorders and Improving Patient Care
 - [ Detecting total and phospho-ser129 α-synuclein in preclinical models.](https://www.revvity.com/blog/detecting-total-and-phospho-ser129-synuclein-preclinical-models): The article discusses the role of α-Synuclein in Parkinson’s disease and other synucleinopathies, highlighting the challenges in detecting this protein at low levels. It introduces an innovative approach using AlphaLISA™ SureFire® Ultra™ assays to measure total and phosphorylated α-Synuclein in complex matrices, along with BioLegend's LEGEND MAX α-Synuclein Aggregate ELISA kit to quantify aggregated levels in brain tissue from PFF-inoculated and sham-treated mice.
 - [Mastering screening: Validating and following up on hits from loss-of-function screens.](https://www.revvity.com/blog/mastering-screening-validating-and-following-hits-loss-function-screens): Learn about the most commonly used strategies in drug discovery for hit validation for loss-of-function screens.
 - [Enhancing drug development with advanced immune profiling.](https://www.revvity.com/blog/enhancing-drug-development-advanced-immune-profiling): Find out about an approach to perform fast protein analysis for drug screening in immune cells.
 - [Cell and gene therapy gets on point with base editors.](https://www.revvity.com/blog/cell-and-gene-therapy-gets-point-base-editors): Learn how base editing has the potential to make in cell and gene therapy, and how it can overcome limitations of traditional CRISPRCas9.
 - [Lentiviral sgRNA CRISPR screening in primary human immune cells.](https://www.revvity.com/blog/lentiviral-sgrna-crispr-screening-primary-human-immune-cells): Revvity preclinical services scientists demonstrate a pooled lentiviral CRISPR-Cas9 knockout screen in primary T cells.
 - [Innovative approaches to combat ADC resistance.](https://www.revvity.com/blog/innovative-approaches-combat-adc-resistance): Explore strategies to combat ADC resistance, from novel payloads to combination therapies, and discover innovations shaping cancer treatments
 - [Base editing goes big: A role in functional pooled screening.](https://www.revvity.com/blog/base-editing-goes-big-role-functional-pooled-screening): Explore how base editing can be applied to functional pooled screening in this blog post.
 - [Exploring the potential of base editing for sickle cell disease.](https://www.revvity.com/blog/exploring-potential-base-editing-sickle-cell-disease): Learn about the potential of base editing for treating sickle cell disease in this blog post.
 - [Revvity supports Abata Therapeutics to impact the trajectory of autoimmune disease with engineered Treg cell therapies.](https://www.revvity.com/blog/revvity-supports-abata-therapeutics-impact-trajectory-autoimmune-disease-engineered-treg-cell): Abata Therapeutics and Revvity impact the trajectory of autoimmunity therapies with enhanced Tregs.
 - [Considerations for engineering a successful knockout cell line generation.](https://www.revvity.com/blog/considerations-engineering-successful-knockout-cell-line-generation): Learn about the key considerations for engineering a knockout cell line in this blog post.
 - [Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.](https://www.revvity.com/blog/homology-directed-repair-plasmid-donor-considerations-successful-hdr-experimental-design): Learn about key considerations for successful homology-directed repair experimental design with a plasmid donor.
 - [Gene manipulation in iPSCs research.](https://www.revvity.com/blog/gene-manipulation-ipscs-research): Learn about why iPSCs are used as cell models in disease research and how our engineering services team can help with iPSC gene manipulation.
 - [Homology-directed repair with a DNA donor oligo: considerations for successful HDR experimental design.](https://www.revvity.com/blog/homology-directed-repair-dna-donor-oligo-considerations-successful-hdr-experimental-design): Learn about key considerations for successful homology-directed repair experimental design with a DNA donor oligo.
 - [Quality assessment of ngs imputation results in agrigenomics.](https://www.revvity.com/blog/quality-assessment-ngs-imputation-results-agrigenomics): Learn how NGS imputation and imputation quality scores impact genotype reliability in agrigenomics to improve plant and animal breeding outcomes.
 - [The logic behind imputation analysis in next-generation sequencing for agrigenomics.](https://www.revvity.com/blog/logic-behind-imputation-analysis-next-generation-sequencing-agrigenomics): Explore genetic imputation methods in NGS and learn how applications of NGS imputation enhance agrigenomics data analysis.
 - [Agrigenomics data analysis: key challenges and solutions.](https://www.revvity.com/blog/agrigenomics-data-analysis-key-challenges-and-solutions): Learn about agrigenomics data analysis challenges, big data challenges in agriculture, and how Revvity solutions help overcome these data analysis challenges in agrigenomics.
 - [SPRI technology: principles, bead composition, and bead-to-sample ratio impact.](https://www.revvity.com/blog/spri-technology-principles-bead-composition-and-bead-sample-ratio-impact): Explore SPRI technology, bead composition, and the impact of SPRI bead-to-sample ratios on cleanup and size selection efficiency in nucleic acid workflows.
 - [Cell homogenization: the ultimate overview for 2024.](https://www.revvity.com/blog/cell-homogenization-ultimate-overview-2024): Learn about cell homogenization, a crucial preparatory step in scientific experiments and sample analysis.
 - [2024's guide to homogenizer consumables: tubes, beads, and well plates.](https://www.revvity.com/blog/2024s-guide-homogenizer-consumables-tubes-beads-and-well-plates): Learn about homogenizer consumables: we’d provide background information as well as best practices on selecting and handling of homogenizer consumables.
 - [Hot topics in genomics: What to watch for at ASHG 2024.](https://www.revvity.com/blog/hot-topics-genomics-what-watch-ashg-2024): The field of genomics is advancing at an amazing rate - some may say at the speed of catalytic perfection! The 2024 ASHG annual meeting welcomes what will surely be a hub of innovation and research discovery, and it’s also right around the corner.
 - [The Evolution of agrigenomics: From microarrays to next-generation sequencing.](https://www.revvity.com/blog/evolution-agrigenomics-microarrays-next-generation-sequencing): Discover how agrigenomics has evolved with NGS and microarray technologies to revolutionize crop research, plant breeding, and agriculture sustainability.
 - [A journey through time: the fight against tuberculosis.](https://www.revvity.com/blog/journey-through-time-fight-against-tuberculosis): World TB Day falls on the 24th of March every year. On this day in 1882, Dr. Robert Koch first announced that he had isolated the bacillus Mycobacterium tuberculosis, which was responsible for causing tuberculosis (TB).
 - [Informatics does the heavy lifting in drug discovery research.](https://www.revvity.com/blog/informatics-does-heavy-lifting-drug-discovery-research): Explore the role of informatics in drug discovery research, leveraging AI and data management for streamlined workflows and enhanced outcomes
 - [A complete guide to viral vectors.](https://www.revvity.com/blog/a-complete-guide-to-viral-vector): Learn about viral vectors: what they are, how they can be applied to science, and the key attribute of AAVs, LVs, and AVs.
 - [Embracing modularity: flexible automation's role in drug discovery research.](https://www.revvity.com/blog/embracing-modularity-flexible-automations-role-in-drug-discovery-research): The full potential of automation and robotics won't be realized until progress is made to extend their capabilities, flexibility, and accessibility.
 - [The significance of longitudinal in vivo imaging in advancing drug discovery.](https://www.revvity.com/blog/the-significance-of-longitudinal-in-vivo-imaging-in-advancing-drug-discovery): The emergence of non-invasive in vivo imaging technologies has revolutionized our ability to longitudinally track, monitor, and visualize disease progression and treatment effects within a single living organism.
 - [World prematurity day: understanding the link between premature birth and preeclampsia.](https://www.revvity.com/blog/world-prematurity-day-understanding-the-link-between-premature-birth-and-preeclampsia): World Prematurity Day on Nov 17 raises awareness about premature births and preeclampsia, a major cause. Early detection and research are key to better outcomes.
 - [Assay treatment duration in cell panel screens: an important factor in drug response profiling of slow acting therapeutics.](https://www.revvity.com/blog/assay-treatment-duration-cell-panel-screens-important-factor-drug-response-profiling-slow): A blog post about assay treatment duration in cell panel screens as an important factor in drug response profiling of slow acting therapeutics.
 - [Trends and innovations: new insights from the 2024 bioprocessing summit (BPS) and bioprocess international (BPI) conferences.](https://www.revvity.com/blog/trends-and-innovations-new-insights-from-the-2024-bioprocessing-summit-and-bioprocess-international-conferences): Presenting the main themes from recent bioprocessing conferences including emerging technologies and methodologies, current challenges, and sustainability
 - [Why you should use 3D cell models for high throughput screening.](https://www.revvity.com/blog/why-you-should-use-3d-cell-models-high-throughput-screening): Learn about the benefits of using 3D cell models for high-throughput screening in this blog post.
 - [Ultra-rapid whole genome sequencing: helping to revolutionize NICU care and end diagnostic odysseys.](https://www.revvity.com/blog/ultra-rapid-whole-genome-sequencing-helping-revolutionize-nicu-care-and-end-diagnostic): Ultra-Rapid Whole Genome Sequencing: Transforming NICU care and ending diagnostic odysseys with swift, accurate genetic insights
 - [Why are miRNAs promising non-invasive Biomarkers?](https://www.revvity.com/blog/why-are-mirnas-promising-non-invasive-biomarkers): Discover how miRNAs serve as promising non-invasive biomarkers in cancer, acting as tumor suppressors or oncogenes by regulating genes involved in tumor growth.
 - [How to address the bottlenecks in AAV manufacturing.](https://www.revvity.com/blog/how-address-bottlenecks-aav-manufacturing): The FDA’s approval of the first adeno-associated virus (AAV)-delivered gene therapy in 2017 marked a turning point in viral vector research. As of April 2024, four AAV-based therapeutics have received approval, with many more in the clinical pipeline.
 - [Adapter design for NGS barcode quality in mutation detection.](https://www.revvity.com/blog/adapter-design-ngs-barcode-quality-mutation-detection): Explore how NGS adapter design with UMI and UDI barcodes improves barcode quality, reduces index hopping, and enhances rare mutation detection.
 - [Ultrasensitive α-Synuclein detection and quantification using immunoassays.](https://www.revvity.com/blog/ultrasensitive-synuclein-detection-and-quantification-using-immunoassays): This blog serves as an introduction to a paper that addresses unmet needs in available tools for α-Synuclein quantification and aggregate characterization and how immunoassays can be used as a powerful tool for studying neurodegenerative disease biomarkers.
 - [BOOSTing lentiviral transduction for T cell therapy success.](https://www.revvity.com/blog/boosting-lentiviral-transduction-t-cell-therapy-success): Revvity’s LentiBOOST™ technology improves lentiviral transduction efficiency and helps to lower cell therapy production costs for a range of cell types, including T cells and HSCs.
 - [The importance of newborn screening software: enhancing efficiency, accuracy, and patient care.](https://www.revvity.com/blog/importance-newborn-screening-software-enhancing-efficiency-accuracy-and-patient-care): Enhance newborn screening efficiency, accuracy, and patient care with advanced NBS software solutions like EVOYA™ and Revvity’s OZ Systems. Streamline workflows & improve outcomes.
 - [Taking advantage of viral cytopathic effects to aid in the rapid screening of effective viral therapies.](https://www.revvity.com/blog/taking-advantage-viral-cytopathic-effects-aid-rapid-screening-effective-viral-therapies): Taking Advantage of Viral Cytopathic Effects to Aid in the Rapid Screening of Effective Viral Therapies
 - [What is Image Cytometry?](https://www.revvity.com/blog/what-image-cytometry): What is Image Cytometry, it’s advantages and applications?
 - [Your cell counts will never be perfect – here's why.](https://www.revvity.com/blog/your-cell-counts-will-never-be-perfect-heres-why): Understanding cell counting variance and how to improve cell counting workflows
 - [Understanding autophagy.](https://www.revvity.com/blog/understanding-autophagy): What is Autophagy?
 - [Is your Trypan blue rupturing dead or dying immune cells leading to an overestimation of cell viability?](https://www.revvity.com/blog/your-trypan-blue-rupturing-dead-or-dying-immune-cells-leading-overestimation-cell-viability): Is your Trypan blue rupturing dead or dying immune cells leading to an over-estimation of cell viability?
 - [Enhancing cellular insights with imaging reagents.](https://www.revvity.com/blog/enhancing-cellular-insights-imaging-reagents): Recent advancements in imaging reagents have revolutionized high-content screening workflows, enhancing our ability to track and quantify cellular events.
 - [Functional characterization of microbial communities through Whole Genome Sequencing.](https://www.revvity.com/blog/functional-characterization-microbial-communities-through-whole-genome-sequencing): Discover how Whole Genome Sequencing (WGS) bridges taxonomy and function of microbial communities, offering insights into their roles and interactions.
 - [Optimizing the efficiency and reliability of cell isolation and analysis techniques.](https://www.revvity.com/blog/optimizing-efficiency-and-reliability-cell-isolation-and-analysis-techniques): Integrating rapid cell separation techniques with advanced characterization methodologies and reagents allows researchers to achieve reproducible results while maximizing efficiency and minimizing costs
 - [Recommendations from the AML MRD advisory board and the utility of Mimix Reference Standards in AML research.](https://www.revvity.com/blog/recommendations-aml-mrd-advisory-board-and-utility-mimix-reference-standards-aml-research): Learn about recent recommendations from an advisory panel on AML MRD testing and standardization and how Mimix reference standards can aid researchers.
 - [How to count cells using a hemocytometer.](https://www.revvity.com/blog/how-count-cells-using-hemocytometer): The hemocytometer has been an essential tool for hematologists, medical practitioners, and biologists for over a century.
 - [Speeding up sample prep TAT from tough research biospecimens](https://www.revvity.com/blog/speeding-sample-prep-tat-tough-research-biospecimens): Clinical researchers and their affiliated laboratories are crucial to accelerating potential medical discoveries that ultimately benefit society and the well-being of its people.
 - [Single-cell RNA and protein sequencing as a robust tool for multisite biomarker detection.](https://www.revvity.com/blog/single-cell-rna-and-protein-sequencing-as-a-robust-tool-for-multisite-biomarker-detection): This blog serves as an introduction to a Nature paper that addresses single-cell RNA sequencing and how it can be used as a robust tool for identifying predictive biomarkers across multiple sites.
 - [Unraveling the power of unique molecular identifiers in cancer research.](https://www.revvity.com/blog/unraveling-power-unique-molecular-identifiers-cancer-research): Explore the power of unique molecular identifiers (UMIs) in cancer research. Learn what UMI sequencing is and how it enhances accuracy in genomic studies.
 - [Partnering with purpose: collaboration with Australian Organoid Facility.](https://www.revvity.com/blog/partnering-purpose-collaboration-australian-organoid-facility): Organoids are becoming increasingly popular advanced cell-based model systems globally.
 - [How to leverage automation of tissue homogenization to address sample prep challenges in drug discovery & development.](https://www.revvity.com/blog/how-leverage-automation-tissue-homogenization-address-sample-prep-challenges-drug-discovery): Those entrenched in the saga of new therapeutic discovery would likely openly attest to their own experiences ensuring proper due diligence when pushing therapeutic candidates along their regulatory path that could one day better the quality of life for those who are ill.
 - [Revolutionizing drug safety: tools reshaping toxicology.](https://www.revvity.com/blog/revolutionizing-drug-safety-tools-reshaping-toxicology): The passage of the Federal Food, Drug, and Cosmetic Act in 1938 mandated animal testing for the development of safe and effective drugs for human use.
 - [Integrating live-cell imaging with optimized organoid pipelines for prostate cancer drug testing.](https://www.revvity.com/blog/integrating-live-cell-imaging-optimized-organoid-pipelines-prostate-cancer-drug-testing): Tumor organoids are becoming increasingly popular advanced model systems for in vitro cancer drug testing. Typically established from patient tumor samples or patient-derived xenografts (PDXs), these 3D cell cultures can replicate the genetic and molecular features of the original tumor.
 - [Advancing allogeneic cell therapy: unleashing the power of an innovative base editing tool.](https://www.revvity.com/blog/advancing-allogeneic-cell-therapy-unleashing-power-innovative-base-editing-tool): Generation of “off-the-shelf” allogeneic CAR-T cells is a rapidly progressing field that is revolutionizing human health through its immense applicability and promise in cell therapy.
 - [A glimpse into forensic toxicology analysis of opioids: new method development.](https://www.revvity.com/blog/glimpse-forensic-toxicology-analysis-opioids-new-method-development): Opioids are a class of medication, broadly umbrellaed by their structural relation to natural plant alkaloids found in opium (opiates).
 - [High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.](https://www.revvity.com/blog/high-content-imaging-sirna-screens-identify-trafficking-factors-alphavirus-infection): The complex relationship between a virus and its host is one of the hottest topics in science right now, and has been given considerable attention in recent weeks as a result of the race to understand the virus that causes COVID-19 and its potential vulnerabilities.
 - [Automated liquid handling systems: more than pipetting robots.](https://www.revvity.com/blog/automated-liquid-handling-systems-more-pipetting-robots): For decades, liquid handling was recognized as a key barrier to increasing experimental throughput, particularly in the life sciences.
 - [Antibody detection provides insights into long-term viral immunity and the efficacy of vaccines.](https://www.revvity.com/blog/antibody-detection-provides-insights-long-term-viral-immunity-and-efficacy-vaccines): With the current global pandemic, tests for detecting antibodies against SARS-CoV-2 have become widely available. These tests are used to determine if a person has been exposed to the virus and can suggest whether they have developed immunity.
 - [Discovery solutions with Alpha, HTRF, and multi-mode microplate readers for viral therapeutics.](https://www.revvity.com/blog/discovery-solutions-alpha-htrf-and-multi-mode-microplate-readers-viral-therapeutics): When time is of the essence, it helps to have the right technology on hand. This is especially applicable to labs involved in the development of highly sought-after viral therapeutics and vaccines.
 - [Optimizing experimental efficiency with multiplex immunoassays.](https://www.revvity.com/blog/optimizing-experimental-efficiency-multiplex-immunoassays): Immunoassays are powerful analytical techniques for quantifying analytes in biological samples, providing critical information for diagnostics, research, and quality control.
 - [Maximizing the impact of single-cell sequencing by addressing current bottlenecks.](https://www.revvity.com/blog/maximizing-impact-single-cell-sequencing-addressing-current-bottlenecks): The human body is formed of a large diversity of cells and cell types, each with unique expression patterns and molecular complexities.
 - [Exploring circulating extracellular vesicles in liquid biopsies for neurological disorders webinar.](https://www.revvity.com/blog/exploring-circulating-extracellular-vesicles-liquid-biopsies-neurological-disorders-webinar): Discover how extracellular vesicles in liquid biopsies offer insights into neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS in this blog.
 - [Microbiome research analysis webinar.](https://www.revvity.com/blog/microbiome-research-analysis-webinar): Join our webinar to explore the latest advances in microbiome research analysis and learn how cutting-edge techniques are revolutionizing microbiome studies.
 - [The automation challenge of ‘Bioprocess 4.0’.](https://www.revvity.com/blog/automation-challenge-bioprocess-40): Drug development technology is evolving rapidly, creating new opportunities for the pharmaceutical industry to produce high-quality targeted large molecule drugs such as biologics and biosimilars.
 - [White paper: screening and characterization of multi-specific antibody therapeutics.](https://www.revvity.com/blog/white-paper-screening-and-characterization-multi-specific-antibody-therapeutics): Antibody therapeutics have grown in complexity over their 30-year history in clinical application. Newer generation antibody therapies target multiple modalities and are multi-specific in nature.
 - [Offsetting COVID-19 staffing limitations in a laboratory: improving workflow efficiency via shorter assay workflows.](https://www.revvity.com/blog/offsetting-covid-19-staffing-limitations-laboratory-improving-workflow-efficiency-shorter): To implement social distancing for COVID-19, many organizations and companies require fewer staff members to be in the laboratory simultaneously.
 - [Evaluating next-generation cytokines for cancer immunotherapy.](https://www.revvity.com/blog/evaluating-next-generation-cytokines-cancer-immunotherapy): Cytokines play pivotal roles in maintaining immune homeostasis and combating various diseases.
 - [Unlocking the potential of organoids: the power of standardization and automation.](https://www.revvity.com/blog/unlocking-potential-organoids-power-standardization-and-automation): Interest in organoids has increased dramatically over the past decade, driven by their remarkable ability to self-organize into complex structures that closely resemble their biological counterparts.
 - [Revolutionizing predictive toxicology testing with organ-on-chip models.](https://www.revvity.com/blog/revolutionizing-predictive-toxicology-testing-organ-chip-models): With as many as 90% of new drug compounds falling short in clinical trials, the journey from a promising drug candidate to a marketable medication is fraught with challenges and uncertainties.
 - [Ubiquitin Ser65 triggers the mechanisms of mitophagy.](https://www.revvity.com/blog/ubiquitin-ser65-triggers-mechanisms-mitophagy): Ubiquitin (Ub) is covalently bound to many misfolded, denatured, or surplus cellular proteins and enables their degradation. It has been shown that PINK1 phosphorylates ubiquitin on Serine 65.
 - [Inhibit or destroy? Why PROTAC technology is emerging as a game changer for drug discovery and cancer therapy.](https://www.revvity.com/blog/inhibit-or-destroy-why-protac-technology-emerging-game-changer-drug-discovery-and-cancer): The concept of targeted protein degradation challenges conventional rules for pharmaceutical drug discovery. Rather than directly modify protein function by occupying an active site,
 - [Impact of aging and gut microbiota on neuroinflammation and parkinson’s disease.](https://www.revvity.com/blog/impact-aging-and-gut-microbiota-neuroinflammation-and-parkinsons-disease): Parkinson’s Disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s Disease (AD).
 - [Gain in accuracy by optimizing your Gαs coupled GPCR assays.](https://www.revvity.com/blog/gain-accuracy-optimizing-your-gas-coupled-gpcr-assays): G-protein-coupled receptors (GPCRs)  mediate most of our physiological responses to hormones, neurotransmitters, and environmental stimulants, and so have great potential as therapeutic targets for a broad spectrum of diseases. 
 - [TYK2 Presents an Attractive Target for the Treatment of Autoimmune and Inflammatory Diseases.](https://www.revvity.com/blog/tyk2-presents-attractive-target-treatment-autoimmune-and-inflammatory-diseases): Over the last few decades, the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway
 - [Differentiate your naive CD4+ T lymphocytes into Th17.](https://www.revvity.com/blog/differentiate-your-naive-cd4-t-lymphocytes-th17): You work on Th17 cells, and you want to know if your differentiation process is the best. Read this blog post – you may settle any doubts.
 - [The role of Immune dysregulation and Mitochondrial dysfunction in Amyotrophic Lateral Sclerosis.](https://www.revvity.com/blog/role-immune-dysregulation-and-mitochondrial-dysfunction-amyotrophic-lateral-sclerosis): Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons (MN). The disease is characterized by moderate and progressive dysfunction and loss of motor neurons.
 - [How to master HTRF phospho assays on brain samples.](https://www.revvity.com/blog/how-master-htrf-phospho-assays-brain-samples): Familiar with cutting tails, tagging mice, genotyping, and finally ending up with a few mice of interest? The cost in terms of time and effort is significant just to reach that point,
 - [How to isolate naïve CD4+ mouse T lymphocytes?](https://www.revvity.com/blog/how-isolate-naive-cd4-mouse-t-lymphocytes): We all know that a better understanding of immunology has enabled many improvements in disease treatments. So naturally, you want to profit from this trend.
 - [5 tips for mastering GPCR signaling with phospho-ERK assay.](https://www.revvity.com/blog/5-tips-mastering-gpcr-signaling-phospho-erk-assay): Good reagents are necessary, but not always enough to obtain the best results. Phospho-ERK1/2 kit is robust and easy to use.
 - [PBMC isolation and cytokine assays made easy.](https://www.revvity.com/blog/pbmc-isolation-and-cytokine-assays-made-easy): Are you working on PBMC from buffy coat or whole blood, but struggling with your PBMC isolation? You asked all your lab colleagues for advice
 - [Therapeutic strategies for Fibrotic diseases.](https://www.revvity.com/blog/therapeutic-strategies-fibrotic-diseases): Upon injury or illness, the human body has an impressive repertoire of machinery in place for self-healing. One important protective mechanism for tissue regeneration and wound healing is the formation of extracellular matrix (ECM).
 - [Quick guide to PBMC freezing.](https://www.revvity.com/blog/quick-guide-pbmc-freezing): The long-awaited blood sample you need has finally arrived! You extracted PBMC and managed to obtain a great yield, albeit with a little shivering
 - [Inflammation pathway reading, the way to tackle autoimmunity?](https://www.revvity.com/blog/inflammation-pathway-reading-way-tackle-autoimmunity): Inflammation is a central part of the human organism’s self-defense arsenal, and greatly contributes to the efficiency of our immune system and responses.
 - [Antidepressant shows potential for treating COVID-19.](https://www.revvity.com/blog/antidepressant-shows-potential-treating-covid-19): The speed at which researchers developed effective vaccines to prevent the spread of COVID-19 required unprecedented international cooperation on a scale never seen before.
 - [Second messenger assays bring clarity to cardiovascular research.](https://www.revvity.com/blog/second-messenger-assays-bring-clarity-cardiovascular-research): GPCRs are key players in cell signaling and a cornerstone of research in cardiovascular disorders and diseases (CVDs).
 - [Retinoic acid focus yields insight into neuroinflammation therapy.](https://www.revvity.com/blog/retinoic-acid-focus-yields-insight-neuroinflammation-therapy): Neuropsychiatric disorders often stem from or feed on neuroinflammatory and neurotoxic environments.
 - [Opening the door to additional CAR-T cell therapies in cancer.](https://www.revvity.com/blog/opening-door-additional-car-t-cell-therapies-cancer): Therapies that utilize a patient’s own immune system to fight against cancer, known as immunotherapies, have revolutionized the field of oncology in recent years.
 - [New technologies in multiple sclerosis drug discovery.](https://www.revvity.com/blog/new-technologies-multiple-sclerosis-drug-discovery): Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), including the brain and spinal cord.
 - [Key facts about neuroinflammation involvement in Alzheimer’s disease.](https://www.revvity.com/blog/key-facts-about-neuroinflammation-involvement-alzheimers-disease): Dementia is a chronic condition characterized by a progressive cognitive impairment that leads to functional disability.
 - [Kinase investigations open new doors in Oncology and Neuroscience.](https://www.revvity.com/blog/kinase-investigations-open-new-doors-oncology-and-neuroscience): he human kinome has 518 protein kinases, which contain 1.7% of human genes and approximately 20 lipid kinases.
 - [In the treatment of human cancer, KRAS remains an untouchable target of choice.](https://www.revvity.com/blog/treatment-human-cancer-kras-remains-untouchable-target-choice): The KRAS gene (homologous to the viral oncogene of Kirsten rat sarcoma 2) is a proto-oncogene that codes for a small GTPase transducing protein called KRAS belonging to the RAS superfamily.
 - [New hope for Huntington’s disease drug discovery.](https://www.revvity.com/blog/new-hope-huntingtons-disease-drug-discovery): Huntington’s disease is a rare hereditary degenerative brain disorder that was described for the first time by George Huntington in 1872.
 - [Impact of FGFRs dysregulation in oncogenic mechanisms.](https://www.revvity.com/blog/impact-fgfrs-dysregulation-oncogenic-mechanisms): Fibroblast Growth Factors (FGFs) have several roles in adult tissues: they mediate metabolic functions, tissue development, repair, and regeneration.
 - [Deciphering TREM2’s role in Alzheimer’s disease.](https://www.revvity.com/blog/deciphering-trem2s-role-alzheimers-disease): Alzheimer’s disease (AD) is a brain disorder that causes progressive neurological atrophy and is the most common cause of dementia. The majority of AD cases are late onset and a clear cause is still unknown.
 - [Strategies for success: Developing safe and effective commercial cell lines.](https://www.revvity.com/blog/strategies-success-developing-safe-and-effective-commercial-cell-lines): Cell lines have been indispensable tools in drug discovery and developmental research for decades. They provide a consistent and reproducible in vitro model system derived from the same lineage of animal, human, microorganism, or plant cells.
 - [When AlphaLISA and HTRF meet inflammatory bowel disease research needs.](https://www.revvity.com/blog/when-alphalisa-and-htrf-meet-inflammatory-bowel-disease-research-needs): Inflammation of the digestive tract wall due to an overactivation of the digestive immune system is a characteristic of inflammatory bowel diseases.
 - [The potential of subset-specific treatment options to overcome cancer resistance. ](https://www.revvity.com/blog/potential-subset-specific-treatment-options-overcome-cancer-resistance): Targeted cancer therapy has been a game changer in cancer treatment, significantly improving the survival and quality of life of many.
 - [How high-content is your high-content?](https://www.revvity.com/blog/how-high-content-your-high-content): High-content screening technology has the potential to accelerate research by extracting huge amounts of information from images of cells, on a cell-by-cell basis.
 - [3 steps for successful tumor xenograft analysis.](https://www.revvity.com/blog/3-steps-successful-tumor-xenograft-analysis): Tumor xenograft models are widely used in cancerology studies. They enable researchers to characterize tumors and study tumorigenesis and metastasis accurately.
 - [The evolving role of cell counting in drug discovery.](https://www.revvity.com/blog/evolving-role-cell-counting-drug-discovery): The field of cell counting has undergone a significant transformation in recent years, especially with the growing use of cells in research, biomanufacturing, and therapeutic products.
 - [Drug repurposing for antiviral therapies: research and strategies with high throughput screening.](https://www.revvity.com/blog/drug-repurposing-antiviral-therapies-research-and-strategies-high-throughput-screening): As the effects of the novel virus are felt worldwide, researchers across the globe are mobilizing to find anti-viral therapies to fight against this new infection.
 - [Challenges and strategies for characterization of next-generation bispecific antibodies.](https://www.revvity.com/blog/challenges-and-strategies-characterization-next-generation-bispecific-antibodies): The emergence of bispecific antibodies has been heralded as the fourth wave of biopharmaceutical innovation, providing opportunities to target two different antigens with a single therapeutic.
 - [Understanding how pre-clinical models impact immuno-oncology therapeutics.](https://www.revvity.com/blog/understanding-how-pre-clinical-models-impact-immuno-oncology-therapeutics): Finding a best-fit or combination of preclinical models in immuno-oncology drug development poses a unique series of challenges.
 - [Understanding – and fighting against – immunotherapy resistance in cancer treatments.](https://www.revvity.com/blog/understanding-and-fighting-against-immunotherapy-resistance-cancer-treatments): Every individual has an immune system, which exists to protect the body from infection. We generally think about the immune system protecting us from threats like influenza, pertussis, or most recently, the SARS-CoV-2 virus.
 - [Synaptotagmin 7: a key player in synaptic function and plasticity.](https://www.revvity.com/blog/synaptotagmin-7-key-player-synaptic-function-and-plasticity): Studying the human brain is arguably one of the greatest challenges faced by life science researchers, not only due to its size, complexity, and the availability of appropriate technologies, but also due to ethical issues that need to be considered.
 - [<i>In Vitro </i>3D cellular model shows promise in understanding rare pediatric neurodegenerative disease.](https://www.revvity.com/blog/vitro-3d-cellular-model-shows-promise-understanding-rare-pediatric-neurodegenerative-disease): The complexity of neurodegenerative diseases, and the associated challenges of modelling the development and function of the human brain, have made many disorders difficult to study experimentally.
 - [Improving our understanding of biofilm formation on indwelling medical devices.](https://www.revvity.com/blog/improving-our-understanding-biofilm-formation-indwelling-medical-devices): While the benefits of indwelling medical devices, such as contact lenses, urinary catheters, and pacemakers, arguably outweigh the risks, medical device-associated infections still account for a large proportion of hospital-acquired infections.
 - [CNS drug discovery using iPSC technology.](https://www.revvity.com/blog/cns-drug-discovery-using-ipsc-technology): Developing drugs to target the central nervous system (CNS) is challenging as a result of the bloodbrain barrier (BBB) acting as an anatomical blockade, preventing many therapeutic candidates from reaching neuronal tissue directly.
 - [Biomarkers: a novel approach to understanding dementia.](https://www.revvity.com/blog/biomarkers-novel-approach-understanding-dementia): Around 50 million people worldwide currently suffer from one or more forms of dementia. Of these, around 850,000 live in the United Kingdom (UK) at an annual care cost of £26 billion (US$38 billion)
 - [Big possibilities for small RNAs in the treatment of neurodegenerative diseases.](https://www.revvity.com/blog/big-possibilities-small-rnas-treatment-neurodegenerative-diseases): Recent research shows that microRNAs (miRNAs), small RNAs with functions beyond protein translation, are abundant in the central nervous system.
 - [Bioprinting workflow enables high-throughput drug discovery in 3D cell cultures.](https://www.revvity.com/blog/bioprinting-workflow-enables-high-throughput-drug-discovery-3d-cell-cultures): Drug discovery can be a long and expensive process, so researchers are always looking for ways to optimize and enhance workflows.
 - [Trust your gut: balancing the microbiome for better health.](https://www.revvity.com/blog/trust-your-gut-balancing-microbiome-better-health): The human gut harbors a diverse and extremely active population of microorganisms known as the microbiota.
 - [Zinc finger proteins: the answer to treating Huntington's.](https://www.revvity.com/blog/zinc-finger-proteins-answer-treating-huntingtons): Since the first clinical description of Huntington’s disease (HD) was described in 1872 by George Huntington, research into the condition has come a long way and genetic testing can now identify those likely to develop the disease.
 - [High content screening system helps discover new cancer immunotherapies and advance personalized medicine.](https://www.revvity.com/blog/high-content-screening-system-helps-discover-new-cancer-immunotherapies-and-advance): A group of scientists at the Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed a new microscopy technique for blood cells that saves time, money, and, most importantly, is already helping to uncover new immunotherapy treatments for cancer.
 - [3D cellular imaging: some critical factors for success.](https://www.revvity.com/blog/3d-cellular-imaging-some-critical-factors-success): Since its introduction in the early 1990s to today, 3-dimensional (3D) imaging still remains a “buzz” word that sounds a bit mysterious.
 - [Now we have a COVID-19 vaccine, are treatments really needed.](https://www.revvity.com/blog/now-we-have-covid-19-vaccine-are-treatments-really-needed-0): When the World Health Organization declared the COVID-19 outbreak a pandemic in March 2020, it was clear that the novel coronavirus posed a significant threat to global health.
 - [Could tumoroids solve the problem of high attrition in cancer trials?](https://www.revvity.com/blog/could-tumoroids-solve-problem-high-attrition-cancer-trials-0): Over the past few decades, our understanding of cancer biology has increased rapidly. Yet our ability to translate this knowledge into clinical success remains poor, with reports of eye-wateringly high attrition rates for cancer therapeutics
 - [Identifying antivirals and vaccines with the power of high content screening.](https://www.revvity.com/blog/identifying-antivirals-and-vaccines-power-high-content-screening): Researchers worldwide are working around the clock to develop effective drugs and vaccines for the SARS-CoV-2 virus.
 - [High content imaging solutions aid in screen for Zika virus inhibitors.](https://www.revvity.com/blog/high-content-imaging-solutions-aid-screen-zika-virus-inhibitors): Although the novel coronavirus is the subject of nearly every media story right now, several years ago it was the Zika virus (ZIKV) gathering a great deal of attention.
 - [AI, machine learning and deep learning boost productivity and depth of insight for cellular imaging.](https://www.revvity.com/blog/ai-machine-learning-and-deep-learning-boost-productivity-and-depth-insight-cellular-imaging): Improved cellular imaging technologies are providing researchers with more robust datasets while maintaining high data quality.
 - [How to improve cell counting processes for accurate cell characterization.](https://www.revvity.com/blog/how-improve-cell-counting-processes-accurate-cell-characterization): Identifying, counting, and performing quantitative measurements on cells or cellular responses throughout discovery and development workflows can be challenging.
 - [High-content imaging system reveals secrets of tuberculosis.](https://www.revvity.com/blog/high-content-imaging-system-reveals-secrets-tuberculosis): Mycobacterium tuberculosis (M. tuberculosis) has been killing humans since the beginning of recorded history.1 Recent estimates claim the disease is responsible for 1.8 million deaths and another 10 million people becoming infected with tuberculous every year.
 - [Visualizing SARS-CoV-2 interactions in 3D.](https://www.revvity.com/blog/visualizing-sars-cov-2-interactions-3d): Since the first reported case of COVID-19 in December 2019, researchers around the world have been working to improve their understanding of the novel coronavirus, SARS-CoV-2.
 - [Rethinking how we prepare for the next pandemic.](https://www.revvity.com/blog/rethinking-how-we-prepare-next-pandemic): The SARS-CoV-2 pandemic has highlighted the fundamental role that research and innovation play in protecting people from the potential deadly effects of infectious diseases
 - [Not just a respiratory disease – the cardio-COVID link.](https://www.revvity.com/blog/not-just-respiratory-disease-cardio-covid-link): Early in the coronavirus pandemic, evidence emerged that COVID-19 was not just a disease of the respiratory system as initially thought.
 - [New insights into lung cancer evolution could help researchers tackle tumor resistance.](https://www.revvity.com/blog/new-insights-lung-cancer-evolution-could-help-researchers-tackle-tumor-resistance): One of the major challenges in oncology research today is the ability of tumors to evolve drug resistance. For researchers in the field, tackling cancer resistance can be a frustrating and somewhat unrewarding pursuit
 - [Epigenetic therapy shows promise as a companion for immunotherapy.](https://www.revvity.com/blog/epigenetic-therapy-shows-promise-companion-immunotherapy): The use of immunotherapies to treat certain types of cancer has expanded greatly over the last 25 years. Today, there are many approved therapies that use immune checkpoint inhibitors to activate T-cell killing.
 - [The role of 16S metagenomics in microbial research.](https://www.revvity.com/blog/role-16s-metagenomics-microbial-research): Explore 16S metagenomics (16S rRNA sequencing) for microbiome research. Learn how 16S rRNA analysis advances microbiome insights and microbial profiling.
 - [A new human neuronal cell model of huntington’s disease for <i>in vitro</i> screening.](https://www.revvity.com/blog/new-human-neuronal-cell-model-huntingtons-disease-vitro-screening): To accelerate their discovery of new treatments for Huntington’s disease (HD), researchers at the University College of London developed a human neuronal cell model of the disease for use in high-throughput screening of potential therapies.
 - [Definitive evidence of narcolepsy as an autoimmune disease.](https://www.revvity.com/blog/definitive-evidence-narcolepsy-autoimmune-disease): Narcolepsy is a chronic neurological disorder in which the brain’s ability to regulate the sleep-wake cycle is disrupted.
 - [Now we have a COVID-19 vaccine, are treatments really needed.](https://www.revvity.com/blog/now-we-have-covid-19-vaccine-are-treatments-really-needed): When the World Health Organization declared the COVID-19 outbreak a pandemic in March 2020, it was clear that the novel coronavirus posed a significant threat to global health. Little was known about how the virus spread, who the disease affected most, and how to best prevent transmission.
 - [Engineered viral RNA gives boost to neurological disease research.](https://www.revvity.com/blog/engineered-viral-rna-gives-boost-neurological-disease-research): In recent years, the therapeutic potential of ribonucleic acid (RNA) has been thrust into the spotlight, with research in this area now thriving. Several RNA-based therapies have been authorized and approved – including some of the first COVID-19 vaccines – and many more are currently in the pipeline.
 - [Dr. Helena Fehling: beating leishmania protozoan parasites with their own weapons.](https://www.revvity.com/blog/dr-helena-fehling-beating-leishmania-protozoan-parasites-their-own-weapons): People in tropical areas around the globe are battling an increasingly common parasitic disease – leishmaniasis. Leishmania protozoan parasites target host macrophages resulting in cutaneous, mucosal, and visceral ulcers, some of which can be extremely disfiguring and even fatal.
 - [Could nanomedicines be the answer to treating brain cancer?](https://www.revvity.com/blog/could-nanomedicines-be-answer-treating-brain-cancer): Although cancer treatment has come a long way in recent years, prognosis for individuals with brain cancer still remains poor.
 - [Can we overcome the emergence of HIV drug resistance with novel inhibitors?](https://www.revvity.com/blog/can-we-overcome-emergence-hiv-drug-resistance-novel-inhibitors): The human immunodeficiency virus (HIV) is one of the largest epidemics in the world today, having claimed over 36 million lives to date.1 In 2020 alone, 37.7 million people were estimated to be living with the virus and around 680,000 people died from HIV-related causes.
 - [Novel approaches for overcoming antimicrobial resistance.](https://www.revvity.com/blog/novel-approaches-overcoming-antimicrobial-resistance): The growing number of drug-resistant pathogens has led the World Health Organization (WHO) to declare antimicrobial resistance, or AMR, a top 10 global public health threat.1 In India, more than 58,000 babies died in one year as a result of infection by resistant bacteria
 - [Next-generation antimalarial drugs urgently needed to reach malaria elimination targets.](https://www.revvity.com/blog/next-generation-antimalarial-drugs-urgently-needed-reach-malaria-elimination-targets): Earlier this year, the World Health Organization (WHO) announced that over one million African children had received one or more doses of the world’s first malaria vaccine, RTS,S/AS01 (RTS,S).
 - [Genome-wide CRISPR study reveals novel immune regulators.](https://www.revvity.com/blog/genome-wide-crispr-study-reveals-novel-immune-regulators): CRISPR genome editing has become a powerful tool for studying gene function, and in recent years the CRISPR-Cas9 system has been adapted to generate two new gene expression-modulating technologies: CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi).
 - [Genetically engineered PDX models help identify therapeutic targets.](https://www.revvity.com/blog/genetically-engineered-pdx-models-help-identify-therapeutic-targets): Decades of research and technological advancements are enabling scientists to more fully understand how tumors proliferate, metastasize, and evolve.
 - [Enhancing 3D Cancer Models to Better Reflect <i>In Vivo</i> Tumor Pathology.](https://www.revvity.com/blog/enhancing-3d-cancer-models-better-reflect-vivo-tumor-pathology): In recent years, the way that we describe—and subsequently understand—cancer development and progression has shifted significantly.
 - [Overcoming throughput, standardization, and analysis challenges for human midbrain organoids.](https://www.revvity.com/blog/overcoming-throughput-standardization-and-analysis-challenges-human-midbrain-organoids): In recent years, interest in human three-dimensional (3D) organ-like microtissues called organoids has skyrocketed, with citations increasing exponentially in the scientific literature over the past decade.
 - [The why, where and how of live-cell imaging.](https://www.revvity.com/blog/why-where-and-how-live-cell-imaging): Live-cell imaging enables researchers to study dynamic cellular processes, behaviour and function in real time and over time, giving a more complete and realistic view of biological function.
 - [Seeing through the dark: high-content imaging of 3D cell models.](https://www.revvity.com/blog/seeing-through-dark-high-content-imaging-3d-cell-models): More and more researchers are turning to 3D cell models for high-content screening to better understand diseases and to test potential therapeutics.
 - [Adopting no-wash immunoassays for higher throughput.](https://www.revvity.com/blog/adopting-no-wash-immunoassays-higher-throughput): Accurate analysis of the presence and concentration of an analyte is a defining factor for research throughout biologics, clinical diagnostics, and pharmacology.
 - [Advances in high-content screening: navigating the data deluge.](https://www.revvity.com/blog/advances-high-content-screening-navigating-data-deluge): Image-based high-content screening (HCS) systems link cellular imaging with high-throughput analysis enabling the extraction of large amounts of quantitative data from biological systems.
 - [Strategies for highly efficient gene editing and modulation.](https://www.revvity.com/blog/strategies-highly-efficient-gene-editing-and-modulation): Genome editing, often referred to as genetic engineering or genetic modification, is the revolutionary process of altering specific regions of an organism’s nucleic acid molecules, such as DNA.
 - [Radiometric detection for precise and efficient molecular quantitation.](https://www.revvity.com/blog/radiometric-detection-precise-and-efficient-molecular-quantitation): Radiometric detection is a well-established and highly effective method for molecular quantitation, leveraging the unique capabilities of radioactivity to gain insights into various biological processes.
 - [10 reasons to automate your nucleic acid separation workflow.](https://www.revvity.com/blog/10-reasons-automate-your-nucleic-acid-separation-workflow): The process of isolating and purifying DNA or RNA molecules from a complex mixture, such as cells, tissues, or biological fluids is a crucial step in various aspects of biological research.
 - [6 factors for improving cell counting results.](https://www.revvity.com/blog/6-factors-improving-cell-counting-results): Major advances in biologics production, cell and gene therapy, and regenerative medicine have prompted the need for highly accurate cell characterization.
 - [Improving drug safety through cardiotoxicity assessment.](https://www.revvity.com/blog/improving-drug-safety-through-cardiotoxicity-assessment): The pharmaceutical industry is under huge pressure to address the high attrition rates in drug development. With around 90% of candidates failing during clinical development,1 the process is not only long and risky, but also expensive for those involved.
 - [Cancer-killing seaweed.](https://www.revvity.com/blog/cancer-killing-seaweed): Anyone who’s visited the ocean knows about seaweed, or do we? For instance, there are more than 9,000 species of seaweed in the world’s oceans. Even its name is deceiving, since seaweed is one of many forms of marine algae that play a vital role in the global food chain, beginning with water-based organisms right up to humans.
 - [Fluorescence imaging is comparable to PET in early detection of tumor metabolism.](https://www.revvity.com/blog/fluorescence-imaging-comparable-pet-early-detection-tumor-metabolism): In the pursuit of novel anti-cancer therapies, researchers need to effectively monitor the efficacy and therapeutic response to promising drug candidates in preclinical models.
 - [The top 7 attributes of cell line-derived reference standards for oncology assays.](https://www.revvity.com/blog/top-7-attributes-cell-line-derived-reference-standards-oncology-assays): Cell line-derived reference standards offer significant advantages over other types of controls used in oncology assays due to their ability to closely mimic the genetic complexity of patient samples.
 - [The future of cell and gene therapy: Revvity at ASGCT.](https://www.revvity.com/blog/future-cell-and-gene-therapy-revvity-asgct): As we prepare for the upcoming American Society for Gene and Cell Therapy (ASGCT) meeting, we had a brief conversation with two of Revvity’s experts, Dr. Michelle Fraser and Dr. Anis Khimani. Together, they discussed the dynamic landscape of cell and gene therapy and how Revvity’s pioneering technologies and services are catalyzing advancements in the field.
 - [Limitations associated with the lack of data analysis tools in metagenomics.](https://www.revvity.com/blog/limitations-associated-lack-data-analysis-tools-metagenomics): Explore the limitations in metagenomics data analysis due to the lack of metagenomic tools and their impact on research outcomes.
 - [Why use fluorescent probes in your in vivo imaging studies?](https://www.revvity.com/blog/why-use-fluorescent-probes-your-vivo-imaging-studies): In vivo fluorescence imaging is a non-invasive tool for visualizing and quantifying cellular and biological functions. Using biologically specific, validated fluorescent probes, scientists can visualize disease pathogenesis and related biological processes within the context of a living system.
 - [Overcoming the challenges of 3D immune cell-killing assays.](https://www.revvity.com/blog/overcoming-challenges-3d-immune-cell-killing-assays): Immunotherapy offers new hope for cancer patients by utilizing the body’s immune system to prevent, control, and eliminate cancer cells.
 - [Making organoids ready for screening.](https://www.revvity.com/blog/making-organoids-ready-screening): Organoids are an extremely valuable tool for in vitro disease modeling and hold great promise in cancer and stem cell research as well as drug discovery and screening.
 - [The future of precision medicine: integrating functional approaches for better outcomes.](https://www.revvity.com/blog/future-precision-medicine-integrating-functional-approaches-better-outcomes): Precision medicine is an approach that considers patients’ individual differences in genes, environment, and lifestyle to personalize medical treatments.
 - [Redefining precision medicine with real-time insights.](https://www.revvity.com/blog/redefining-precision-medicine-real-time-insights): Increasingly, we are realizing that every tumor is different, meaning that a one-size-fits-all approach to cancer treatment will be ineffective.
 - [Precision medicine boosted by functional drug testing using patient-derived model systems.](https://www.revvity.com/blog/precision-medicine-boosted-functional-drug-testing-using-patient-derived-model-systems): Advances in genomic sequencing and the massive expansion in treatment options over the past two decades are changing our approach to cancer treatment. Whereas older therapeutic strategies relied on non-cancer-specific mechanisms of action, molecular profiling has supported the rise of targeted therapies
 - [How to streamline your mAb hybridoma screening.](https://www.revvity.com/blog/how-streamline-your-mab-hybridoma-screening): In the years since hybridoma technology was invented, over 100 mAbs have entered the clinic and this class of drugs represents one of the fastest-growing areas of research and development.
 - [Novel therapeutic candidate puts the STING back into immunotherapy.](https://www.revvity.com/blog/novel-therapeutic-candidate-puts-sting-back-immunotherapy): The potential to harness an individual’s immune system to treat cancer has revolutionized the oncology field. Coined immunotherapy, this umbrella term describes several types of treatment, including immune checkpoint inhibitors, immune system modulators, and adoptive cell therapies.
 - [REVIEW: Bioluminescent-based <i>in vivo</i> imaging of glucose uptake.](https://www.revvity.com/blog/review-bioluminescent-based-vivo-imaging-glucose-uptake): Impaired glucose consumption is one of the principal markers for many disease conditions such as cancer, diabetes, obesity, and some neurologic disorders. Positron emission tomography (PET) is the most commonly used technique for imaging and quantifying glucose uptake.
 - [Imaging cell death to validate novel anti-cancer treatments.](https://www.revvity.com/blog/imaging-cell-death-validate-novel-anti-cancer-treatments): In recent years, a discernable shift has taken place in the development of cancer therapeutics, marked by a growing emphasis on innovative drug delivery strategies.
 - [Seven steps to designing an effective in vivo fluorescence imaging study.](https://www.revvity.com/blog/seven-steps-designing-effective-vivo-fluorescence-imaging-study): Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects.
 - [How ultrasound may predict tumor response to therapy earlier.](https://www.revvity.com/blog/how-ultrasound-may-predict-tumor-response-therapy-earlier): Monitoring how well a tumor responds to treatment is a critical part of clinical oncology. Response assessment can help diagnose recurrence, determine the efficacy of novel therapeutics in clinical trials, and guide personalized treatment approaches in clinical care.
 - [Expanding cardiovascular research: an innovative approach to evaluating pulmonary arterial hypertension.](https://www.revvity.com/blog/expanding-cardiovascular-research-innovative-approach-evaluating-pulmonary-arterial): We’ve all had our blood pressure taken; however, blood pressure measurement isn’t just related to your heart. There is more than one type of hypertension.
 - [Illuminating cancer research: what tumor burden alone can't tell you.](https://www.revvity.com/blog/illuminating-cancer-research-what-tumor-burden-alone-cant-tell-you): Cancer research has witnessed remarkable advancements in recent years, enabling scientists to understand many of the intricacies underlying this complex disease.
 - [Molecular imaging is helping to reduce post-surgical infections.](https://www.revvity.com/blog/molecular-imaging-helping-reduce-post-surgical-infections): Most of us know someone with an about orthopedic implant. News of hip, knee, and even elbow replacements are common. But these are just a few of the more than two dozen orthopedic implants now available to replace or support bones ravaged by time, injuries, trauma, or disease.
 - [Killing cancer with bacteria.](https://www.revvity.com/blog/killing-cancer-bacteria): When most of us encounter bacteria, we reach for a sanitizer. Researchers at the Cork Cancer Research Centre in Cork, Ireland, have a much different reaction.
 - [In vivo imaging study highlights potential for non-invasive evaluation of NASH.](https://www.revvity.com/blog/vivo-imaging-study-highlights-potential-non-invasive-evaluation-nash): Nonalcoholic steatohepatitis (NASH) is a chronic yet silent disease, and patients present with few or no symptoms at early stages. The condition affects around 12% of the US population and there are currently no treatments available for those affected.
 - [The important role <i>in vivo</i> bioluminescence imaging plays in COVID-19 research.](https://www.revvity.com/blog/important-role-vivo-bioluminescence-imaging-plays-covid-19-research): In February 2020, just before the World Health Organization (WHO) declared COVID-19 a global pandemic, WHO Director-General Dr Tedros Adhanom Ghebreyesus stated that bringing the outbreak under control would necessitate harnessing the power of science.
 - [Radioligand binding assays: from opiate receptors to drug discovery mainstay.](https://www.revvity.com/blog/radioligand-binding-assays-opiate-receptors-drug-discovery-mainstay): In the early 1970s, Professor Solomon Snyder and colleagues reported a technique that enabled the identification of opiate receptors in the brain.1 This was the first discovery of its kind, providing direct evidence for drug receptors as molecular entities.
 - [Optical imaging facilitates key neurological disease research.](https://www.revvity.com/blog/optical-imaging-facilitates-key-neurological-disease-research): As the global population is progressively becoming older, we are seeing an increase in the prevalence of neurological diseases. Many of these conditions disable patients long before they become fatal, meaning the burden of these diseases is likely to be huge in years to come.
 - [Radiolabeled α-Bungarotoxin sheds light on role of neuronal nicotinic acetylcholine receptors.](https://www.revvity.com/blog/radiolabeled-bungarotoxin-sheds-light-role-neuronal-nicotinic-acetylcholine-receptors): One protein family that has been implicated in various neurological conditions is the nicotinic acetylcholine receptor (nAChR) family. These pentameric ligand-gated ion channel proteins are widely expressed in the central and peripheral nervous systems and are activated by the binding of acetylcholine (ACh).
 - [How CRISPR can identify regulators of Alzheimer's-related protein tau?](https://www.revvity.com/blog/how-crispr-can-identify-regulators-alzheimers-related-protein-tau): Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central or peripheral nervous system. Millions of people are affected by these conditions across the globe, and with improved life expectancy in many parts of the world, it is likely that incidence will increase in the future.
 - [How to choose the right plate reader?](https://www.revvity.com/blog/how-choose-right-plate-reader): Laboratories rely on microplate readers to translate experimental observations into raw data in order to process and analyze results. Microplate readers detect signals within assays, turning the targeted biological, chemical or physical signal into an optical signal so researchers can quantify the target of interest.
 - [Genomic sequencing paves the way for better antiviral treatments.](https://www.revvity.com/blog/genomic-sequencing-paves-way-better-antiviral-treatments): Within a few weeks of the outbreak, scientists in Wuhan, China were able to isolate and sequence the new highly contagious viral genome in our current pandemic.
 - [Hey…walkaway on the automated side.](https://www.revvity.com/blog/heywalkaway-automated-side): The success of drug discovery labs lies in optimized workflows. Countless hours and valuable resources are often spent on physically preparing and loading plates into readers-that time could be spent analyzing data or researching a novel, potentially breakthrough target.
 - [Accelerating vaccine development for the novel infectious disease with pseudoviruses.](https://www.revvity.com/blog/accelerating-vaccine-development-novel-infectious-disease-pseudoviruses): Time is of the essence when it comes to the development of a vaccine for the novel infectious disease in our current pandemic. The world has changed due to its impact – and the race to discover a vaccine is crucial for our return to normalcy.
 - [How a SARS-CoV-2 infection can impact our reproductive health.](https://www.revvity.com/blog/how-sars-cov-2-infection-can-impact-our-reproductive-health): This article describes the short and long-term impact of SARS-CoV-2 infection on male reproductive health based on two studies carried out in Belgium.
 - [Bispecific antibodies: successes, challenges, and strategies.](https://www.revvity.com/blog/bispecific-antibodies-successes-challenges-and-strategies): Bispecific antibodies (BsAb) are promising biotherapeutics for an increasing range of diseases. There are currently seven BsAb approved by the U.S. Food and Drug Administration (FDA) and/or the European Medicines Agency (EMA) for a range of indications:
 - [Can tumors be reverse-engineered to produce a local-acting 'vaccine'?](https://www.revvity.com/blog/can-tumors-be-reverse-engineered-produce-local-acting-vaccine): Recent developments and novel strategies such as immunotherapies and targeted therapies have made significant advancements in cancer treatments. Long-term benefits have been demonstrated using these approaches, leading to multiple approvals from regulatory bodies.
 - [Could boosting autophagy with host-directed therapies help control TB infection?](https://www.revvity.com/blog/could-boosting-autophagy-host-directed-therapies-help-control-tb-infection): Tuberculosis (TB) is a potentially lethal bacterial infection that spreads in the air from one person to another. In 2022, the World Health Organization (WHO) reported that the number of people infected with Mycobacterium tuberculosis (Mtb), including drug-resistant strains, had risen globally for the first time in almost 20 years. The disease killed over 1.6 million people and 10.6 million people fell ill with TB worldwide.
 - [Researchers identify novel immunotherapeutic compound targeting key cancer pathway.](https://www.revvity.com/blog/researchers-identify-novel-immunotherapeutic-compound-targeting-key-cancer-pathway): Immunotherapy has revolutionized cancer treatment and proved to be pivotal in the field of oncological research. Among several immunotherapeutic approaches that have been pursued, inhibiting the PD-1 (programmed cell death protein-1)/PD-L1 pathway has gained increased attention in recent years and shown exciting clinical success in a range of human cancers.
 - [SARS-CoV-2 protease inhibitors: an attractive approach for treating COVID-19.](https://www.revvity.com/blog/sars-cov-2-protease-inhibitors-attractive-approach-treating-covid-19): The current SARS-CoV-2 pandemic has highlighted the substantial threat posed by pathogenic coronaviruses to humans. To date, over six million people have died from COVID-19 across the globe and more than 500 million cases have been reported.
 - [Managing the data deluge of high-content screening workflows.](https://www.revvity.com/blog/managing-data-deluge-high-content-screening-workflows): Integral to many research and testing facilities are the high-content screening (HCS) technologies that continue to evolve alongside imaging and analysis systems.
 - [Overcoming solid tumor treatment hurdles with mRNA-based CAR T-cells.](https://www.revvity.com/blog/overcoming-solid-tumor-treatment-hurdles-mrna-based-car-t-cells): Over the last decade, chimeric antigen receptor (CAR) T-cell therapies have attracted growing interest for their potential to treat a wide range of cancers.
 - [Morphological profiling: a scalable approach to monitor immune cell activity.](https://www.revvity.com/blog/morphological-profiling-scalable-approach-monitor-immune-cell-activity): Microscopy images of cells contain vast amounts of phenotypic information, making the phrase “a picture speaks a thousand words” highly relevant to the field of high-content imaging (HCI).
 - [The effects of climate change on farming and food.](https://www.revvity.com/blog/effects-climate-change-farming-and-food): One wouldn’t normally think about food endangerment, especially when faced with the abundance seen in grocery stores today
 - [The laboratory workforce is shrinking.](https://www.revvity.com/blog/laboratory-workforce-shrinking): The laboratory workforce is shrinking, making it more difficult to fill open positions.
 - [Improving reliability by reducing human errors.](https://www.revvity.com/blog/improving-reliability-reducing-human-errors): According to a study by Johns Hopkins, more than 250,000 people in the United States die every year because of medical mistakes, making it the third leading cause of death after heart disease and cancer.
 - [How the clinical reporting team is the new Sherlock Holmes in genetics.](https://www.revvity.com/blog/how-clinical-reporting-team-new-sherlock-holmes-genetics): Rare disease patients present as medical mysteries. Physicians listen to their stories, make clinical observations, and then often turn to genomic testing to find answers.
 - [Busting the top 9 myths about genetic testing.](https://www.revvity.com/blog/busting-top-9-myths-about-genetic-testing): Even though genetic tests are more available and affordable than ever, many patients and physicians still have misconceptions about them.
 - [Revvity Omics: expertise in drug development, from inception to market.](https://www.revvity.com/blog/revvity-omics-expertise-drug-development-inception-market): No one wants to miss an opportunity for success, particularly in drug development. When pharmaceutical companies reach out to Revvity Omics only at a later stage in their drug development, they miss out on the deep expertise Revvity Omics brings to the early-stages of drug creation and delivery.
 - [Precision medicine: beyond newborn screening.](https://www.revvity.com/blog/precision-medicine-beyond-newborn-screening): Revity, Inc. was established in May 2023 as a science-based company that leverages innovation in life sciences and diagnostics to improve lives globally. Revvity Omics is the company’s genomics services business.
 - [A delegate's reflections from the 75th World Health Assembly.](https://www.revvity.com/blog/delegates-reflections-75th-world-health-assembly): From May 22-28, 2022, more than 190 Ministers of Health, numerous elected officials and other policy makers and shapers convened in Geneva, Switzerland for the 75th World Health Assembly (WHA).
 - [Pomegranate peel extract shows promising antiviral effects against COVID-19.](https://www.revvity.com/blog/pomegranate-peel-extract-shows-promising-antiviral-effects-against-covid-19): Since the World Health Organization (WHO) declared the novel coronavirus (COVID-19) outbreak a global pandemic on March 11, 2020, researchers around the world have been working tirelessly to discover effective preventive treatments and therapeutic agents.
 - [An overview of RAS protein mutations in cancer and KRAS-targeted therapeutics.](https://www.revvity.com/blog/overview-ras-protein-mutations-cancer-and-kras-targeted-therapeutics): RAS proteins are present in all mammalian cells where they act as signal transducers for pathways regulating cell growth, proliferation, differentiation, and survival. More than 150 human RAS proteins have been identified to-date.
 - [Researchers develop novel assay for simultaneous measurement of bsAb target binding.](https://www.revvity.com/blog/researchers-develop-novel-assay-simultaneous-measurement-bsab-target-binding): Over the last three decades we’ve seen significant advances in the development and commercialization of therapeutic antibodies across numerous indications, including many cancers, as well as infectious, autoimmune, and metabolic diseases.
 - [Fast-tracking sample prep start: from months to days.](https://www.revvity.com/blog/fast-tracking-sample-prep-start-months-days): As next generation sequencing (NGS) laboratories evaluate new automated sample preparation solutions, focusing on vendors who have vendor-qualified automated library protocols can play a key role in meeting their objectives.